Exploring the Functional Role of SETD2/H3K36me3 during Cellular Differentiation by Ambrosi, Christina








Exploring the Functional Role of SETD2/H3K36me3 during Cellular
Differentiation
Ambrosi, Christina





Ambrosi, Christina. Exploring the Functional Role of SETD2/H3K36me3 during Cellular Differentiation.
2020, University of Zurich, Vetsuisse Faculty.
Dissertation
zur











Prof. Dr. Tuncay Baubec 
(Vorsitz und Leitung der Dissertation) 
Prof. Dr. Matthias Altmeyer
Dr. Johannes Zuber
Zürich, 2020  




Mathematisch-naturwissenschaftliche Fakultät der Universität Zürich 
Dissertation 
Exploring the Functional Role of SETD2/H3K36me3 during Cellular Differentiation
Autor
Christina Ambrosi





June 2020. All rights reserved. 
I. Summary
Dissertation by Christina Ambrosi 
I. Summary
Chromatin modifications on DNA and histones, are dynamic and reversible marks required for 
genome function and transcriptional regulation by altering genome organisation and accessibility. 
They are relevant for mammalian development and disturbed patterns are associated with human 
disease. The mechanisms that deposit and  regulate chromatin modifications have been largely 
elucidated. However, the current challenge remains to understand how these patterns precisely 
influence gene activity and other biological processes. 
In particular, the trimethylation of histone H3 at lysine 36 (H3K36me3) is suggested to play an 
important role in active gene transcription. This modification accumulates on the bodies of all 
highly-transcribed genes through a mechanism which is highly conserved from yeast to human. 
This post-translational histone modification is uniquely set by the RNA Polymerase II-interacting 
methyltransferase SETD2. Impaired action of this enzyme and the consequent loss of H3K36me3 
histone marks are increasingly reported to be key events in promoting cancer growth and 
malignancy. Thus, gaining insights into their role in mediating proper chromatin and cellular 
function could provide essential contributions to human health. Based on yeast studies, it has been 
found to be involved in regulating transcriptional elongation and mRNA processing. However, the 
function of SETD2/H3K36me3 in mammalian systems remains poorly understood. 
Towards understanding the function of SETD2-mediated H3K36me3 in mammalian cells, we 
generated murine embryonic stem cells  devoid of H3K36me3 as a system that enabled us to 
functionally address the influence of the enzyme and its mark on gene regulation. Comprehensive, 
genome-wide quantification of transcriptome and interactome differences by functional genomics 
methods allowed to identify a crucial role  for SETD2/H3K36me3 in establishing gene expression 
programs during neuronal differentiation. We could further identify a potential mechanistic link 
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1. Introduction
1.1.  Gene Regulation
Each cell within a multicellular organism has distinguishable properties. This specific cellular 
identity is determined by the expression of genes in a time and place-dependent manner and is 
passed onto daughter cells by sequence-dependent and -independent mechanisms. Thus, the 
governance of gene expression is a highly complex and tightly-regulated process that ensures cell 
identity at any given time.
1.1.1.     Chromatin
The central dogma of molecular biology defines the framework for the faithful information transfer 
between biopolymers, comprising DNA, RNA, and polypeptides, in living organisms. Their 
sequences encode biological information which can be copied, converted, and translated in an 
irreversible manner. Cellular replication is the process of copying the double-stranded DNA 
molecules during S phase of the cell cycle, assuring correct information transfer to daughter cells 
upon cell division. Transcription is the process of converting a specific sequence of DNA into RNA 
in the nucleus. Translation is the final process of decoding messenger RNA molecules into 
functional polypeptides and proteins in the cytoplasm of the cell. Further levels of regulation may 
occur through co- or post-transcriptional and -translational processes (Crick, 1970). 
The human body consists of over 200 different cell types which exhibit particular characteristics 
and functions whilst containing the same genetic material in the nucleus - the DNA. The smallest 
units of the latter are nucleotides which consist of three different chemical moieties: a backbone of 
a phosphate group and a five-membered deoxyribose sugar ring, completed with a specific 
nitrogen base. In DNA, there are four types of nitrogen bases: the pyrimidines cytosine (C) and 
thymine (T) as well as the purines adenine (A) and guanine (G). Their specific order determines all 
further information transfer and is thereby referred to as the genetic code. Specifically, a three-
nucleotide codon in a nucleic acid sequence specifies a single amino acid, the smallest unit of 
proteins. In its biological form, DNA forms a right-handed double-helix in which two antiparallel 
strands are coiled around each other via hydrogen bonds formed between a purine and pyrimidine 
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(base pairs A-T and G-C). This structure exhibits a minor and a major groove of which the latter is 
wider and more frequently subject of DNA binding proteins (Alberts, 2002). 
The human genome consists of roughly three billion base pairs which have to be assembled in the 
approximately 6 µm-wide diameter of the nucleus. This requires a high degree of compaction 
realised through a complex structure of DNA and proteins - the chromatin. The fundamental 
element of chromatin is constituted by the nucleosome, a core particle of 146 DNA base pairs 
wrapped around an octamer of basic histone proteins: two dimers of histones H2A and H2B as well 
as a tetramer of histones H3 and H4 (Kornberg and Thomas, 1974). Proteins which assist 
nucleosome assembly and folding into an oligomeric structure are called chaperones (Ellis, 2006). 
Histones are highly conserved, small proteins with a central fold domain consisting of three alpha-
helices separated by two loop regions, constituting a positively charged protein motif recognising 
specific DNA sequences (Arents et al., 1991; Luger et al., 1997). For instance, the negatively 
charged DNA double helix is bent in 1.65 tight turns around the histone octamer which requires 
extensive compression of the minor groove. AT-periodic sequences are easier to compress and 
therefore found more frequently in segments where the minor groove faces the octamer core, 
facilitating a sharper bending of the DNA around the nucleosome. In contrast, nucleosome linker 
regions show strong preference to sequences that resist DNA bending and do not aid nucleosome 
formation (Struhl and Segal, 2013).
The histones’ N-terminal tails are variable and rather unstructured, but generally rich in lysine and 
arginine residues - the sites of various post-translational modifications (PTMs) (Bannister and 
Kouzarides, 2011). In addition to sequence composition, these PTMs can change the overall 
charge of the histone core which facilitates alterations in DNA accessibility and protein-protein 
interactions with the nucleosome, thereby playing a key role in gene regulation (Lawrence et al., 
2016). The chapter 1.2.2. focuses in more detail on of post-translational modifications of histones 
and their regulatory role.
Several nucleosomes can form a nucleofilament by their regular spacing along the genome. This in 
turn can adopt series of more complex structures, such as 30 nm fibres, ultimately resulting in 
highly-condensed, coiled chromosomes. With the exception of the germ cells, each human cell 
contains a total of 46 chromosomes - two copies of each of the 22 homologous chromosomes, one 
set inherited from the mother and one from the father, plus two so-called sex chromosomes (X and 
Y in males, two Xs in females). Besides the lack of space in the nucleus, the different forms of 
compaction are also necessary to regulate gene expression as well as the replication of the DNA 
molecule during cell division. This latter is facilitated through an ordered series of stages, 
 13
1. Introduction
Dissertation by Christina Ambrosi 
collectively referred to as the cell cycle. Therein, the coiled chromosomes are highly condensed 
and subsequently separated for distribution to the two daughter cells during mitosis, the division of 
the nucleus of a eukaryotic cell. 
During interphase, the most frequent, metabolic cell cycle phase (including G1, S, and G2 phase), 
when the cell is not dividing, the DNA molecules are highly transcribed and replicated. For these 
processes, parts of the chromatin need to be accessible and uncoiled which is defined as 
euchromatin. On the contrary, heterochromatin does not alter its condensation throughout the cell 
cycle and is formed principally on the periphery of the nucleus (Rae and Franke, 1972; Passarge, 
1979). Thus, the dynamic structure of chromatin results in functional territories, permitting or 
restricting its accessibility and interaction with protein machineries, which ultimately influences all 
processes of gene regulation (Dixon et al., 2016). 
1.1.2.     Transcription Factors
In a given cell type, only a subset of genes are expressed in a highly-regulated fashion with many 
levels and stages of control. Transcription factors (TFs) can decode the genome by interpreting 
DNA sequences and exerting control over gene expression which determines cell identity (Lee and 
Young, 2013). Their regulatory domains and physiological roles are highly conserved among 
metazoans. However, over time many TFs have diverged with growing complexity and control 
different regulatory gene networks depending on the cell type (Bejerano et al., 2004). The number 
of TFs scales with genome size (van Nimwegen, 2003). Roughly 10 % of genes in the genome 
encode TFs, comprising the largest family of human proteins (Fulton et al., 2009; Vaquerizas et al., 
2009). 
TFs bind DNA with their DNA-binding domain (DBD) in a sequence-dependent manner by 
recognising specific motifs at cis-regulatory sites (promoters and enhancers) adjacent to the genes 
they regulate (Mitchell and Tjian, 1989; Ptashne and Gann, 1997). By binding to these regulatory 
sites, they initiate or restrict transcription by impacting the chromatin state through attraction or 
repulsion of other factors. Further, the binding of several, distinct TFs (homotypic clusters) is often 
required for a cooperative action in gene regulation (Jolma et al., 2015).
The recognition of similar motifs due to similarity in their tertiary structure typically corresponds to 
specific TF families or subfamilies, like C2H2 zinc finger (ZF) or Helix-loop-helix factors (bHLH), 
which are differentially expressed among different cell types (Matys et al., 2006). On the contrary, 
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general transcription factors (GTFs, e.g. TFIIA, TFIID) are ubiquitously expressed, bind to the 
region surrounding the transcriptional start site of a gene, referred to as core promoter, and 
facilitate the formation of a preinitiation complex (PIC) upon transcriptional activation.
1.1.3.     Eukaryotic Transcription
Eukaryotic transcription is the process of converting a specific sequence of DNA into RNA in the 
nucleus and proceeds in three steps: initiation, elongation, and termination (Figure 1). 
1.1.3.1.    Transcriptional Initiation
For a gene to be transcribed, the chromatin environment needs to be opened up for recruitment 
and action of the transcriptional machinery. Major TFs have the ability to bind nucleosomal DNA at 
regulatory sites throughout the genome and initiate conformational changes or even displace 
nucleosomes directly or indirectly through the recruitment of chromatin remodelling factors (Frietze 
and Farnham, 2011).(Shandilya and Roberts, 2012)
Transcriptional initiation at protein-coding genes takes place at the core promoter. One well-studied 
element of the latter is a short consensus sequence, the TATA box, usually located 25 base pairs 
upstream of the transcriptional start site (TSS) at the 5’ end of a gene. The TATA box is the site of 
the preinitiation complex formation. A generalised view of PIC assembly consists of the TATA-
binding protein (TBP), which is a subunit of the general transcription factor II D (TFIID), binding to 
the 5’TATA(A/T)A(A/T)-3’sequence. This process then causes the recruitment of several more 
general transcription factors like TFIIA, TFIIB, TFIIE, TFIIF, and TFIIH (Alberts 2002). In the next 
step, the assembled PIC provides the DNA-directed RNA polymerase II (Pol II), a multi-protein 
(RBPs) complex which catalyses the synthesis of messenger RNA (mRNA) from protein-coding 
DNA (Young, 1991). 
Besides the PIC assembly, other factors such as activators and repressors modulate the 
transcription initiation rate by influencing recruitment, assembly, and accessibility. For instance, the 
initial binding of TBP to the promoter can be assisted by the SAGA complex which inhibits TPB 
from promiscuous binding to DNA (Papai et al., 2020). The latter is changed to a more open 
confirmation through recruitment of the histone acetyltransferases CBP/p300 and the SWI/SNF 
complex providing space for Pol II to bind by removal of histone PTMs and nucleosome 
remodelling, respectively (Vo and Goodman, 2001; Clapier et al., 2017). Further, the impact of TF 
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binding varies depending on the local context and presence of other accessory proteins (Reiter et 
al., 2017). 
Mediators of TF effector activity constitute large multi-subunit protein complexes which contain 
domains for chromatin binding and remodelling to facilitate bridging of TFs directly to Pol II. The 
mediator complex is recruited by many TFs bound to cis-regulatory elements and thus, associates 
with a great amount of active genomic loci. The interactions between TFs, mediator, and the PIC 
lead to large-scale structural changes, i.e. the formation of enhancer-promoter DNA loops (Allen 
and Taatjes, 2015). The mediator complex also interacts with the super elongation complex (SEC) 
influencing the next step of transcription, the elongation of Pol II in the 5’ to 3’ direction of the gene.
1.1.3.2.    Transcriptional Elongation
Following the formation of the pre-initiation complex, transcriptional elongation begins with 
promoter escape of Pol II. The carboxy-terminal domain (CTD) of RBP1, a subunit of Pol II, is 
phosphorylated on serine residues at position 5 and 7 (Ser5-P, Ser7-P). These phosphorylation 
marks are deposited by the TFIIH-associated cyclin-dependent kinase CDK7 and cause the 
disruption of Pol II’s interaction with the mediator complex (Wong et al., 2014). The CTD generally 
plays an important role throughout the gene expression cycle as an interactive hub for 
transcriptional regulation and localisation of chromatin as well as mRNA processing factors 
(Heidemann et al., 2013). It contains 52 tandem repeats of a YSPTSPS amino acid sequence 
(Meinhart and Cramer, 2004; Phatnani and Greenleaf, 2006). The serine residues of these repeats 
are unphosphorylated during initiation, ensuring interactions with the Mediator complex (Wong et 
al., 2014; Tsai et al., 2017). 
Messenger RNA synthesis starts until Pol II pauses within a region of 25 - 35 nucleotides 
downstream from the TSS. In this paused state, Pol II stays stably associated with the DNA and is 
only capable of resuming when further signals elicit the progression into productive elongation 
(Nechaev et al., 2010; Kwak et al., 2013). Promoter-proximal pausing is present on the majority of 
actively transcribed and developmentally regulated genes in metazoans. It serves as a checkpoint 
for timed gene activation to readily switch from long-lived pausing to undergoing productive 
elongation, in addition to aiding the establishment of permissive downstream chromatin. It adds an 
additional regulatory step in the transcription cycle that allows activators or repressors of 
transcription to exert combinatorial control of transcription levels (Adelman and Lis, 2012). Pausing 
is established through TFIID and a complex formed by the negative elongation factor NELF (NELF-
A, NELF-B, NELF-C/NELF-D, and NELF-E) and DSIIF (DRB Sensitivity Inducing Factor) that 
remain bound to Pol II until its release (Wu et al., 2003; Vos et al., 2016; Fant et al., 2020).
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Phosphorylation of the CTD residue serine at position 2 (Ser2-P) by CDK9, part of the positive 
transcription elongation factor b (P-TEFb), is essential to overcome the inhibitory effect of NELF. 
The paused Pol II is therefore released into productive transcription combined with gradual loss of 
Ser5-P (Peterlin and Price, 2006). Here, the activity towards serine 2 residue is only effective after 
phosphorylation of serine 7 by CDK7. Hence, successful transcriptional initiation is necessary for 
priming elongation (Czudnochowski et al., 2012). Towards the 3’ end of the gene, 
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Figure 1 - The Process of Transcription.
Eukaryotic transcription is the process of 
converting a specific sequence of DNA into RNA 
in the nucleus. The main steps are (A) initiation, 
(B) pause release, (C) successful elongation, 
and (D) transcriptional termination. Adapted from 
Shandilya and Roberts, 2012.
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hyperphosphorylation on serine 2 is mediated by CDK12 (Peterlin and Price, 2006; Bartkowiak et 
al., 2010). 
Correspondingly, chromatin-modifying and RNA processing complexes which are attracted by 
Ser2-P of the CTD enrich around two kilo bases downstream of the TSS to facilitate successful Pol 
II elongation and co-transcriptional processes (more detail in chapter 1.1.4. and 1.3.2.) (Bartkowiak 
and Greenleaf, 2011; Jonkers et al., 2014). The elongation factor P-TEFb interacts with the 
Mediator complex and necessary cofactors (Peterlin and Price, 2006). It is mostly associated with 
the larger super elongation complex (SEC) which comprises various factors that promote P-TEFb 
binding and support RNA synthesis (Luo et al., 2012). P-TEFb also phosphorylates Spt5 as a 
critical step for pause release that leads to dissociation of NELF which further enhances the rate of 
elongation (Yamada et al., 2006; Cheng and Price, 2007).
To catalyse mRNA synthesis, Pol II carries out most of the necessary function intrinsically, omitting 
accessory factors. It contains several subunits such as helicases for unwinding DNA and DNA 
binding proteins for the sliding movement over the gene. Together, these accessory subunits make 
elongation rates incredibly constant and precise; allowing for acceleration while transcribing 
through genes and slowing down at exons (Bushnell and Kornberg, 2003; Gnatt et al., 2001; 
Jonkers et al., 2014). Pol II incorporates nucleotides to the newly synthesised RNA chain by a 
Brownian-Ratchet mechanism facilitating a forward and backward movement along the DNA 
template (Bar-Nahum et al., 2005; Martinez-Rucobo and Cramer, 2013).
Successful elongation also requires constant nucleosome (dis-)assembly. Each nucleosome which 
is encountered by Pol II functions as an inherent barrier due to the compact wrapping of DNA 
around the nucleosome core. First, to overcome these boundaries, torsional stress of the 
elongating Pol II creates supercoils that destabilise consecutive nucleosomes (Teves et al., 2014). 
Second, a number of specialised elongation factors have evolved to modulate chromatin structure, 
such as polymerase-associated factor 1 (PAF1), SPT6 and Facilitates Chromatin Transcription 
(FACT) (Orphanides et al., 1998; Squazzo et al., 2002; Ardehali et al., 2009). The latter functions to 
destabilise the nucleosome core by removing a single H2A/H2B dimer ahead of Pol II and re-
depositing it after Pol II passaging. The transcribing Pol II uses one single DNA strand to direct the 
next nucleotide to be added to the 3’ end of the growing mRNA. This occurs in a transcription 
bubble of about 25 exposed DNA basepairs (Cramer, 2004). Eight nucleotides of newly-
synthesised RNA remain paired to the template DNA, whereas the rest of the RNA releases the 
template allowing the unwound DNA behind Pol II to be again compacted by FACT.
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During elongation, Pol II transcribes from the 5’ to the 3’ end of the DNA template, resulting in the 
nascent RNA from the exit channel. Pol II is also able to backtrack one nucleotide in the reverse 
direction by extrusion of the transcript through the nucleotide entry channel (Nudler, 2012; 
Sheridan et al., 2019). This backward movement is stimulated by TFIIS and facilitates elongation 
as well as proofreading (error rate roughly 10-5) of the newly introduced nucleotide during 
elongation (Blank et al., 1986; Sheridan et al., 2019). Pol II exhibits an intrinsic endonuclease 
activity cleaving the misincorporated nucleotide and allowing transcription to resume correctly 
(Sigurdsson et al., 2010).
1.1.3.3.    Transcriptional Termination
Transcriptional termination at protein-coding genes results in the dissociation of the nascent 
transcript when the elongating Pol II passes the 3’ end of a gene. Pol II terminates transcription 
randomly with no specific location to stop and the newly-synthesised mRNA (pre-mRNA) is cleaved 
at its terminator sequence before transcription by Pol II ends (Porrua et al., 2016). The pre-mRNA’s 
cleavage site is found after an upstream AAUAAA sequence and before a GU-rich downstream 
part. If transcribed, these sequences are bound by cleavage-polyadenylation specificity factors 
(CPSFs) in a complex with WDR33 and FIP1 and by the cleavage stimulatory factor (CSTF), 
respectively (Nojima et al., 2015; Clerici et al., 2018). Additionally, the phosphorylation state of the 
CTD is of high importance for transcriptional termination: serine-2 is hyperphosphorylated (Ser2-P) 
towards the 3’ end and interacts with this cleavage complex, slowing down transcription (Hirose 
and Manley, 1998; Heidemann et al., 2013; Zhang et al., 2015a). The pre-mRNA is disengaged 
approximately 20 bp downstream of the AAUAAA polyadenylation site (PAS) and directly subjected 
to the polyadenylation machinery, catalysing the complementation of a poly(A)-tail to 3’ end of the 
mRNA (see chapter 1.1.5. for more detail) (Dreyfus and Regnier, 2002; Stewart, 2019). 
It is generally acknowledged that Pol II continues transcribing past the GU-rich site of the DNA 
template. The biochemical details of the termination reaction after Pol II passes the PAS remain 
less understood; however, there are two models accepted as to how the termination process 
occurs: the torpedo and the allosteric model (Rosonina et al., 2006). The latter suggests that Pol II 
senses its passage through a PAS which induces a conformational change and its graduate 
dissociation from the DNA template prior cleavage of the nascent transcript (Osheim et al., 1999; 
Zhang et al., 2015a). Thus, termination is not completed by cleavage of the pre-mRNA, but is 
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In contrast, the torpedo model includes the requirement of cleavage of the nascent RNA. The 
remaining upstream part of the pre-mRNA is digested one nucleotide at a time by the 5’-3’ 
exoribonuclease 2 (XRN2). XRN2 cleans up the residual RNA in kinetic competition (“torpedo”) 
with the continuing Pol II. When reaching the latter, XRN2 is suggested to either push Pol II off the 
DNA by passing it or pulling the DNA out of the Pol II channel, both leading to transcriptional 
termination (Luo and Bentley, 2004; Luo et al., 2006).
1.1.4.     Co-transcriptional Regulation
Eukaryotic pre-mRNAs are subject to extensive processing while being transcribed in the nucleus. 
RNA processing reactions are required to generate translatable, stable mRNAs, which are 
exported through the nuclear pore to sites of cytoplasmic translation (Bentley, 2014). Any mRNA 
that is not properly processed is degraded immediately after transcription (for detail see chapter 
1.1.5.2.). It is critical to ensure this quality of the transcriptome which ultimately results in the 
proteome. In order to achieve such precise processing, many factors are recruited to the site of 
transcription by the CTD of the elongating Pol II and withdrawn in a time- and place-dependent 
manner, constituting a dynamic interaction network that governs the quality of mRNAs (McCracken 
et al., 1997; Ahn et al., 2004). 
1.1.4.1.    5’ Capping and 3’ polyadenylation
Most eukaryotic genes exhibit a short RNA tract before and a longer one downstream of the coding 
region, the 5’ and 3’ untranslated region (UTRs), respectively. The 5’ UTR starts with a 7-
methylguanosine (m7G) cap, whereas the 3’ UTR end exhibits a polyadenylated tail (Figure 2A and 
2C). Both additions protect the mRNA from degradation and facilitate its export to the cytoplasm 
( Alberts, 2002). Additionally, these moieties serve as a recognition site for subsequent translational 
initiation and termination (see chapter 1.1.5.3.). 
The 5’ cap is introduced to the nascent mRNA as the DNA is still transcribed by the elongating Pol 
II. The terminal phosphate group at the 5’ end is removed by the RNA triphosphatase, resulting in a 
bisphophate group (Wen et al., 1998). The mRNA guanylyltransferase utilises a GTP to form a 5’-5’ 
triphosphate linkage to add guanine to the mRNA which is in turn methylated at position 7 by the 
mRNA guanine-N7-methyltransferase (Shatkin, 1976; Pillutla et al., 1998). 
While Pol II is still transcribing downstream of the actual end of a gene, the pre-mRNA is cleaved 
between the AAUAAA polyadenylation consensus sequence (PAS) and a GU-rich sequence. The 
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functional pre-mRNA is released from Pol II and its 3’ end subjected to the process of 
polyadenylation. The mRNA 3’ processing is facilitated by a multi-protein polyadenylation complex 
which is attracted by the phosphorylated CTD of Pol II (Ser2-P) and signals transcriptional 
termination (Zhang et al., 2015a). This complex contains amongst others the cleavage/
polyadenylation specificity factor (CPSF) that catalyses the cleavage by recognising the PAS on 
the mRNA (Lutz, 2008). Specificity is increased through the cleavage stimulation factor (CstF) 
binding to the GU-rich site further downstream. The polyadenylate polymerase binds to CPSF and 
immediately adds about 250 adenosine monophosphates (poly(A)-tail) to the exposed 3’ end of the 
mRNA (Bienroth et al., 1993; Balbo and Bohm, 2007). The polyadenylation complex is also tightly 
associated with the spliceosome, a machinery that removes non-coding sequences from a pre-
mRNA.
1.1.4.2.     Splicing
The protein-coding DNA sequence is based on exons of a gene, which are separated through 
intervening intron sequences. These non-protein coding parts are precisely removed from the pre-
mRNA and exons are rejoined in frame by a process called splicing, which results in correctly 
coding transcripts (Figure 2B) (Alberts, 2002). The responsible protein complex is the spliceosome 
which comprises subunits of small nuclear ribonucleoproteins (snRNPs), which are proteins 
coupled to the small nuclear RNAs (snRNAs, U1, U2, U4, U5, and U6), and additional complex 
members such as helicases (Wahl et al., 2009). 
Another requirement for successful splicing is the interaction of the spliceosome with pre-mRNA. 
The introns of the latter contain signal sequences which include a 5’ splice site (starts with GU), a 
branch point sequence with a highly conserved adenosine residue, and a 3’ splice site (ends with 
AG). The excision of one intron is coordinated in two trans-esterification reactions on each 5’ and 3’ 
end. The spliceosome assembles on the pre-mRNA by interaction of U1 snRNA with the 5’ splice 
site, whereas the U2 snRNA binds to the branch point. This exposes the hydroxyl (-OH) group of 
the conserved adenosine residue as a nucleophile to attack the phosphodiester bond at the 5’ 
splice site. The remaining snRNPs assist the rearrangements and sequential release of the 5’ 
exon. Due to a conformational change in the snRNA U2 the interaction with the branching point is 
disrupted and U5 is able to interact with both the 5’ and 3’ splice site, bringing the terminal -OH 
group of the 5’ exon in close proximity to the last nucleotide of the 3’ splice site. Following a trans-
esterification reaction at this site, the 3’ exon is connected to the 5’ exon, releasing the excised 
intron in a lariat form (Wahl et al., 2009; Chan et al., 2018). 
 21
1. Introduction
Dissertation by Christina Ambrosi 
All eukaryotes express mRNAs that are monocistronic. Once transcribed and processed, the 
mRNA can only be translated into one single protein. The process of alternative splicing adds a 
layer of multiplicity to this rule. Generally, the splicing occurs on every new arising splice site in a 
constitutive and orderly fashion during transcription. However, one pre-mRNA can give rise to 
several mature mRNAs for translation (isoforms) due to the use of alternative splice sites. This is 
facilitated by the exclusion of exons referred to as exon skipping, by alternative splice site usage 
which extends or shortens exons. Additionally, this process works through intron retention which 
includes an intron sequence in the mature transcript (Lee and Rio, 2015). Alternative splicing 
results ultimately in protein variants containing or lacking certain domains and thus, pursuing 
different functions in a tissue- and cell type-specific manner (Chen and Manley, 2009).
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Figure 2 - Co-transcriptional Processing.
Eukaryotic pre-mRNAs are subject to extensive 
processing while being transcribed in the 
nucleus. RNA processing reactions are required 
to generate translatable, stable mRNAs, which 
are exported through the nuclear pore to sites of 
cytoplasmic translation. (A) 5’ capping, (B) 3’ 
polyadenylation, and (C) splicing. Adapted from 
Bentley, 2014.
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The pattern of alternative splicing further depends on cis-acting cues on the pre-mRNA, such as 
N6-methyladenosine, and on the context-dependent level and activity of regulatory splicing 
activators and repressors, like the heterogeneous nuclear ribonucleoproteins (hnRNPs) (Krecic 
and Swanson, 1999; Xiao et al., 2016; Zhou et al., 2019). Besides, components of the spliceosome 
are recruited and instructed by the phosphorylated CTD of the elongating Pol II (Phatnani and 
Greenleaf, 2006). The latter can interfere with the splice site interaction through its elongation rate. 
For instance, slower elongation leaves more time for the spliceosome assembly at weaker splicing 
sites, thereby excluding the adjacent (intron) sequence in the final transcript. Additionally, related 
chromatin structure and modifications influence splice site recognition and splicing machinery 
assembly, such as the histone modification H3K36me3 in gene bodies (see chapter 1.3.2.) or 
general nucleosome positioning during transcription (Moore and Proudfoot, 2009; Luco and Misteli, 
2011).
There are also downstream consequences of alternative splicing, changing the abundance of 
mature mRNAs. For instance, sequence alterations can determine the efficiency of mRNA export 
from the nucleus or can alter the mRNA stability by constituting longer/shorter 3’ UTRs or 
containing pre-mature stop codons (see chapter 1.1.5.) (Moore and Proudfoot, 2009; Di 
Giammartino et al., 2011). Thus, splicing has a critical influence on the information transfer from 
transcription to translation and ultimately on the cell identity.
1.1.4.3.    N6-methyladenosine (m6A)
Messenger RNAs also undergo dynamic and reversible chemical modifications to control gene 
expression. The most abundant modification on mRNAs is N6-methyladenosine (m6A) which is 
widely conserved among eukaryotic species and is considered to heavily influence mRNA life 
cycles (Roundtree et al., 2017; Zhao et al., 2017). It is observed in long exons, but mostly 
accumulates at the 3’ end of the transcript (stop codon, 3’ UTR) at the sequence motif DRACH (D 
= A, G, or U; R = G or A; H = A, C or U) (Dominissini et al., 2012). 
m6A is set co-transcriptionally by a multicomponent methyltransferase complex containing the core 
enzymes Methyltransferase Like 3 and 14 (METTL3, METTL14). METTL3 exhibits the catalytic 
function to transfer a methyl group from the donor substrate S-adenosyl methionine (SAM) to the 
adenine nucleobases, whereas METTL14 lacks enzymatic activity, but stabilises the complex 
through structural support and binds to the RNA (Sledz and Jinek, 2016). Both methyltransferases 
associate with Wilms Tumor 1 Associated Protein (WTAP) which serves for RNA binding specificity 
and methylation efficiency (Ping et al., 2014). However, transcript specificity and choice of motif 
site for m6A remain only poorly understood. 
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Studies have shown that the m6A writer complex can be recruited to the mRNA in several ways: 
specific transcription factors at promoters or histone modifications, RNA-binding proteins as well as 
slowly elongating Pol II have been proposed to facilitate m6A (Slobodin et al., 2017). For instance, 
TGFβ signalling promotes methylation on a subset of mRNA in pluripotent cells (Bertero et al., 
2018). Since m6A is enriched near stop codons, it is also likely that structural components on the 
mRNA, such as terminal exon-exon junctions constitute key features for its enrichment (Batista et 
al., 2014). Co-transcriptional enrichment for m6A also hints to an interaction with active Pol II and 
other chromatin features for transcriptional elongation. It was shown that METTL3 is directly 
recruited to Pol II and interference with Pol II speed correlates with m6A levels on the mRNA 
(Slobodin et al., 2017). Alternatively, exons show higher nucleosome density than introns and 
therefore enrich for active histone modifications, such as histone 3 trimethylation on lysine 36 
(H3K36me3) (Kolasinska-Zwierz et al., 2009; Tilgner et al., 2009). Thus, enrichment for m6A on 
longer exons or towards the 3’ end of the gene correlates with the accumulation of H3K36me3 on 
actively transcribed genes (see chapter 1.3.2.) (Dominissini et al., 2012; Huang et al., 2019). 
However, since there is no known domain of METTL3 or 14 for binding to H3K36me3 and loss of 
this mark only accounts for 40 % decrease of m6A, the specific mechanisms for transcript and site 
specificity required for m6A deposition are not completely elucidated, yet.
It is better understood which impacts m6A can have on mRNA properties and sequential 
processes. It directly effects the mRNA transcript through changing the charge, secondary 
structures, and interactions with proteins, which in turn shape transcript regulation by modulating 
mRNA processing, export, translation and decay (Roundtree et al., 2017; Zhao et al., 2017). YTH 
domain-containing proteins bind m6A and depending on their localisation play a role in these 
processes. For instance, YTH Domain Containing 1 (YTHDC1) supports exon inclusion in a small 
number of genes by recruiting or blocking different splicing factors (Xiao et al., 2016). Upon export 
to the cytoplasm, m6A is read by cytosolic readers like YTH domain-containing family protein 2 
(YTHDF2 or DF2) which co-localises with both deadenylation and decapping enzyme complexes, 
promoting degradation of the destabilised mRNA (Wang et al., 2014; Du et al., 2016). In contrast, 
DF1 (YTHDF1) binds m6A and the eukaryotic translation initiation factor eIF3, a multi-protein 
complex that recruits the small ribosome subunit to mRNAs to promote their translation (Wang et 
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1.1.4.4.     Regulation of Transcriptional Noise
Variability on gene expression between cell types in an isogenic population is referred to as 
transcriptional noise. It originates from fluctuations in the concentration, state, and location of 
shared molecular players in key processes such as mRNA expression or protein binding in a single 
cell at a given time. These fluctuations are caused in different ways and their degree varies 
between different genes and organisms (Balazsi et al., 2011). Gene expression noise is of 
stochastic nature and is distinguished in two types: extrinsic and intrinsic (Elowitz et al., 2002). 
Extrinsic noise occurs gene-independently, carrying the potential to affect all genes in a similar 
manner. It originates from environmental perturbations in the surroundings of an individual cell, 
ultimately leading to local changes in the cellular concentrations of factors shared among genes 
like Pol II (Cao and Grima, 2020). Extrinsic features also include physical properties like cell size 
and growth rate. For instance, during mitosis cell contents separate unequally that can impact the 
availability of all molecular players and downstream processes (Huh and Paulsson, 2011).
In contrast, intrinsic noise is dependent on gene-to-gene variations from each cell to another. Thus, 
one gene can differ in its expression between two ore more cells due to fluctuation in the stochastic 
binding and diffusion of intracellular molecules. For instance, the activity of cis-regulatory elements 
(promoter, enhancers) depends on the presence and binding of TFs to these sites which is in turn 
based on the differential expression and stability of their mRNAs, resulting from a cascade of 
(co-)transcriptional processes including chromatin cues (Thattai and van Oudenaarden, 2001; 
Hebenstreit, 2013; Fujita et al., 2016). 
Transcriptional bursting has been shown to be a major phenomenon that influences noise levels. It 
reflects fluctuations of promoters in their “on” or “off” state in irregular intervals leading to 
differential transcription rates at these genes. The frequency, length and strength of these bursts in 
a given period of time dictates the amount of mRNAs transcribed from the gene that can differ from 
cell to cell in a population (Kumar et al., 2015). Gene promoters which exhibit low nucleosome 
occupancy downstream of the TSS also show low transcriptional noise indicating that chromatin 
states and remodelling have a large influence on gene expression initiation (Cairns, 2009). 
Generally, transcription is a highly controlled process for which chromatin needs to be arranged in 
order to facilitate passaging of Pol II on nucleosome-depleted DNA. Chromatin accessibility is 
amongst others altered by the acetylation state of histone tails (see chapter 1.2.2.). Increasing 
acetylation levels downstream of the promoter results in open chromatin and correlates positively 
with bursting frequency (Struhl, 2007; Nicolas et al., 2018). 
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Each cycle of transcription, chromatin in gene bodies is opened and packaged again for successful 
Pol II elongation. This compaction is tightly controlled to prevent transcriptional initiation from sites 
other than the canonical 5’ start of the gene which is referred to as spurious transcription or cryptic 
initiation. The latter can contribute to gene expression noise (Kaplan et al., 2003; Weinberger et al., 
2012). Examples for these pervasive, non-coding transcripts are mRNAs from orphan promoters, 
lying within a gene, mobile repetitive elements (transposons) as well as antisense transcripts, since 
cryptic transcription may be bi-directional interfering with sense transcription (Jensen et al., 2013). 
Some of these RNAs may be functional, but mostly their uncontrolled transcription needs to be 
contained to avoid the disruption of cellular events like the production of the corresponding, 
canonical full-length transcript (Jacquier, 2009). Thus, there are lots of factors involved in the 
control of transcriptional directionality and chromatin accessibility at coding sequences. For 
instance, the SAGA complex with its histone acetyltransferase (HAT) and a histone deubiquitinase 
module is known to stimulate correct transcription initiation by guiding TBP to the promoter DNA. 
This in turn provides the correct directionality and choice of 5’ start site for PIC assembly and 
transcription (Papai et al., 2020). 
Further, the histone deacetylase Rpd3S recognises H3K36me3 in gene bodies and deacetylates 
these histones within transcribed regions after Pol II passage, thereby erasing the transcriptional 
memory and reestablishing the chromatin to a hypoacetylated state that is repressive for spurious 
transcription (see details chapter 1.3.2.) (Carrozza et al., 2005). The same holds true for SPT6 and 
FACT - histone chaperones which evict and reassemble nucleosomes in the wake of transcription 
in conjunction with other remodelling complexes to prevent spurious transcription (Kaplan et al., 
2003; Mason and Struhl, 2003). Overall, these different parameters in and around the process of 
transcription ultimately determine the levels of mRNA for each gene in a cell and thus the amount 
of noise within a population.
1.1.4.5.     Co-transcriptional DNA Repair
The integrity of the genome and the accuracy of transcription as well replication are prerequisites 
for cell survival. However, the cell frequently encounters DNA lesions from both environmental and 
endogenous sources that can cause DNA to undergo various modifications, including single or 
double strand breaks, base damage, helix distortions or inter-strand crosslinking. Therefore, the 
DNA damage response (DDR) has emerged as a checkpoint system that arrests the ongoing cell 
cycle through checkpoint kinases (CHK1/2) and as a cellular network to inspect the genome and 
repair these DNA lesions. Given the differences in these aberrant DNA structures, the DDR 
comprises several specialised pathways which influence cellular processes like transcription or 
replication to ensure genome stability (Jackson and Bartek, 2009). 
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Genes that are actively transcribed are endogenous DNA-damage hotspots, but they are also 
sensed and repaired in very fast manner (Ljungman and Lane, 2004; Fousteri and Mullenders, 
2008). A specific pathway evolved in which single-strand lesions that block Pol II elongation are 
resolved - the well conserved, transcription-coupled nucleotide excision repair (TC-NER) 
(Brueckner and Cramer, 2007; Hanawalt and Spivak, 2008). The TC-NER is a sub-pathway of the 
ubiquitous process of nucleotide excision repair (NER) which removes lesions from the template 
DNA strands throughout the genome. Generally, this pathway senses bulky single-strand breaks 
which alter the DNA helical structure, e.g. lesions triggered by ultraviolet (UV) light, and disrupt 
DNA base pairing. Therein, the damaged nucleotide is first recognised, followed by the removal of 
a single-stranded segment around the lesion by an exonuclease. The missing DNA strand is 
resynthesised by a DNA polymerase using the sequence of the complementary strand as a repair 
template (Scharer, 2013). Further, transcription, replication and recombination are error-prone 
processes: wrong incorporation of nucleotides or incorrect base pairing govern the need for 
proofreading. General errors such as mismatches, insertions or deletions are corrected by the 
mismatch repair pathway choice, using a mechanism similar to the NER (Li, 2008). 
Of all different classes of DNA damage, double-strand breaks (DSBs) are the most malignant. If left 
unrepaired, they can trigger cell death and, if misrepaired, they can cause deletions or 
chromosomal translocations; early incidences in carcinogenesis (Jackson and Bartek, 2009; 
Surova and Zhivotovsky, 2013). DSBs can be directly induced by ionising radiation, but they also 
arise indirectly, e.g. from two closely located single-strand breaks or during the repair of other 
lesions. For instance, during S phase of the cell cycle, replication forks can collapse, when 
encountering single-strand breaks, base damage, or the repair machinery at a lesion (Hanawalt 
and Spivak, 2008). Slowing or stalling of replication is referred to as replication stress which can 
ultimately lead to fork collapse and in turn to more DNA damage (Zeman and Cimprich, 2014).
DSBs are resolved by sensors, signal transducers, and effectors. The MRE11–RAD50–NBS1 
(MRN) complex senses DSBs and triggers the ATR and ataxia telangiectasia-mutated (ATM) 
kinases, key transducers for the phosphorylation of the histone variant H2.AX (serine 139 residue, 
γH2AX) (Falck et al., 2005). The spreading of γH2AX around the damage amplifies the recruitment 
of additional DDR factors like the mediator of DNA damage checkpoint protein 1 (MDC1), the p53-
binding protein (53BP1) or BRCA1 which determine the subsequent steps for repair (Cortez et al., 
1999; Stucki et al., 2005; Fradet-Turcotte et al., 2013). For instance, 53BP1 is antagonised by 
BRCA1 and removed from the DSB site to favour one of the two DSB repair downstream 
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pathways: homologous recombination (HR) over non-homologous end joining (NHEJ) (Escribano-
Diaz et al., 2013; Hustedt and Durocher, 2016). 
NHEJ aligns the broken DNA ends back together and is independent of all cell cycle phases 
(Chang et al., 2017). In detail, DNA break ends are stabilised and prevented from resection by a 
DNA-dependent protein (DP) kinase holoenzyme which further attracts the DNA ligase IV (LIG4), 
X-ray repair cross-complementing protein 4 (XRCC4) and the XRCC4-like factor (XLF) (Graham et 
al., 2016). They are key effectors of NHEJ by aligning and ligating DSB ends to resolve the DNA 
break in a rapid, but error-prone fashion (Jackson and Bartek, 2009). In contrast, during S/G2 
phase the cell commits to homologous recombination for its repair pathway of choice due to the 
presence of a template sister chromatid (Krejci et al., 2012). After initiation of DNA end resection by 
MRE11 with its endo- and exonuclease activity, a 3’-tailed, single-stranded DNA (ssDNA) is 
exposed. This ssDNA is bound by RPA for protection from DNA degradation and from the formation 
of secondary structures (Jackson and Bartek, 2009). RAD51 and RAD52 outcompete RPA with the 
help of BRCA1- and BRCA2 to form a presynaptic filament on the DNA (Sleeth et al., 2007). The 
latter searches for a homologous sequence to invade for the presynaptic complex to rectify the 
lesion in an error-free manner (Wright et al., 2018).
DNA replication during S phase is initiated at numerous origins, whereas transcription takes place 
throughout the cell cycle. Thus, these two processes need to be facilitated in a coordinated manner 
to avoid replication stress (Wei et al., 1998; Hamperl and Cimprich, 2016). Although there are 
mechanisms in place to minimise spatiotemporal collision of the two processes, the interference of 
the transcriptional machinery with the replisome can occur in a direct and indirect fashion. Besides 
the actual physical collision of the two, their productive processing on the DNA can also be 
impaired through structural constraints of the DNA. Both processes require unwinding of the DNA, 
introducing torsional stress when the complex are in close proximity which can impede with their 
progression. Unresolved replication fork stalling ultimately leads to fork collapsing and the 
accumulation of replication stress-derived DNA damage (Zeman and Cimprich, 2014). 
Recently, we showed that replication fork speed and origin firing can be further impaired by 
deregulation of the pre-mRNA cleavage machinery during transcriptional termination in mammalian 
cells. In particular, a multi-screening approach identified the pre-mRNA cleavage factor WDR33 to 
confer replication stress resilience through successful mRNA cleavage and release of Pol II at the 
TTS. Depletion of WDR33 thus resulted in increased replication stress and in the gating of nascent 
mRNAs together with their genomic origin to the nuclear periphery, undermining genome stability 
(see chapter 8.2. for details) (Teloni et al., 2019).
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Chromatin cues are also important for successful DDR. Generally, gene expression regulation of 
signalling and repair factors, i.e. modulating their levels, can indirectly influence DDR pathways. In 
contrast, chromatin modifications and environment can also directly attract or repulse DNA repair 
proteins (D'Alessandro and d'Adda di Fagagna, 2017). For instance, chromatin-scaffold proteins 
are recruited to sites with DNA lesions, facilitating the formation of permissive chromatin for repair 
directly or indirectly through interaction with chromatin modifiers (Altmeyer et al., 2013; Wang et 
al., 2013). Additionally, DNA damage arising during active transcription is generally resolved 
quickly due to the presence of active chromatin marks such as H3K36me3 or acetylation for 
recruitment of specific DDR factors, fine-tuning the choice of DDR pathway (see chapter 1.1.4.5.) 
(Daugaard et al., 2012; Gong et al., 2015; Huang et al., 2018).
 
1.1.5.     Post-transcriptional processes
In order to ensure that functional proteins are produced, gene transcripts are regulated at many 
different stages during and in between transcription and translation, the latter being the synthesis 
of proteins from mRNA. 
1.1.5.1.     Nuclear mRNA Transport
Translation takes place in the cytoplasm. Thus, all processed mRNAs have to be exported from the 
nucleus. This transport is facilitated by the highly conserved transcription-export complex (TREX) 
(Strasser et al., 2002) which contains the THO complex (THOC1, 2, 3, 5, 6 and 7) and additional 
factors such as RNA helicases ALY and UAP56. It binds to the 5’ region of the mRNA and recruits 
the export receptor NXF1:NXT1 heterodimer. This factor then locates to the nuclear pore complex 
(NPC) and promotes binding of TREX to the RNA. The latter changes its conformation which is 
required its active passage through the pore (Viphakone et al., 2019). NPCs are macromolecular 
assemblies that span the nuclear envelope and serve as barriers to the passive diffusion of 
molecules larger than 40 kDa. Thus, there is a need for cargo-carrier complexes to overcome this 
barrier in an energy-dependent manner. When reaching the cytoplasm, the transport system 
disassembles and is imported back to the nucleus (Stewart, 2019).
1.1.5.2.     mRNA Degradation
mRNAs can be incorrect or exhibit improper function either because of mutations within their genes 
or because of errors made during transcription or co-transcriptional processing. It is particularly 
crucial to eliminate impaired mRNAs, since the resulting proteins can be non- or dysfunctional 
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having acquired dominant-negative or gain-of-function activity. Furthermore, controlling mRNA 
levels is a general cellular process to regulate the abundance of proteins and thereby the 
processes these proteins engage in. Thus, there are many quality control mechanisms in place to 
conduct mRNA surveillance at every stage of RNA biogenesis (Garneau et al., 2007).
As discussed in chapter 1.1.4., mRNAs are co-transcriptionally processed to increase their stability 
and enhance their translation. In particular, the 5’ 7-methylguanosine cap and the 3’ poly(A) tail are 
two integral stability determinants. Upon export to the cytoplasm, these structures interact with 
translation initiation complex elF4E and PABP, respectively, in order to protect the mature transcript 
from exonucleases. For mRNA degradation, either one of the two determinants need to be 
compromised; e.g. through decapping or the mRNA being internally cleaved (Garneau et al., 
2007). Further, m6A methylation is known to regulate the stability of mRNAs. In the cytoplasm, the 
m6A-binding factor YTHDF2 co-localises with both deadenylation and decapping enzymes leading 
to a destabilisation and degradation of the mRNA (Du et al., 2016). 
There are three different mRNA degradation pathways: Nonsense-mediated decay (NMD), no-go 
decay (NGD), and non-stop decay (NSD) (Garneau et al., 2007). NMD detects and degrades 
mRNAs with a premature stop codon which can originate from mutations and frame shifts by 
nucleotide deletions or insertions in the underlying gene. It is also activated by other features such 
as an unusually long 3ʹ UTR (Amrani et al., 2004). NMD is evolutionarily conserved and considered 
to be the most important RNA decay pathway since it acts before the energy-consuming translation 
of a corrupt mRNA is initiated. NMD is dependent on the activity of the RNA-dependent helicase 
and ATPase UPF1. The latter promotes the decay steps of NMD by translocating along single-
stranded RNA in an ATP-dependent manner and facilitates the completion of mRNA degradation 
by unwinding the structured mRNA and abolishing the interaction of messenger ribonucleoproteins. 
Its activity is further stimulated by other NMD factors like UPF2 and UPF3X (Kurosaki et al., 2019). 
In contrast, NGD and NSD act during translation of the mRNA at the ribosome. NGD recognises 
incorrect mRNAs through detection of stalled ribosomes, e.g. due to the presence of stable 
intramolecular or intermolecular mRNA secondary structures, truncations, or chemically damaged 
sequences. NGD endonucleolytically cleaves the mRNA near the stall site which is degraded by 
the exosome in a 3’ to 5’ fashion and by XRN1 in a 5’ to 3’ fashion (Doma and Parker, 2006). NSD 
is able to detect mRNAs with a premature poly(A) tail or without a natural stop codon, generated by 
breakage or by the absence of an in-frame stop codon. This causes translation to proceed along 
the poly(A) tail and forces the ribosome to stay associated to the mRNA. Therefore, NSD also 
facilitates the release mechanism of the ribosome and degradation of the utilised mRNA upon 
 30
1. Introduction
Dissertation by Christina Ambrosi 
normal translational termination (van Hoof et al., 2002). This mRNA decay is facilitated by the SKI 
complex which load a 3’ to 5’ exonuclease on nonstop mRNAs, and by the specialised ribosome 
rescue complex DOM34/HBS1 that binds to the 60S ribosomal subunit and triggers the ribosome 
quality control (RQC) pathway (Brandman et al., 2012).
1.1.5.3.     mRNA Translation
After export from the nucleus, correct mRNAs are subjected to translation into functional proteins 
at the ribosome. Translation is a highly controlled process, as the rate and efficiency of translation 
is coupled to the metabolic and proliferative state of a cell (Malys and McCarthy, 2011). All mRNAs 
are translated in the 5’ to 3’ direction into a polypeptide chain from the amino to the carboxy 
terminus. Starting from the start codon (AUG), every triplet of bases codes for one amino acid in 
the polypeptide chain (genetic code) (Alberts, 2002).
After dissociation from the transcriptional machinery, mRNAs have been extensively modified (see 
chapter 1.1.4.). The 3’ poly(A) tail in particular is bound by the poly(A)-binding protein (PABP) 
which promotes mRNA stability and export to the cytoplasm. There, PABP also binds the 
translation initiation factor elF4G. The latter is part of the elF4F (elF3, elF4A, elF4G, elF4E) 
complex of which elF4E associates with the 5’ cap of the mRNA. This locks the transcript in a loop 
structure necessary for translation to commence at the ribosome. The ribosome consists of two 
subunits, the 40S and 60S, which come together upon translation. For initiation, the small subunit 
is locked to the 5’ end through association with by elF3, promoted amongst others by the 
modification of m6A on the mature transcript (Wells et al., 1998; Wang et al., 2015). 
Translation requires the interaction of three different kinds of RNAs: mRNA, transfer RNA (tRNA) 
and ribosomal RNA (rRNA) as well as various adaptor proteins. Upon binding of the ribosome to 
the mRNA, the 43S preinitiation complex examines the mRNA to identify the start codon AUG 
which codes the starting amino acid methionine. tRNAs are non-coding RNAs which deliver amino 
acids to the ribosome. They are charged with an amino acid that is covalently bonded by 
aminoacyl tRNA synthetases. For specificity, they also exhibit an anticodon site which is 
complementary to the mRNA codon. Translation elongation starts when the methionine-charged 
initiator tRNA associates with the ribosome by elF2, leading to structural changes and the 
assembly of both subunits to the complete ribosome (Sonenberg and Hinnebusch, 2009). 
During elongation of the nascent polypeptide chain, amino acid are added in three steps: first, each 
new tRNA is positioned to the A site of the ribosome. Second, the correct amino acid is covalently 
bound to the chain and third, the mRNA shifts by one codon towards the 3’ end. Translational 
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elongation is an energy-consuming process and is facilitated by elongation factors such as eEF2 
which travel with the ribosome and utilise ATP (Schuller and Green, 2018). Further, elF4A of the 
elF4F complex is an ATP-dependent helicase that aids the ribosome by resolving mRNA 
secondary structures that could interfere with the translation process (Hellen and Sarnow, 2001).
Correct assignment of amino acids to the nascent peptide chain is crucial. Even though the 
ribosomes are usually considered accurate, it is subject to errors that can lead either to the 
synthesis of erroneous proteins or to the premature abandonment of translation. There are 
mechanisms in place which co-translationally sense aberrant peptide chain sequences. For 
instance, peptides, which are truncated due to immature STOP codons on a wrong mRNA 
template, are ubiquitinated and immediately degraded by the proteasome. This is usually signalled 
by a stalled ribosome to the NGD pathway which releases and degrades the defect mRNA from the 
ribosome (Joazeiro, 2019). The ribosomal subunits are disassembled and rescued in a process 
mediated by the DOM34/HBS1 complex. The complex association with the 60S subunit is 
subsequently recognised by the RQC pathway, leading to the rapid degradation of the immature 
peptide chain (Brandman et al., 2012).
The termination reaction of the translational process is dependent on the release factor eRF1 
which induces the disassembly of the ribosome-mRNA units upon recognition of one of the STOP 
codons (UAG, UAA, UGA). Upon hydrolysis from the ribosome, the nascent polypeptide chain 
spontaneously adapts a well-defined three-dimensional structure, its biologically functional protein 
conformation, mainly guided by hydrophobic amino acid interactions as well as proteins called 
chaperones (Alberts, 2002). 
Proteins also undergo post-translational modifications (PTMs) which diversify the limited pool of 20 
amino acids exponentially. PTMs are pivotal for the regulation of protein stability, distribution in the 
compartments of the cell and their interaction as well as function. Sites on the protein that carry 
PTMs are often nucleophilic such as the hydroxyl groups found on serine, threonine, and tyrosine, 
or the amine groups of lysine, arginine and histidine. PTMs can additionally occur on the or N- or 
C-terminus of proteins themselves. Examples for PTMs are phosphorylation, methylation, 
acetylation or ADP-ribosylation which are catalysed by a large family of enzymes specific to each 
modification. They are also in many cases readily reversible due to the presence of deconjugating 
enzymes; allowing quick changes in interactions and function (Millar et al., 2019). Especially 
histone proteins are heavily post-translationally modified which influences chromatin structure and 
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1.1.6.     Regulating Gene Expression in a Cell Developmental Context
All cells contain the same full complement of DNA, but each cell type only accesses portions of the 
genome in a spatiotemporal fashion to express a gene program that results in a specific proteome 
which is relevant for the cell’s lineage commitment and function. During development, cells 
undergo differentiation from a multi-potent precursor state to a specialised, mature cells in order to 
function in a network amongst other cell types, ultimately leading to the formation of independent 
tissues and functional organs. This is considered a tightly controlled, irreversible process, 
regulated by driving transcription and growth factors which guide the activation and repression of 
various genes. Thus, cell fate specification results from a framework of lineage-specific signalling 
cues (Goldberg et al., 2007). 
Conrad Waddington first described this concept of an epigenetic landscape for the process of 
cellular decision-taking during development. Using a metaphor, the cell was represented as a ball 
that encounters hills and valleys while rolling down towards its specific final fate. For reaching the 
latter, the cell commits to permitted and directed trajectories when entering a specific valley, 
prohibiting the option to go back up the hill of a less differentiated state (Waddington, 1957).
There are three basic categories of cells that make up an adult organism: germ cells, somatic cells, 
and stem cells. Germ cells originate in the primitive streak to the developing gonads. They undergo 
meiosis and produce mature, haploid gametes (eggs or sperm) for reproduction. Somatic cells only 
divide by mitosis, are diploid and give rise to any other specialised cell of the body than a germ or 
stem cell. Stem cells display an undifferentiated cell that carries the potential to differentiate into 
one identical and one more specialised cell (asymmetric division) or can divide for self-renewal into 
two identical daughter cells (symmetric division). Stem cells generally remain undifferentiated due 
to environmental cues in a particular niche; hence, they differentiate only if they leave their niche 
and receive differential intrinsic and extrinsic signals. 
There are two types of stem cells: adult stem cells are found in most tissues in an adult, 
multicellular organisms, acting as a repair system for the body by maintaining the normal turnover 
of regenerative organs, such as blood, skin, or intestinal tissues. They are considered multipotent 
as they only give rise to a limited number of cell types. In contrast, embryonic stem cells (ES cells) 
arise from the inner cell mass of a blastocyst, the pre-implantation embryo (Thomson et al., 1998). 
They are pluripotent and generate the primitive ectoderm, which ultimately differentiates during 
gastrulation into all derivatives of the three germ layer: endoderm, mesoderm, and ectoderm, 
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producing multipotent progenitor cells that then give rise to all specialised cells in the adult tissues. 
For instance, the ectoderm forms amongst others the epidermis and the nervous system, the 
mesoderm constitutes the hematopoietic system as well as cardiac and skeletal muscular tissue, 
and the endoderm forms the internal lining of organ tissues (Alberts, 2002).
ES cells also display an established model system in research. They can be maintained indefinite 
under specialised culture conditions, are amendable to many changes, and easily manipulated to 
investigate mechanisms during pluripotency and upon differentiation to mimic developmental 
processes. There are two distinct states of pluripotency regulated by different factors and pathways 
in a murine in vitro system: 2i- and serum-cultured mES cells represent a naive or primed 
pluripotent state, respectively (Marks et al., 2012). The conventional ES cells are prone to 
differentiate - also referred to as being in a metastable pluripotent state - which is shown amongst 
others in the upregulation of genes which are already specific for lineage differentiation. As they 
are exposed to signals for both differentiation and self-renewal through serum and leukemia-
inhibitory factor (LIF)-containing ES cell medium, these cells more closely represent the day E6.5 
of murine embryogenesis. The earlier state of pluripotency (E4.5) can be received by 
reprogramming the conventional mES cells under 2i conditions using of two small-molecule kinase 
inhibitors (PD0325901, CHIR99021) (Ying et al., 2008; Ficz et al., 2013). They do not only block 
the differentiation process via the MAP kinase pathway targeting MEK, but also enhance self-
renewal of mES cells by inhibiting glycogen synthase kinase-3 and activating WNT signalling. 2i-
mES cells are postulated to represent the ground state of pluripotency. They are more 
homogeneous in morphology, exhibit a redistribution of trimethylation of histone H3 on lysine 27 
(H3K27me3) and genome-wide DNA methylation is nearly absent, mimicking reduced lineage 
priming. On the contrary, the latter alterations are already established in the conventional mES 
cells, reflecting a more primed state when cultured in serum+LIF medium (Marks et al., 2012). 
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1.2.  Chromatin Modifications
In response to cell-intrinsic and cell-extrinsic signals, precise control of gene expression is critical 
for maintaining cellular identity. The dynamic regulation of gene expression in eukaryotes depends 
on a complex cooperation between transcription factors, RNA Polymerase II and coregulators that 
amongst others modulate the chromatin landscape. Chromatin remodelling facilitates specific gene 
expression pattern which is established by changes in chromatin marks such as DNA methylation 
(5mC) and post-translational modifications of histones (PTMs) (Mikkelsen et al., 2007). Covalent 
modifications of cytosines and of histone tails constitute molecular marks which are written, read, 
and erased to distinguish between active and inactive chromatin. This influence on gene 
expression programs can be direct through altering chromatin accessibility or indirect by 
downstream effects dependent on the binding and activity of reader-domain carrying proteins. 
1.2.1.    DNA Methylation
Each cell within a multicellular organism has distinguishable properties established by its unique 
gene program. This specific cellular identity is determined by the expression of genes in a time- 
and place-dependent manner and is passed onto daughter cells by DNA sequence-dependent and 
-independent mechanisms. Heritable processes, which do not alter the DNA sequence itself, are 
termed “epigenetic” (Bird, 2007). 
Methylation of cytosine bases is one of the best mechanistically understood epigenetic modification 
and plays various roles in genome regulation. Three conserved enzymes, DNA methyltransferase 
1 (DNMT1), DNMT3A, and DNMT3B, are responsible for the deposition of methylated cytosine 
bases in mammals (Smith and Meissner, 2013). Therein, DNMT1 is considered the maintenance 
enzyme which restores the fully methylated state of the DNA after replication, whereas the DNA 
methyltransferases 3A and 3B catalyse de novo DNA methylation. All three enzymes are essential 
for normal development (Okano et al., 1999). Individual deletions of Dnmt1 and 3b as well as the 
combined knock-out of Dnmt3a and 3b induce embryonic lethality in mice (Lei et al., 1996). 
1.2.1.1.    Functions of DNA methylation
DNA methylation is the most common chemical modification of cytosines, is accurately propagated 
during cell division and associated with long-term repression of transcription (Holliday and Pugh, 
1975). In mammals, DNA methylation occurs at the majority of CpG dinucleotides throughout the 
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entire genome, except for those in regions of CpG-dense, but unmethylated DNA, referred to as 
CpG islands (Zemach et al., 2010). The latter are associated with promoters of actively transcribed 
genes. Methylation of such CpG islands leads to stable heritable transcriptional silencing (Weber et 
al., 2005). Further, DNA methylation is involved in the repression of entire chromosomes during 
development (mammalian X inactivation) (Mohandas et al., 1981), is required for the silencing of 
transposable elements (De La Fuente et al., 2006), and the regulation of genomic imprinting 
(Rainier and Feinberg, 1994). It has also been associated to processes involved in ageing and 
tumorigenesis (Egger et al., 2004; Jones et al., 2015). 
Given the dynamic distribution and effects of this epigenetic mark, it has been well studied in many 
different mammalian cell lines and tissues at various stages of development. To gain a detailed 
overview as to how recent observations have helped to understand the context-dependent roles of 
DNA methylation, we put together a review publication which can be found in chapter 7.1. (Ambrosi 
et al., 2017). 
We further described a ChIP-based method to investigate the binding preferences of mammalian 
DNMTs, using prior biotin-tagging of the latter. Therein, the ease of biotin-avidin interactions 
circumvents limitations arising from low-specificity, commercially available antibodies and ensures 
reproducible results in a high-throughput fashion (see chapter 7.2. for more details on this book 
chapter) (Manzo et al., 2018).
1.2.1.2.    Genic DNA methylation
Unlike its role at promoters, DNA methylation of gene bodies is compatible with active transcription 
of the underlying gene and even scales with transcriptional activity. In mES cells, it is preferentially 
established by the de novo-methyltransferase DNMT3B (Baubec et al., 2015). In spite of the 
biological relevance of this enzyme and genic DNA methylation for development, it is not fully 
understood to what extent they cause further transcriptional regulation. 
A precondition to address these questions is comparing the distribution of cytosine methylation 
throughout the genomes of a variety of species. Given the hyper-mutability of methylated cytosines 
to thymine, methylated CpGs are unexpectedly enriched within gene bodies (Bird, 1980). 
Conservation, but also differences between epigenomes within and between eukaryotic groups 
raises the question whether there is a common underlying mechanism at work, or whether the 
gene body DNA methylation has evolved for distinct biological roles in different organismal groups 
(Suzuki and Bird, 2008; Zemach et al., 2010). 
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One suggested function, which retains the concept that DNA methylation is a transcriptional 
repressor, could be the reduction of transcriptional noise (Suzuki and Bird, 2008). It has already 
been observed that intragenic DNA methylation is negatively correlated to transcriptional 
interference owing to spurious initiation within an active transcription unit (Huh et al., 2013). This 
idea can be extended by the fact that DNA methylation was primarily a mechanism for silencing of 
repetitive DNA elements, such as retroviruses or transposable elements. Thus, genic DNA 
methylation can block the initiation of transcription at these elements allowing at the same time 
error-free transcription of the host gene. 
In general, complex transcriptional initiation at sites other than the 5’ end is a common 
phenomenon in Drosophila and humans and has to be strongly regulated (Suzuki and Bird, 2008). 
For instance, cryptic transcription has to be prevented from “orphan promoters“. These promoters 
might have been used at early stages of development, but escaped their repression by DNA 
methylation in the germline having maintained their high CpG density (Illingworth et al., 2010). It 
has also been indicated that DNMT3B-mediated de novo DNA methylation in gene bodies prevents 
a random entry of Pol II and subsequent spurious initiation of transcription in mES cells (Neri et al., 
2017). However, the observed loss of intragenic methylation was not complete (max. 10-20 % 
reduction), while complete removal of methylation as observed in Dnmt-triple-KO cells or mES 
cells grown in 2i did not lead to increased cryptic transcription (Teissandier and Bourc'his, 2017).
Another co-transcriptional mechanism which might be influenced by gene body DNA methylation is 
splicing (see chapter 1.1.4.2.). It has been indicated that exons are often more highly methylated 
than introns, and transitions in the level of DNA methylation often occur at exon-intron boundaries 
(Maunakea et al., 2010; Shukla et al., 2011). Pol II has been shown to accumulate preferentially at 
spliced exons, leading to the hypothesis that DNA methylation dynamics can lead to the reduction 
of Pol II elongation rates which facilitates splice site recognition and spliceosome assembly 
(Jonkers et al., 2014). However, numerous questions are left unanswered about the direct role of 
genic DNA methylation in transcription and splicing.
1.2.2.     Post-Translational Modifications of Histones (PTMs)
Proteins can be chemically modified after translation, e.g. with the addition of methyl, phosphate, 
acetyl or ubiquitin groups. The presence or absence of these marks regulate the protein activity, 
stability, and localisation. For instance, phosphorylation can result in either activation or 
deactivation of a factor in a signalling cascade, addition of ubiquitin can flag proteins for their 
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degradation by the proteasome, or most commonly the addition of methyl groups can result in 
protein-protein interactions that serve transcriptional regulation, stress response, or nuclear 
transport.
Particularly, covalent post-translational modifications (PTMs) of the core histones aid such diverse 
DNA-related processes influencing transcriptional activity, chromatin packaging and DNA damage 
response. PTMs are universal regulatory components among eukaryotes from yeast to human and 
act by directly determining the level of DNA compaction and indirectly by influencing the 
recruitment of regulatory effector proteins such as transcription factors, chromatin‐modifying 
enzymes (chaperones) and effector proteins. Such actions result in diverse consequences for gene 
expression (Li, 2002).
Histones are most often modified on their N-terminal ‘tail’ region which is exposed and therefore 
easily accessible (Figure 3) (Luger et al., 1997). As well as the tails, other histone regions can also 
be modified such as the outside-facing region of the octamer, referred to as the lateral surface. 
This external globular histone domains can be extensively modified and have direct contact with 
the DNA, resulting in an important role in all DNA-based processes. However, these globular 
modifications are less studied, but not focus of this thesis work. They can be further reviewed in 
(Lawrence et al., 2016).
The histone tails are 40 amino acid long protein domains which are rich in basic amino acids, such 
as lysines and arginines (Figure 3). Given the vast number of different histone tail marks, the 
combinatorial possibilities are extensive which greatly multiplies the information content encoded 
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Figure 3 - Sites of important post-translational modifications on the histone tail.
PTMs found on the tails of the core histones H2A, H2B, H3, and H4 include Me - methylation, Ac - acetylation, 
P - phosphorylation, and Ub - ubiquitination. From cusabio.com
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by the molecule. The levels of histone modifications are accurately balanced throughout the 
genome with distinct distributions and roles in the transcriptional state. Histone modifications are 
established through a dynamic cooperative action between histone PTM writers, erasers, and 
effector proteins called readers which bind depending on the neighbouring amino-acid sequence 
and the individual modification state. They can further be recruited by sequence‐specific, DNA‐
binding transcription factors. Additionally, the act of transcription as well as general features such 
as the DNA CpG content and DNA methylation status can direct their recruitment (Li, 2002; 
Jambhekar et al., 2019). 
Eukaryotic gene expression is greatly facilitated through the synergistic collaboration of 
transcription factors and the transcriptional machinery, chaperones and the presence of specific 
chromatin modifications. For instance, active enhancers are marked by the presence of H3K27 
acetylation, active promoters are marked by H3K4 trimethylation, and active gene bodies are 
enriched with trimethylation on histone H3 Lysine 36. In contrast, PTMs coinciding with repressed 
genes encompass a broad domains of trimethylation of lysine 27, trimethylation of H3 lysine 9, and 
lysine 119 ubiquitination on Histone 2A (Jambhekar et al., 2019).
 
Of all the histone marks, histone lysine methylation is highly important and has been extensively 
studied. It is established by SET (Su(var)3-9, Enhancer of Zeste, Trithorax) domain-containing 
methyltransferases which bind and utilise the cofactor S-Adenosyl methionine (SAM) to add a 
methyl group (-CH3) to lysine residue in an anabolic, nucleophilic reaction. This process converts 
SAM to S-Adenosyl homocysteine (SAH), which in several steps is regenerated back into SAM, 
referred to as SAM-e cycle (Trievel et al., 2002). The SET domain is evolutionarily highly 
conserved, carrying a 130-amino acid sequence motif representing the catalytic core. Its activity is 
further dependent on an adjacent pre-SET, cysteine-rich region which preserves the structure 
necessary for the catalytic reaction (Wood and Shilatifard, 2004). Methyltransferases often carry 
additional functional domains such as transcriptional activation/repression domains and domains 
for protein-protein or protein-DNA/RNA interaction to act in protein complexes and to mediate 
transcriptional output (Figure 4A) (Rea et al., 2000; Jambhekar et al., 2019).
Histone lysine methylation entails the addition of one, two or three methyl groups, adds 
hydrophobicity to the molecule, while only mildly changing the chromatin structure. Thus, its output 
is mainly facilitated by reader proteins which specifically recognise the methylation status with their 
chromo, PHD, PWWP, tudor, ADD, or ankyrin repeat domain (Figure 4B) (Hyun et al., 2017). The 
biological significance is also dependent on the combinatorial readout of multiple histone 
modifications, such as H3K4me3-H3K27me3 marked nucleosomes (bivalent promoters, see 
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1.2.3.1.) or the occurrence of phosphorylation on an arginine or threonine in close proximity to the 
methylated lysine (Fischle et al., 2005; Musselman et al., 2012). Therein, PTMs can cooperatively, 
antagonistically, or independently alter the local readout for transcription and chromatin compaction 
(Zhang et al., 2015b). 
In order to study the biological readout of these reader domains, we have established ChromID, an 
experimental tool for analysing protein composition of specific chromatin environments (see 
chapter 8.1. for details). We used protein domains as interchangeable building blocks referred to 
as engineered chromatin readers (eCRs), binding to trimethylation of H3K4, H3K9 and H3K27 or 
DNA methylation to study their subnuclear localisation and genomic binding preferences in mES 
cells. In addition, we fused eCRs to a biotin ligase to unravel the protein network at bivalent 
promoters (see chapter 1.2.3.1. and 8.1.) (Villasenor et al., 2020).
1.2.3.1.     Establishing Chromatin Environments
There are three main types of chromatin environments in the genome: active euchromatin, 
facultative and constitutive heterochromatin. A crucial function of these different chromatin states is 




Figure 4 - Histone modification readout.
(A) Combinatorial readout of PTMs is facilitated through the influence by adjacent PTMs on the same or adjacent 
histone tail and through the action of multiple reader domains within the same protein or within subunits of an effector 
complex. (B) Recognition of histone PTMs found on the histone 3 N-terminal tail by different indicated reader domains 
(me - methylated, ac - acetylated lysine, ph - phosphorylated serine/threonine residues). WD - tryptophan-aspartic 
acid; PHD - plant homeodomain; ADD - ATRX, DNMT3, DNMT3L; BD - bromodomain; CD - chromodomain; PWWP - 
prolin-tryptophan-tryptophan-prolin. Adapted from Musselmann et al., 2012.
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instability. Each of these chromatin states is associated with a distinct set of chromatin 
modifications which orchestrate DNA-based biological tasks (Kouzarides, 2007). Euchromatin 
represents the largest proportion of the genome (92 %) (International Human Genome 
Sequencing, 2004). It is kept accessible for the regulation of gene transcription, for repair, 
replication or chromosome condensation and when actively transcribed, it exhibits a high degree of 
H3/H4 acetylation as well as H3K4, H3K36, and H3K79 trimethylation (Barski et al., 2007). 
H3K4me3 is a hallmark for active euchromatin (Santos-Rosa et al., 2002). In mammals, six SET-
domain containing methyltransferases (KMT2F/SETD1A, KMT2G/SETD1B, KMT2A/MLL1, 
KMT2B/MLL2, KMT2C/MLL3, KMT2D/MLL4) are responsible for this mark (Figure 5). Each one of 
them represents a catalytic subunit of large protein complexes by associating with four common 
core subunits: DPY30, WD repeat domain 5 (WDR5), retinoblastoma-binding protein 5 (RbBP5), 
and absent, small or homeotic-2 like (ASH2L). These writer complexes also contain accessory 
subunits that establish a distinct genomic binding behaviour (Hyun et al., 2017). The enzymatic 
redundancy is useful for targeting specific activities in a context-dependent fashion, such as 
methylation at an enhancer versus promoter regions, and for the selective establishment of the 
different methylation levels (me1, me2, me3) (Husmann and Gozani, 2019).
Generally, H3K4me3 levels coincide with CpG islands, the latter being associated with 50-70 % of 
promoters and appointing H3K4me3 as a mark for active transcription start sites (Santos-Rosa et 
al., 2002; Deaton and Bird, 2011). This is further supported by the association of SETD1 with the 
PAF complex and the initiating Pol II at promoters (Ng et al., 2003). H3K4me3-methyltransferases 
are also recruited by specific transcription factors or transcriptional coactivators engaging in the 
stimulation of gene expression (Zhang et al., 2015b). In contrast, H3K36me3 is located in gene 
bodies of actively transcribed genes due to its non-redundant writer SETD2, which associates with 
the Ser2-P elongating form of Pol II (Wagner and Carpenter, 2012). This particular histone 
modification is further elaborated in Chapter 1.3.
Besides H3K4me3, various H3/H4 acetylation marks coincide with cis-regulatory elements and 
transcriptional start sites of active genes. Histone acetylation is further spread throughout the body 
of actively transcribed genes and is heavily involved in transcriptional regulation and facilitation of 
co-transcriptional processes (Eberharter and Becker, 2002). There are many effector proteins 
which contain bromodomain to read acetylated lysine residues (Figure 4B) (Fujisawa and 
Filippakopoulos, 2017). H4 histone tail acetylation also directly effects DNA compaction by 
reducing the positive charge of histones. This abolishes electrostatic interactions with DNA, 
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resulting in a decreased chromatin compaction and increased DNA accessibility (Gansen et al., 
2015).
Constitutive heterochromatin represents highly condensed, inactive domains in the genome which 
accumulate in the periphery of the nucleus by attachment to the inner nuclear membrane. It is 
composed of high copy number tandem repeats such as satellite repeats and transposable 
elements, mostly found at the pericentromeric or telomeric parts of chromosomes. However, it also 
occurs at perinuclear, euchromatic regions for the establishment of stable gene silencing which is 
critical for processes like differentiation and memory establishment (Zhang et al., 2015b). 
The constitutive heterochromatic state is associated with low levels of acetylation and high levels 
of H3K9 as well as DNA methylation. The methyltransferases SUV39H1 and SUV39H2 catalyse 
H3K9 di- and trimethylation at satellite repeat regions in pericentric heterochromatin. Further, 
SETDB1 mediates silencing of specific target genes by H3K9me2/3 establishment through 
association with Krüppel-associated box (KRAB) associated protein 1 (KAP1) (Schultz et al., 
2002). Similarly, the heterodimer of G9a and GLP targets H3K9me1/2 towards euchromatin in 
order to silence gene expression (Dillon et al., 2005; Tachibana et al., 2005). G9a and GLP both 
contain an ankyrin repeat domain which can recognise H3K9me1/2, allowing the enzymes to act in 
a feed-forward loop and spread the H3K9me2 modification (Figure 5) (Tachibana et al., 2002).
This principle of propagation is further supported by the H3K9me2 and H3K9me3-dependent 
recruitment of the heterochromatin proteins 1 (HP1). HP1α and HP1β are co-recruited by 
SUV39H1/2 and bind to H3K9me3 with their chromodomains. This allows SUV39H1/2 to 
disseminate H3K9me3 to neighbouring nucleosomes (Bannister et al., 2001; Lachner et al., 2001). 
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of Histone Methylation.
Depicted are histone H3 and H4 
methyltransferases and methylases 
with respect to different organisms 
and methylation levels (mono- (  ), di- 
(  ), and tri- (  ) methylated. From Hyun 
et al., 2017.
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Similarly, KRAB domain zinc finger proteins are the largest family of transcriptional regulators. 
They read H3K9me marks and recruit TRIM28/KAP1 which in turn attract HP1 and SETDB1, 
supporting the spreading of the repressive H3K9me3 histone mark especially on irreversibly 
silenced transposable elements (Ecco et al., 2017). 
HP1 additionally recruits many other factors for heterochromatin formation like histone 
deacetylases, co-repressors and chromatin remodellers which leads to a tight compaction of 
nucleosomes and gene silencing (Hall et al., 2002). For instance, HP1 is known to recruit the de 
novo DNA methyltransferase DNMT3A. The resulting DNA methylation then reinforces the 
condensed chromatin structure (Fuks et al., 2003). Moreover, DNMT1, the proliferating cell nuclear 
antigen (PCNA) and G9a act synergistically during replication. They colocalise to the fork to set 
H3K9 methylation in order to faithfully maintain DNA methylation. This is further supported by the 
interaction between the ubiquitin-like, containing PHD and ring finger domain 1 (UHRF1) with 
H3K9 methylation, hemimethylated DNA and DNMT1 (see details in chapter 7.1.) (Liu et al., 2013).
In contrast, facultative heterochromatin represents genomic regions which harbour the opportunity 
to adopt open or closed conformations depending on temporal and spatial contexts. It is most often 
associated with genes of key transcriptional regulators important for biological processes such as 
genomic imprinting, X chromosome inactivation, or cell cycle control (Plath et al., 2003; Hidalgo et 
al., 2012). For instance, during early development the establishment of the different embryonic 
lineages is tightly regulated by expressing a proper dosage of gene products at a specific point in 
time. Here, genomic imprinting, which leads to expression of a gene from only one allele through 
the silencing of one of the parental copies, becomes crucial for this developmental stage and is 
tightly regulated through the introduction of facultative heterochromatin (Inoue et al., 2017). 
The facultative chromatin state is characterised by levels of H3K27 mono-, di- and trimethylation 
and H2A lysine 119 monoubiquitination (H2AK119ub1). All three states of H3K27 methylation are 
established by the Polycomb repressive complex 2 (PRC2) to create and maintain repressive 
heterochromatin. This evolutionary conserved Polycomb group complex contains four core 
subunits: the enhancer-of-zest homolog EZH2/1, SUZ12, EED, and retinoblastoma-binding 
proteins P46 and 48 (RBAP46/48) (Schuettengruber et al., 2017). EZH2 carries the catalytic SET 
domain, but alone it has no enzymatic activity (Figure 5). Only its affiliation in the PRC2 complex 
with other subunits permits methylation of H3K27 (Pasini et al., 2004). EED and SUZ12 therein 
recognise H3K27me3 and the histone tail itself, respectively, and spread the H3K27me3-
repressive mark to neighbouring nucleosomes in a feedforward fashion (Hansen et al., 2008). 
Additionally, accessory factors associate with PRC2 like the AE binding protein 2 (AEBP2), JARID2 
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and polycomb-like proteins (PCLs), which are thought to modulate PRC2 local targeting specificity 
and activity, ensuring the spreading and maintenance of H3K27me3 domains (Zhang et al., 
2015b).
H3K27me3 is a well-studied and integral mark of facultative heterochromatin. It is crucial for the 
repression of developmental genes in place- and time-dependent fashion (Zhang et al., 2015b). 
Various mechanisms of PRC-mediated gene silencing are known, such as direct chromatin 
compaction, chromatin looping, prevention of H3K27ac deposition by excluding the histone 
acetyltransferases (HATs) p300 and the CREB-binding protein (CBP), or inhibition of engaged Pol 
II (Simon and Kingston, 2009; Pasini et al., 2010; Schuettengruber et al., 2017). However, H3K27 
methylation is not the only instance for facultative heterochromatin as it can serve as a signal for 
PRC1-mediated chromatin compaction. The canonical PRC1 is an E3 ubiquitin ligase complex 
which introduces mono-ubiquitylation on lysine 119 of histone H2A through its catalytic subunit 
Ring Finger Protein 1A/B (RING1A/B). It also contains Chromobox protein homologs 2, 4, 6, 7, or 8 
which read H3K27me3, one out of six PCGF proteins, and the polyhomeotic-like protein 1 (PHC1) 
(Gao et al., 2012). Although it is of importance for the silencing of a great number of developmental 
genes, such as the Hox gene clusters, during early development, there remains a debate on how 
both Polycomb repressive complexes are initially recruited and in which order they act on each of 
their target genes (Bracken et al., 2006).
It is well established that Polycomb group protein activity is directly regulated through the interplay 
with other chromatin marks. For instance, H3K27ac is known for its role in gene activation and 
stands in competition with H3K27me3 for the same lysine residue on histone 3 - resulting in a 
mutually exclusive relationship between these two marks. During ES cell differentiation, the 
clearance of H3K27ac by the Nucleosome Remodelling Deacetylase (NuRD) complex enables the 
attraction of PRC2, facilitating a switch from high levels of acetylation to methylation on H3 lysine 
27 at promoters (Reynolds et al., 2012; Kim et al., 2015). On the contrary, the presence of 
H3K4me2/3 and H3K36me2/3 in cis inhibits PRC2 activity through inhibition of EZH2 (Schmitges et 
al., 2011; Streubel et al., 2018). However, if only one of the two histone H3 tails is modified with 
H3K4me3, PRC2 can catalyse H3K27me3 on the other, resulting in asymmetrically decorated 
nucleosomes (Voigt et al., 2012). Most often, these nucleosomes coincide with CpG islands in the 
genome, referred to as bivalent promoters; the latter regulating developmental genes in ES cells 
(Mikkelsen et al., 2007; Mohn et al., 2008). Due to an engaged, but paused Pol II, the poised 
chromatin state can promptly switch to a transcriptionally active (H3K4me3 only) or inactive 
(H3K27me3 only) status upon differentiation cues (Bernstein et al., 2006; Bracken et al., 2006; 
Mikkelsen et al., 2007).
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Genes containing these two bivalent markers exhibit higher levels of gene expression noise when 
compared to completely active or Polycomb-repressed genes, suggesting that both gene activation 
and silencing account for the stochasticity of gene expression. Further, genes with higher noise are 
often situated close to other fully Polycomb-repressed genes, suggesting that H3K27me3-
heterochromatin spreading further increases transcriptional noise (Faure et al., 2017; Kar et al., 
2017). Thus, there need to be mechanisms in place to ensure proper gene expression of 
developmental genes by reducing H3K27me3-domain spreading. At bivalent promoters, this is 
contained by DNA methylation at CpG shores, supported by the evidence that loss of DNA 
methylation leads to a widening of H3K27me3 domains to those shores (Lynch et al., 2012; 
Reddington et al., 2013). 
We found a dynamic enrichment of DNMT3A1, the longer isoform of DNMT3A, to be preferentially 
localised to these H3K27me3-positive CpG islands shores (see chapter 8.3.). We also observed 
that this preferential recruitment overlaps with elevated 5-hydroxymethylcytosine (5hmC) levels, 
hinting to a balance between DNMT3A1 and TET activity to fine-tune PRC2 domain boundaries. 
We also showed that DNMT3A1 localisation follows H3K27me3-redistribution during differentiation 
(Manzo et al., 2018). How H3K27me3 itself is needed for the recruitment of this DNMT3A isoform 
remains to be shown.
1.2.3.2.     Core Histone variants
Aside from various histone modifications, another layer of regulating all DNA template-based 
reactions is represented by histone variants. In eukaryotes, histones form the building blocks of 
chromatin, the nucleosomes, and display one of the most conserved and abundant protein 
families. The core histones H2A, H2B, H3 and H4 are replication-coupled being expressed only in 
S phase of the cell cycle and providing a stable source for packaging of newly replicated DNA. 
They are encoded by multiple gene copies that are present in clusters on different chromosomes 
and they lack introns as well as typical polyadenylation at the 3’ end, but contain a consensus 
stem-loop structure downstream of the termination site (Williams and Marzluff, 1995; Buschbeck 
and Hake, 2017). 
Aside from these canonical proteins, histone variants have evolutionary emerged with special 
properties and localised functions. They are encoded by single genes and contain polyA-tails as 
well as introns which are spliced during RNA processing, resulting in alternative splice isoforms 
(Figure 6). They are expressed at very low levels, but throughout the cell cycle which provides 
variant-specific transcription and deposition at any time. There are eight variants of H2A (H2A.X, 
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H2A.Z.1, H2A.Z.2.1, H2A.Z.2.2, H2A.Bbd, macroH2A1.1, macroH2A1.2, macroH2A2) and six 
variants of H3 (H3.3, histone H3-like centromeric protein A (CENP-A), H3.1T, H3.5, H3.X, H3.Y). 
There are no known variants for histone 4 (Buschbeck and Hake, 2017).
Variants do not only differ in their expression from the replication-coupled canonical histones, but 
also in their genomic distribution. Whereas the canonical histones are equally incorporated 
throughout the genome, nucleosomes containing variants show distinct localisations, suggesting 
specific roles. For instance, H3.3 coincides with promoters and gene bodies of actively transcribed 
genes, whereas CENP-A accumulates in centromeric regions (Chow et al., 2005; Wirbelauer et al., 
2005; Black et al., 2007). For proper temporal and spatial deposition of these histone variants, 
there are specific chaperones and remodelling complexes in place, such as complex, chromatin 
assembly factor 1 (CAF1) for DNA synthesis-independent and -dependent H3.1 and H3.2 
deposition or histone cell cycle regulation-defective homologue A (HIRA) and ATRX for H3.3 
incorporation (discussed in Mattiroli et al., 2015). 
The replacement of core histones with variants increases the nucleosomal and functional diversity. 
This change in the nucleosome composition can alter chromatin structure in a direct manner and 
indirectly through specific reader proteins being sensitive to the histone variant status (Buschbeck 
and Hake, 2017). Further, due to their differential amino acid composition and genomic location, 
histone variant tails can be diversely modified. For instance, the phosphorylation of serine 139 of 
the H2A.X variant, referred to as γH2A.X, displays an early marker for DNA double strand breaks 
(Paull et al., 2000). It is read by the E3 ubiquitin-protein ligase RNF8 which facilitates chromatin 
decondensation through the interaction with the NuRD-complex member CHD4 (Mailand et al., 
 46
Figure 6 - Variants of Core Histones.
Depicted are variants of histone H2A, H2B 
and H3 (variants shown in pale colours). 
Rectangles represent core regions and lines 
represent flexible histone tails. Percentages 
indicate conservation (% sequence identity) of 
the variants relative to their replication-
coupled counterparts. H2A.Bbd - H2A Barr 
body deficient; CENP-A - histone H3-like 
centromeric protein A; H2BFWT - histone 
H2B type WT; TSH2B - testis-specific histone 
H2B. Adapted from Buschbeck and Hake et 
al., 2017.
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2007; Luijsterburg et al., 2012). γH2A.X is further bound by mediator of DNA damage checkpoint 
protein 1 (MDC1), the MRN complex and ATM kinases which orchestrate the downstream DNA 
damage response (see chapter 1.1.4.5) (Turinetto and Giachino, 2015). Likewise, H3.3 often 
acquires modifications associated with active chromatin (H3K27Ac, trimethylation of H3K4, H3K36, 
and H3K79) and is deprived at silencing marks like methylation on K9 and K27 (McKittrick et al., 
2004). The zinc finger MYND domain-containing protein 11 (ZMYND11) reads H3.3K36me3 in 
gene bodies of actively transcribed genes, linking histone variants to the modulation of 
transcriptional elongation (Wen et al., 2014).
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1.3.  SETD2 and Trimethylation of Lysine 36 on Histone 3
This study places emphasis on the elucidation of a functional role of genic lysine 36 trimethylation 
of histone 3 (H3K36me3) in transcriptional regulation. This histone modification is solely set by the 
methyltransferase SET domain containing 2 (SETD2) and decorates actively transcribed genes 
(Edmunds et al., 2008). The variety of reader proteins that interact with this mark suggest that 
H3K36me3 can directly as well as indirectly influence relevant pathways that control genome 
function and gene expression which remain to be elucidated.
1.3.1.     Writers and Erasers of Histone 3 Lysine 36 Methylation
H3K36 methylation is an abundant and highly conserved mark in eukaryotes. In yeast, all three 
stages of H3K36 methylation are set by Set2, whereas in mammals eight different 
methyltransferases have evolved: Nuclear receptor-binding SET domain enzymes NSD1-3, SETD2 
(KMT3A), SETD3, SETMAR, SMYD2 and ASH1L (Figure 5) (Wagner and Carpenter, 2012). 
SETD2 solely sets H3K36me3 with its conserved 130 amino-acid SET domain (Figure 7), 
restricting the other enzymes to mono- and/or di-methylation (further reviewed in McDaniel and 
Strahl, 2017). Interestingly, SETD2 does not require the preexistence of H3K36me2 to establish 
trimethylated K36 on histone 3 in vitro, as it exhibits higher affinity to unmethylated H3K36 (Sun et 
al., 2005; Kuo et al., 2011). 
There are distinct patterns of genomic distribution for the different methylation stages. Whereas 
H3K36me2 is more pervasive and enriched in both intergenic regions as well as proximal to the 
TSS, H3K36me3 is mutually exclusive to H3K4me3 and mainly found in the bodies (starting from 
around 2 kilobases into the gene) of actively transcribed genes (Santos-Rosa et al., 2002; 
Bannister et al., 2005; Edmunds et al., 2008). SETD2 binds with its SRI domain (Figure 7) the 
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Figure 7 - Domain architecture of SETD2. 
SETD2 exhibits a conserved domain organisation: Associated with SET (AWS), Su(var)3-9, Enhancer-of-zeste and 
Trithorax (SET) and post-SET (PS) domains, all three required for the catalytic function; a coiled-coil (CC) and WW 
domain, and Set2–Rpb1 interaction domain (SRI), the latter binding to the Ser2-P CTD of Pol II. Adapted from 
McDaniel and Strahl, 2017.
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phosphorylated Ser2-P C-terminal tail of the elongating Pol II (subunit RPB1) (Krogan et al., 2003; 
Edmunds et al., 2008). This interaction results in H3K36me3 spreading over the transcribed region, 
a mechanism which is conserved from yeast to humans. The uncoupling of H3K36me3 genomic 
distribution from H3K36me2 over evolution through different responsible enzymes indicates 
biologically distinct roles of the two methylation states (Wagner and Carpenter, 2012). This is 
further supported by the fact that NSD family members exhibit a PWWP domain that recognises 
H3K36me3, achieving a distinct genomic distribution (Vermeulen et al., 2010; Hyun et al., 2017).
In mammals, there are two families of H3K36 demethylases: JHDM3/JMJD2/KDM4A-D are 
responsible for demethylation of H3K36me2 and H3K36me3 (Hyun et al., 2017). In contrast, 
JHDM1/KDM2A-B only demethylates H3K36me1 and H3K36me2. This enzyme carries a PHD 
finger which recognises H3K4me3, explaining a mutually exclusive relationship between H3K4me3 
and H3K36 methylation (Bannister et al., 2005). This notion is supported by the colocalisation of 
JHDM1 to H3K4me3-enriched CpG island promoters, ensuring active removal of H3K36me2 from 
the TSS (Blackledge et al., 2010).
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Figure 8 - Chromatin modifications on actively transcribed genes. 
SETD2 interacts with the C-terminal of active RNA Polymerase II (Pol II) and mediates tri-methylation of lysine 36 on 
histone three (H3K36me3). Several factors are recruited by this mark via PWWP domains to actively transcribed 
regions, indicating a potential co-regulatory function. The role of H3K36me3 for mammalian gene regulation remains to 
be elucidated. Several mechanisms like RNA maturation or Pol II speed alteration could be influenced.
1. Introduction
Dissertation by Christina Ambrosi 
1.3.2.     Functional Role of SETD2-mediated H3K36me3
SETD2 activity results in bookmarking of transcribed gene bodies by the H3K36me3 mark. SETD2/
H3K36me3 are essential for normal development since Setd2 knock-out induces embryonic 
lethality in mice at day E10.5-11.5, with embryos showing growth and neurodevelopment defects 
(Hu et al., 2010). However, their role is not fully understood, but their association with active 
transcription and results from single-gene or correlative studies suggest that various regulatory 
mechanisms could be influenced (Figure 8).
In yeast, it has been shown that lack of histone H3K36me3 results in increased cryptic transcription 
(Sen et al., 2015). In particular, the H3K36me3 reader Rpd3S plays a pivotal role as a histone 
deacetylase in guaranteeing that gene bodies remain hypoacetylated after the Pol II elongates 
through. If its activity is impaired by loss of H3K36me3, increased acetylation can result in cryptic 
transcription initiation and altered deposition of histones across gene bodies (Li et al., 2003; Lee et 
al., 2013). Therein, Rco1 and Eaf3 components of the Rpd3S complex recognise H3K36me3, 
activating Rpd3S deacetylase activity. This suppresses antisense transcription from nucleosome-
free regions as well as spurious cryptic transcripts from initiating within the open reading frame 
(Carrozza et al., 2005). H3K36me3 has also been shown to prevent the incorporation of acetylated 
histones (Venkatesh et al., 2012). Further, in higher eukaryotes, FACT complex subunit SPT16 
binds to H3K36me3-carrying nucleosomes and promotes FACT-mediated exchange of histone 
H2B, but not H3, during transcription-coupled nucleosome displacement in order to maintain 
chromatin integrity during transcription (Carvalho et al., 2013).
In C. elegans, H3K36me3 is differentially distributed between exons and introns which is 
suggested to regulate exon selection for alternative splicing (Kolasinska-Zwierz et al., 2009). 
Based on this model, SETD2/H3K36me3 could cause severe effects on transcriptional elongation 
by directly or indirectly altering RNA polymerase II kinetics with influences on co-transcriptional 
splicing (de la Mata et al., 2003). This is further supported by MRG15 binding to H3K36me3, a 
protein that regulates alternative splicing through the attraction of the splicing factor polypyrimidine 
tract-binding protein (PTB) to the pre-mRNA (Luco et al., 2010). Reduction of SETD2 by 
proteosomal degradation is triggered via polyubiquitylation mediated by SPOP/CUL3 and induces 
alternative splicing events, supporting a role of H3K36me3 in splicing (Zhu et al., 2017). Further, 
ZMYND11 specifically recognises H3.3K36me3 and causes intron retention besides modulating 
the elongation rates of Pol II as a transcriptional co-repressor (Daugaard et al., 2012; Wen et al., 
2014). It was also shown that H3K36me3 prevents intron retention potentially by marking weak 
splice donor sites and coordinates tissue-specific usage of alternative exons through the PWWP-
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containing reader lens epithelium-derived growth factor (LEDGF) (Pradeepa et al., 2012; Liu et al., 
2014).
The binding of LEDGF to H3K36me3 also links this mark to the DNA damage response system to 
maintain genome stability. LEDGF attracts carboxy-terminal binding protein and interacting protein 
(CtIP) to sites of DNA damage within transcribed genes. CtIP in turn facilitates binding of RAD51 
which ultimately leads to the repair pathway choice of homologous recombination (HR) (Daugaard 
et al., 2012; Pfister et al., 2014). Generally, DNA repair of DSBs in actively transcribed genes is 
faster compared to inactive genes, suggesting a role for transcription in the repair of this type of 
lesions (Aymard et al., 2014). SETD2 binds to the transcribing Pol II and its loss ultimately results 
in the absence of H3K36me3 in gene bodies and decreased recruitment of important downstream 
DNA damage response factor such as 53BP1 or RPA (Aymard et al., 2014; Kanu et al., 2015). This 
in turn leads to reduced levels of ATM as well as p53 phosphorylation, impairing DNA repair by HR 
and threatens genome integrity (Carvalho et al., 2014). SETD2/H3K36me3 also act as regulators 
of DNA mismatch repair pathway in G1 and early S phase. H3K36me3 is bound by PWWP-
containing MSH6 subunit of the MutS alpha complex to commence the mismatch repair reaction (Li 
et al., 2013; Huang et al., 2018).
Interestingly, similar roles in gene regulation have been proposed for gene body DNA methylation. 
It was shown that the de novo methyltransferase DNMT3B is particularly responsible for targeted 
DNA methylation of actively transcribed gene bodies in mES cells (Baubec et al., 2015). In relation 
to this, the presence of the lysine 36 trimethylation of the histone 3 promotes gene body DNA 
methylation by recruitment of DNMT3B through its PWWP domain, whereas H3K4me3 prevents 
the DNMT3B enzyme from adding methyl tags to DNA (Morselli et al., 2015; Rondelet et al., 2016). 
It had already been speculated before that genic DNA methylation is negatively correlated to 
transcriptional interference owing to spurious initiation within an active transcription unit (Huh et al., 
2013; Neri et al., 2017). Another study showed that co-transcriptional splicing might also be 
influenced by gene body DNA methylation, again hinting to a potential interplay with SETD2/
H3K36me3 actions. This idea can be extended by the fact that exons are often more highly 
methylated than introns and transitions in the level of DNA methylation often occur at exon-intron 
boundaries (Maunakea et al., 2010; Shukla et al., 2011). Recently, a direct functional link between 
DNA methylation and SETD2/H3K36me3 was established in mouse oocytes where loss of SETD2 
impaired the establishment of the correct DNA methylome. This resulted in aberrant genomic 
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This study in mouse oocytes also highlighted the importance of the interplay between histone 
marks. Loss of H3K36me3 in murine oocytes also led to the invasion and aberrant deposition of 
H3K4me3 and H3K27me3 into former DNA methylation and H3K36me3 territories (Xu et al., 2019). 
It is generally suggested that active marks such as H3K36me3 restrict the spreading of the 
silencing marks H3K27me3 through direct inhibition of PRC2 (Schmitges et al., 2011). This is 
amongst others facilitated by two PCL family proteins (PHF1/PCL1 and PHF19/PCL3) which 
constitute accessory components of the PRC2 complex and contain a Tudor domain with high 
affinity to H3K36 methylation (Brien et al., 2012; Cai et al., 2013). Indeed, it was recently found that 
H3K36me2/3 loss leads to genome-wide expansion of H3K27me3 at PRC2/PRC1 target genes 
(Streubel et al., 2018). Moreover, H3K27me1 correlates with H3K36me3 within transcribed genes, 
promoting active transcription, and its deposition is dependent on H3K36me3 in embryonic stem 
cells. SETD2 deficiency leads to an increase of H3K27me2 in gene bodies. The latter usually 
prevents firing of non-cell-type-specific enhancers and thus decreases gene expression when 
falsely deposited (Ferrari et al., 2014).
It is a well-established concept that histone methyltransferases can be enzymatically inactive or 
methylate non-histone targets. For instance, EZH2 was shown to not only trimethylate H3K27, but 
also the transcription factors STAT3 (Dasgupta et al., 2015). Similarly, it has been identified that 
SETD2 secures genomic stability by trimethylating lysine 40 of α-tubulin during mitosis and 
cytokinesis which are important processes in regards to the morphology changes during 
differentiation (Park et al., 2016a). Furthermore, SETD2 was shown to be involved in the 
interferon-alpha-induced antiviral defense by introducing monomethylation at lysine 525 of STAT1 
(Chen et al., 2017). However, the recognition of such disparate substrates by SETD2 still require 
further investigation.
1.3.3.    Clinical Relevance
SETD2 was suggested to function as a tumor suppressor in a highly tissue-specific context, 
suggesting a substantial need for SETD2 presence to avert tumorigenesis and thus could have 
important implications for future therapeutic strategies (Figure 9) (Duns et al., 2010). 
Downregulation of SETD2 is most often found in human clear cell renal cell carcinomas (ccRCC, 
15-20 % of all cases) and is amongst others associated with aberrant RNA splicing (Dalgliesh et 
al., 2010; Kanu et al., 2015; Tiedemann et al., 2015). Therein, the pathogenic SET domain 
mutation (R1625C) as well as Pol II-interacting SRI domain mutation (R2510H) were found, 
suggesting individual roles for the enzymatic product H3K36me3 and the enzyme itself, 
respectively (Hacker et al., 2016)
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Some tumors exhibit a more aggressive phenotype and worse prognosis as a pathogenic SETD2 
depletion is considered to increase genome instability, promoting adaptability and clonal survival 
(Simon et al., 2014; Ho et al., 2016; Park et al., 2016a). After initial evidence for a potential tumor-
suppressive role of SETD2 in ccRCC, subsequent sequencing studies have identified recurrent 
SETD2 mutations across a broad spectrum of human malignancies, such as lung adenocarcinoma, 
bladder cancer or glioblastoma (Lawrence et al., 2014; Fahey and Davis, 2017; Husmann and 
Gozani, 2019; Chen et al., 2020). Furthermore, recent studies have identified mutations in histone 
3-encoding genes at or near the lysine 36 residue, the SETD2 substrate, in a number of paediatric 
cancers including chondrosarcoma (K36M mutation) (Behjati et al., 2013; Fang et al., 2016) and 
glioblastoma multiforme (G34R/V mutation) (Schwartzentruber et al., 2012; Sturm et al., 2012), 
further highlighting the relevance of H3K36 methylation and the tumour suppressor SETD2. 
In contrast, SETD2 loss can also support sensitivity of cancer cells to pharmacologic inhibition, 
suggesting a context-dependent role of SETD2/H3K36me3 in disease. This has been recently 
shown to be of high importance for acute lymphoblastic leukemia (ALL) and acute myeloid 
leukemia (AML) with MLL-fusion protein signature. Here, deficiency of SETD2 increased DNA 
damage in cells, reduced cell cycle progression, and promoted differentiation of AML cells (Skucha 
et al., 2018). Another study indicated that specific inhibition of PI3Kβ induces synthetic lethality 
with SETD2 loss in ccRCC (Terzo et al., 2019).
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Figure 9 - Potential Tumor-Suppressive Roles of SETD2. 
The potential tumor-suppressive functions of SETD2 by the 
identification of recurrent deletions, frameshifts, or truncating or 
damaging missense mutations, and by biological studies. CNS - 
central nervous system, HSTL - hepatosplenic T cell lymphoma, 
EATL-II - enteropathy-associated T cell lymphoma type II, ALL - 
acute lymphoblastic leukemia; AML - acute myeloid leukemia. 
Adapted from Husmann and Gozani, 2019.
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As SETD2-mediated H3K36me3 is suggested to engage in the maintenance of transcriptional 
fidelity, its role could be also required to assure correct gene expression during the organism’s 
whole lifespan by fostering longevity and could thus play a role in the process of ageing (Pu et al., 
2015). Given these links to disease or ageing, understanding the role of H3K36me3 in 
transcriptional regulation will provide major contributions to human health. However, further work is 
necessary to elucidate the action of tumor suppression by SETD2, the relationship to H3K36me3 
and the effects on downstream genetic context.
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2. Aims
Although there is a clear correlation between chromatin modifications and gene expression states, 
it will be important to establish their direct role in regulating transcription and cell identity. In 
particular, given the crosstalk between SETD2-mediated H3K36me3 and other chromatin marks as 
well as chromatin-bound factors, the individual and overlapping roles in maintaining cell identity 
require to be explored in more detail. 
Single-gene or correlative studies propose a complex picture of SETD2-mediated H3K36me3 
function in various transcription-dependent and -independent processes. However, due to the lack 
of functional and comprehensive investigations in defined cellular models, the direct function of this 
mark and its enzyme in mammalian cells still remains be elucidated. With this thesis work, I wanted 
to address the role of SETD2 and H3K36me3 in regulating gene expression through a combination 
of genome-wide transcriptional readout measurements and functional rescue experiments in a 
highly-controlled cellular differentiation model.
I was able to address the following questions: 
‣ What is the contribution of chromatin modifications to gene expression noise and 
cellular identity of murine embryonic stem cells?,
‣ How do chromatin modifications regulate gene transcription during development?,
‣ What is the functional role of SETD2-mediated H3K36me3 for establishment and 
maintenance of gene expression programs?
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3. Exploring the Functional Role of SETD2/
H3K36me3 during Cellular Differentiation
3.1. Chromatin modifications do not influence gene expression 
noise in murine embryonic stem cells.
To directly address the contribution of chromatin modifications to gene expression and cellular 
identity, we have performed single-cell RNA sequencing of wild-type and various CRISPR-
mediated knock-out mouse embryonic stem cell lines, generated in the same genetic background 
(Figure 1A). This set includes a line where all DNA methyltransferases were mutated (Dnmt1,3a,
3b-TKO) (Domcke et al., 2015), a cell line lacking H3K27me3 (Eed-/-) (Villasenor et al., 2020), and 
a cell line lacking the H3K36me3 methyltransferase SETD2 (Baubec et al., 2015). In addition, we 
generated a cell line lacking DNA methylation and H3K36me3 by mutating Setd2 in the Dnmt-TKO 
background (here termed quadruple-KO, QKO), to test the combinatorial contribution of these 
marks on gene expression (Supplementary Figure S1A-D). All cell lines retained pluripotency and 
were able to proliferate without apparent morphological changes in serum + LIF conditions 
(Supplementary Figure S2A-E). We performed single-cell RNA sequencing on ~ 300 sorted cells 
for each line using SORT-seq (Hashimoto et al., 2012; Maurano et al., 2015) and obtained ~ 280 
cells, with an average of 6000-7000 genes detected per cell after quality control and filtering 
(Supplementary Figure S3A and Material and Methods). 
By visualising the transcriptional relationship of all cells using the uniform approximation and 
projection method (UMAP), we observed that removal of chromatin marks does not result in 
individual clusters for all individual mutant lines (Figure 1B), but rather forms a heterogenous cloud 
of cells, with Eed-/- cells as the only mutant line forming a separate cluster. Lack of DNA 
methylation results only in a minor separation from wild-type cells, while absence of H3K36me3 in 
the Setd2-/- cells does not result in any separation from the background line (both in Setd2 single 
knock-out and QKO cells) (Figure 1B). This limited separation of epigenetic mutants is also 
observed using Principal Component Analysis (PCA, Supplementary Figure S3B) and reflects the 
limited changes in gene expression upon removal of H3K27me3, DNA methylation, or H3K36me3 
(Supplementary Figure S2E, S3C and Table 1), in accordance with previous results obtained from 
bulk RNA-seq in mES cells (Boyer et al., 2006; Tsumura et al., 2006; Chamberlain et al., 2008; 
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Baubec et al., 2015). Nevertheless, we were able to identify known genes that change expression 
upon removal of DNA methylation or H3K27me3 such as upregulation of Meg3 and Dazl1 in TKO/
QKO mES cells or Hoxd13 and Lefty2 in Eed-/- ES cells (Supplementary Figure S3C). 
Next, we wanted to quantify the consequences of chromatin modification removal on gene 
expression noise (cell-to-cell variability). We calculated the coefficient of variation (CV) for each 
gene in the individual cell lines and used pathway and gene set overdispersion analysis (PAGODA) 
(Fan et al., 2016) to adjust the variance for mean expression levels (Supplementary Figure S4A). 
We further collected genome-wide ChIP-seq datasets generated in bulk wild-type ES cells of 
identical background and analysed the association of these chromatin landmarks with the 
quantified adjusted variance of overlapping genes in wild-type ES cells. We observe the 
previously-described gene expression noise relationships with chromatin marks, transcriptional 
activity and CpG density at promoters and gene bodies - namely elevated noise at Polycomb-
regulated genes and low variability at genes with CpG island promoters and H3K36me3 at gene 
bodies (Figure 1C and Supplementary Figure S4B-C) (Faure et al., 2017; Kar et al., 2017). 
Extending this analysis to DNA methylation, indicates a moderate increase in gene expression 
noise from genes with high promoter methylation. Next, we asked if the observed noise-chromatin 
associations are altered upon removal of the chromatin marks. Towards this we quantified the 
adjusted coefficient of variation in the cell lines lacking DNA methylation, H3K27me3 or 
H3K36me3, and compared this to wild-type cells. We did not observe any significant changes in 
cell-to-cell variation upon removal of these marks, indicating that there is no causal relationship 
between chromatin modifications and the observed transcriptional noise in pluripotent stem cells 
(Figure 1C and Supplementary Figure S4C).
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Figure 1 - Chromatin modifications do not influence gene expression noise in murine stem cells.
(A) Schematic overview of ES cell lines subjected to SORT-seq procedure. Setd2-/- cells lack all H3K36me3, Eed-/- 
lack H3K27me3, Dnmt TKO lack DNA methylation (5mC), and QKO (Setd2-/- in Dnmt TKO) cells lack both H3K36me3 
and 5mC. FACS - fluorescence-activated cell sorting. (B) Visualisation of the transcriptional relationship between the 
different ES cell lines with the uniform manifold approximation and projection (UMAP) method for single-cell RNA-seq 
data. Each dot represents one cell. (C) Boxplots showing the gene expression noise relationship with different 
chromatin marks (regions with top/bottom 10 % occupancy) and changes upon loss of those. Shown is elevated noise 
at Polycomb-regulated genes (H3K27me3) and low variability at genes with CpG island promoters (DNA methylation) 
as well as H3K36me3 at bodies of protein-coding genes. See also Supplementary Figure S4. 
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3.2. Chromatin modifications influence exit from pluripotency and 
differentiation.
We next wanted to compare the contribution of these chromatin modifications to the establishment 
of new gene expression programs during exit from pluripotency and lineage commitment. Towards 
this, we first removed LIF from the medium to induce exit from pluripotency. Immediately after LIF 
withdrawal, chromatin-modification-deficient cells showed a significant decrease in cell survival, as 
described in previous studies (Jackson et al., 2004; Boyer et al., 2006; Sakaue et al., 2010; Zhang 
et al., 2014) (Figure 2A, Supplementary Figure S5A). Therein, Eed-/- cells were compromised 
stronger in comparison to the other mutant cell lines with a cell death of over 60 % (Supplementary 
Figure S5A). Setd2-/- cells showed increased cell death after the first passage, but prolonged 
passaging resulted in an increased survival rate from ~40 % to 80 % (Figure 2A).
Removal of LIF leads to uncontrolled differentiation of stem cells towards multiple lineages, 
therefore we wanted to compare the consequences of chromatin modification loss using a 
controlled differentiation system. Towards this, we differentiated the ES cells to neuronal 
progenitors and to mature glutamatergic neurons following an established in vitro differentiation 
protocol (Bibel et al., 2007) (Figure 2B-D, 2F, Supplementary Figure S5). As expected, cell lines 
lacking DNA methylation and H3K37me3 failed to reach the neuronal progenitor stage and did not 
give rise to post-mitotic neurons (Supplementary Figure S5B, S5D). The decrease in survival over 
time was accompanied by morphological changes of Eed-/- and TKO/QKO cellular aggregates 
such as hollow structures and frayed edges, indicating cellular detachment and increased cell 
death (Supplementary Figure S5C). In contrast, we observed that the Setd2 knock-out cells did not 
show any differences compared to wild-type cells up to the neuronal progenitor stage (NPC), 
suggesting that exit from pluripotency and early lineage commitment is not affected in absence of 
H3K36me3 (Figure 2B, Supplementary Figure S5C). This was reproduced in two independent 
knock-out clones and one constitutive Setd2 shRNA knock-down cell line (Figure 2B). However, 
further differentiation of Setd2-deficient progenitors to mature neurons was strongly impaired, with 
only 20 % of post-mitotic neurons surviving, indicating a potential role of SETD2/H3K36me3 in 
terminal differentiation or maintenance of neuronal identity (Figure 2C-D).
Following these observations, we wanted to explore the contribution of SETD2/H3K36me3 during 
the transition from progenitor to fully differentiated neurons. First, we asked if the reduced 
generation of neurons is due to impaired establishment or failure to maintain neuronal cell identity 
in absence of H3K36me3. To test this, we established a Tet-inducible Setd2 shRNA knock-down 
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(shSetd2) mES cell line and repeated the differentiation protocol while inducing shRNA expression 
at different timepoints (Supplementary Figure S6A). Loss of SETD2 and H3K36me3 in post-mitotic 
neurons was controlled by RT-qPCR, Western Blot and ChIP-seq (Figure 2E, Supplementary 
Figure S6B, S6D). Cells that were treated constantly or from early stages on (day d6, d8) with 
doxycycline showed a lower cell survival and low number of differentiated neurons, similar to the 
knock-out cells. In contrast, induction immediately after the early steps of neuronal differentiation 
(day d10) did not affect cell survival with 86-91 % surviving neurons (Figure 2F, Supplementary 
Figure S6C). This data indicates that SETD2 and H3K36me3 are necessary for lineage 
commitment, but dispensable once the neuronal identity has been established. 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Figure 2 - Chromatin modifications influence exit from pluripotency and differentiation.
(A) Wild-type (WT) and Setd2-/- mES cells were cultured without leukemia-inhibitory factor (-LIF) over three passages. 
Shown are percentages of survival (life/dead stain) of three independent experiments. (B) Cell count assay using live-
dead stain at stage of cellular aggregates (CA) day 4 and day 8 during embryoid body formation. Depicted are 
percentages of survival in WT, Setd2-/- and Setd2 knockdown (shSetd2) cells. (C) Microscopy images of in vitro-
derived neurons of WT, Setd2 -/- and constitutive Setd2 knockdown cells at day d14. Shown are percentages of 
survival after dissociation (plated/attached) of three independent experiments; 100x magnification. (D) Survival rate 
(plated/attached) of terminal neurons of wild-type, Setd2 -/- and constitutive Setd2 knockdown cells at day d10; n=3. 
Statistical significance assessed by Student’s t-test (p*** < 0.0001). (E) Representative microscopy images of in vitro-
derived neurons of two Tet-inducible Setd2 knockdown cell lines. Cells were treated with 1 μg/ml doxycycline (DOX) 
continuously or from day d10 on. Shown are percentages of survival after dissociation (plated/attached) of three 
independent experiments. (F) Immunoblot analysis for SETD2 levels in nuclear extracts of WT, Setd2 -/- and Tet-
inducible shSetd2 knockdown terminal neurons at day d14 (+/- 1 μg/ml DOX). LAMIN B served as loading control.
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3.3. Setd2-/- compromises gene expression during terminal 
differentiation.
SETD2-mediated H3K36me3 is suggested to be involved in the regulation of transcriptional fidelity 
across the genome (Sen et al., 2015; Faure et al., 2017; Meers et al., 2017). Thus, we assessed 
the transcriptome of Setd2-/- neuroprogenitors, the cell state before cell death. PolyA-RNA 
sequencing analysis showed minor changes in gene expression in Setd2-deficient NPCs with ~300 
differentially expressed genes (Figure 3A). Gene ontology analysis of down-regulated genes 
showed high enrichment for neurodevelopmental-related processes, suggesting a deregulation of 
neuronal transcriptional programs already at this stage (Figure 3B). Given these mild, but 
detectable changes in the overall transcriptome and remaining 20 %-survival rate upon terminal 
differentiation, we wanted to investigate if absence of H3K36me3 results in increased cellular and 
gene expression heterogeneity at the progenitor stage. We therefore performed single-cell RNA-
sequencing at the NPC stage. Visualising the transcriptional relationship of all cells using the 
UMAP method showed that removal of H3K36me3 results in a separation of Setd2-/- from wild-
type NPCs (Figure 3C), in agreement with transcriptional differences observed from bulk RNA-seq.
Next, we wanted to quantify the consequences of H3K36me3 removal on gene expression noise 
(cell-to-cell variability). We calculated the coefficient of variation (CV) for each gene in the 
individual cell lines and used PAGODA (Fan et al., 2016) to adjust the variance for mean 
expression levels (Figure 3D). Comparison of CV values with genome-wide ChIP-seq datasets 
generated in bulk wild-type and Setd2-/- NPCs showed again similar trends as observed in ES 
cells, such as higher variability at H3K27me3-regulated promoters (Figure 3E, Supplementary 
Figure S7A-B). However, these associations were still present in cells lacking H3K36me3, 
supporting that H3K36me3 does not contribute to cell-to-cell variation in gene expression of NPCs.
Given the changes in transcription for neurodevelopmental genes in Setd2-/- NPCs in our bulk 
RNA-seq data (Figure 3A-B) and the observed separation in the single-cell data (Figure 3C), we 
further assessed the expression of neuronal transcription factors in the single-cell RNA-seq data 
and by RT-qPCR in NPCs (Figure 3F, Supplementary Figure S7C and D). We did not only observe 
the impaired upregulation of major neuronal transcription drivers (e.g. Pax6, Pax3, Olig2, Nestin), 
but also the significant upregulation of wrong differentiation drivers (e.g. Sox17, Cdx2) as well as a 
insufficient downregulation of pluripotency marker genes (Nanog, Pouf5F1), the latter indicating an 
incomplete or a delay in differentiation. This data suggests a role of SETD2-mediated H3K36me3 
in fine-tuning the correct establishment of gene expression programs. 
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Figure 3 - Chromatin modifications influence exit from pluripotency and differentiation.
(A) DESeq2 MA plot of bulk PolyA-RNA-seq results depicting differences in gene expression between wild-type (WT) 
and Setd2-/- NPCs (~350 DEGs, p-value < 0.05, LFC > I1I). (B) Gene ontology (PantherGO) enrichment analysis for 
down-regulated genes in Setd2-deficient NPCs. Shown are the most enriched GO terms with a -log(p-value) > 5. 
(C) Uniform approximation and projection (UMAP) method for single-cell RNA-seq data of WT and Setd2-/- neuronal 
progenitors. There is a mild cluster formation between the two cell lines. (D) Calculation of the coefficient of variation 
and its adjustment for mean expression levels for each gene in individual WT and Setd2-/- neuronal progenitor cells 
using the pathway and gene set overdispersion analysis (PAGODA). (E) Genome-wide signals at gene bodies (starting 
+2kb from TSS) of ChIP-seq datasets generated in bulk neuronal progenitor cells were associated with the quantified 
adjusted variance to analyse gene expression noise relationships with chromatin marks in WT and Setd2-/- NPCs. 
(F) RT-qPCR of various lineage marker analysis in WT and Setd2-/- NPCs (n=3). Statistical significance assessed by 
Student’s t-test (p** < 0.01, p*** < 0.0001). Hprt - housekeeping gene, Oct4 (Pou5f1), Gata6, Nanog - embryonic stem 
cell markers; Nestin, NeuroD1, Pax3, Pax6, Olig2 - neuronal marker; Fgf4 - growth factor, Gata4 - extra-embryonic 
endoderm marker, Cdx2 - trophoblast marker, Sox17 - parietal endoderm marker. 
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3.4. SETD2/H3K36me3 ensure correct gene expression during 
differentiation.
To further address the impact of Setd2-/- in ES cell-derived neuronal progenitor cells, we measured 
the expression of the neuronal surface markers CD24/CD56 by FACS. We observed a significant 
decrease in the expression of these markers during the last stage of embryoid body formation, 
prior to the dissociation of NPCs. More than twice as many CD24-/CD56- double-negative NPCs 
were detected in the Setd2-/- population (~21 %) as in wild-type cells (~8 %) (Figure 4A-B), 
indicating a deficit in developmental progression for Setd2-/- cells. Prolonged cultivation of 
embryoid bodies in retinoic acid for four more days (CAd12) showed a small, but positive effect on 
the survival of Setd2-deficient cells (Supplementary Figure S8A). However, this increase in survival 
was also observed for the wild-type cells (Supplementary Figure S8B). Further, surface marker and 
RT-qPCR analysis at day 12 of cellular aggregation confirmed that Setd2-/- cells showed only a 
minor improvement of marker gene or surface marker (CD24-/CD56- double-negative: ~5 % in 
wild-type, ~22 % in Setd2-/- at CAd12) expression in comparison to WT or Setd2-/- cells at day 8 of 
cellular aggregation (Figure 3F, 4B, Supplementary Figure S7D, S8C-D). Thus, prolonged 
cultivation of progenitors minimally improves differentiation, but does not completely revert gene 
expression changes caused by the lack of SETD2/H3K36me3. 
In order to assess if this deficit in developmental progression is dependent on failure to establish 
the correct gene expression program, we generated Setd2-/- ES cell lines with Tet-inducible 
expression of the two bHLH transcription factors that promote neurogenesis: Neurogenin 1 and 
Neurogenin 2 (iNgn) (Material and Methods, Supplementary Figure S8E). Induced expression of 
these factors have been shown to enable rapid neurogenesis by inducing genetic programs 
involved in the transition from stem cells to pre-natal neurons (Busskamp et al., 2014). We argued 
that their expression in Setd2-/- cells could be sufficient to rescue incorrect establishment of gene 
expression programs in absence of H3K36me3 and to induce neurodifferentiation. Induction of 
iNgn indeed increased the survival rate by ~30 %, leading to a partial rescue of the cell death 
observed in absence of SETD2/H3K36me3 (Figure 4C-D). In addition, RT-qPCR analysis for 
selected lineage marker genes confirmed this partial rescue on a molecular level, where induction 
of Ngn1/2 in Setd2-/- cells showed a change in expression of lineage markers similar to wild-type 
cells (Figure 4E). This correction of the transcriptional program in comparison to wild-type NPCs 
(+DOX) is not complete; however, it is sufficient for an overall improvement in cell survival. This 
data suggests that SETD2-mediated H3K36me3 ensures accurate transcriptional programming 
upon cellular differentiation and its loss leads to failure to establish correct gene expression during 
neuronal differentiation. Nevertheless, this deficit can be rescued by enforcing the correct 
transcriptional programs through induced expression of neuronal transcription factors. 
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Figure 4 
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Figure 4 - Setd2-/- cell-derived NPCs exhibit an inaccuracy in lineage programming which is 
partially rescued by introduction of a major neurotranscription factor.
(A) - (B) Flow cytometry measurements for the surface markers CD24 and CD56 in wild-type (WT) and Setd2-/- ES 
cell-derived neuronal progenitor cells after embryoid body dissociation. (A) Exemplary flow cytometry dot plots. (B) Plot 
indicates the percentage of double-negative (CD24-/CD56-) NPCs (four independent measurements per sample are 
shown). Statistical significance assessed by Student’s t-test (p** < 0.01). (C) Microscopy images of in vitro-derived 
neurons shows successful differentiation of neuronal cells derived from WT control ES cells and partial rescue of cell 
death in Setd2-deficient cells by inducible overexpression of Neurogenin2-Neurogenin1 (iNgn). Similar results were 
obtained from two independent replicates. Cells were either mock-treated or continuously treated with 1 µg/ml 
doxycycline (DOX) during in vitro differentiation. (D) Shown are percentages of survival after dissociation (plated/
attached) of three independent experiments described in (C). n=3. Statistical significance assessed by Student’s t-test 
(p** < 0.01, p*** < 0.0001). (E) RT-qPCR of various lineage marker analysis in WT and Setd2-/- NPCs, the latter 
expressing Neurogenin1 and Neurogenin2 upon 1 µg/ml doxycycline treatment (n=3). Hprt - housekeeping gene, Oct4 
(Pou5f1), Nanog - embryonic stem cell markers; Pax3, Pax6, Ngn1, Crabp1, Msx3, Foxd3 - neuronal marker; Fgf4 - 
growth factor, Sox17 - parietal endoderm marker. 
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In summary, we have identified a crucial role for SETD2-mediated H3K36me3 in the accurate 
establishment of gene expression during neuronal development. Given the readout of this histone 
modification and the role of SETD2 as a potential tumor suppressor as described in chapter 1.3., 
we wanted to further decipher the potential mechanism as to how this enzyme and its mark 
contribute to the establishment of gene expression profiles needed for terminal differentiation. 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3.5. DNA Damage Response in Absence of SETD2/H3K36me3.
H3K36me3 has been shown to play a role in aiding DNA damage response and DNA repair 
pathway choice in actively transcribed regions (Pfister et al., 2014; Huang et al., 2018). Loss of 
SETD2-mediated H3K36me3 in cancer cells has been further linked to increased DNA damage 
and genomic instability (Skucha et al., 2018). Thus, we wanted to assess the potential role of 
elevated DNA damage levels in the low survival during differentiation of cells lacking SETD2/
H3K36me3. In collaboration with Fede Teloni (Altmeyer lab, UZH), we first investigated 
phosphorylation levels of the DNA damage marker γH2A.X in Setd2-/- mES cells using 
quantitative, image-based cytometry (QIBC) (Toledo et al., 2013). We found that even after 
challenging the cells with DSB-inducing agent Camptothecin, no differential DNA damage 
response between WT and knock-out ES cells could be detected (Figure 5A-B). We further 
investigated phosphorylation γH2A.X by immunoblotting using a γH2A.X-specific antibody in 
NPCs, the stage before cell death establishes. Again, we were not able to detect changes in the 
DNA damage response in Setd2-/- cells (Figure 5C), suggesting that the loss of H3K36me3 does 




Figure 5 - H3K36me3 loss does not impair DNA Damage Response. 
(A)-(B) Untreated or treated (1µM Camptothecin CPT for 1h) WT and Setd2-/- mES cells have been fixed, 
permeabilised, and stained for γH2AX level in a duplicate fashion. Automated fluorescence microscopy and follow-up 
normalisation of the Cy5 signal (γH2AX) to the DAPI signal (cell nuclei) of 1000 cells shows no significant differences 
in DNA damage response. (A) Mean Cy5 intensity of each cell in one sample. (B) Quantification of (A) showing 
average mean intensity of all cells in replicates, n=2. (C) Immunoblot analysis of serine 129 phosphorylation of H2A.X 
in untreated WT and Setd2-/- neuronal progenitors (NPCs). H1 serves as loading control. 
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3.6. Histone H3.3 Variant Incorporation at H3K36me3-high Sites.
H3.3, a histone variant that is structurally very close to the canonical histone H3, has been 
associated with genomic regions that undergo elevated chromatin-turnover, such as sites of active 
transcription (Buschbeck and Hake, 2017). Its role in histone replacement at active genes is highly 
conserved and has been proposed to participate in the transmission of active chromatin states 
(Orsi et al., 2009). H3.3 is co-transcriptionally incorporated in gene bodies, therefore tri-methylation 
on lysine 36 is predominantly found on histone H3.3 (H3.3K36me3), and specific reader proteins 
have been identified that recognise H3.3K36me3 (Wen et al., 2014).
Since H3.3 becomes enriched in maturing post-mitotic cells, it is particularly important for neuronal 
plasticity (Maze et al., 2015). Thus, the increased incorporation of H3.3 into actively transcribed 
gene bodies during neuronal differentiation could be influenced in absence of H3K36me3, 
potentially leading to a differential downstream readout and altered gene expression (Wen et al., 
2014). To test this hypothesis, we studied histone H3.3 localisation by introducing an exogenous 
biotin-tagged H3.3 protein to a heterologous site (Figure 6A) in wild-type and Setd2-/- ES cells. 
Chromatin immunoprecipitation experiments followed by sequencing (ChIP-seq) in mES cells and 
NPCs did not show drastic differences in H3.3 levels at H3K36me3-rich gene bodies (Figure 6B), 
suggesting that H3.3 localisation is not influenced by H3K36me3 loss.  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Figure 6 - No differential H3.3 levels at formerly H3K36me3-high gene bodies. 
(A) Schematic overview of the generation of H3.3-bio overexpressing ES cells. H3.3 gene was inserted with a biotin-
acceptor peptide sequence into BirA ligase and RMCE-competent ES cells. Positive clones were further differentiated 
to neuronal precursors (NPC). HYG - hygromycin, TK - thymidine kinase. (B) Clustered heatmaps showing H3.3 bio-
ChIP-seq signals in gene bodies, starting 2 kilobases from transcription start (TSS) until transcription termination (TTS) 
site) of WT vs. Setd2-/- mES cells and NPCs. Signals were ranked according to H3K36me3 ChIP-seq signals in WT 
cells. 
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3.7. Influence of H3K36me3 loss on the Chromatin Landscape.
Binding analysis by ChIP-seq for H3K27me3, RNA Pol II as well as Ser2-P Pol II and H4-
panacetylation have been performed in late neuronal progenitors to elucidate as to what extent 
these are influenced by lack of H3K36me3, and if these changes are associated with the altered 
transcriptional output observed in Setd2-/- NPC (Figure 7). We focused our analysis of H3K36me3-
rich gene bodies, starting 2 kilobases from the TSS, as changes should be expected there upon 
depletion of SETD2/H3K36me3.
We did not observe large rearrangements of these chromatin modifications upon loss of 
H3K36me3 could in Setd2-/- late neuronal precursors. However, at formerly H3K36me3-enriched 
sites, a slight decrease in Pol II signal and increase in H4-panacetyl signal can be observed 
(Figure 7A-B). This is in line with the observed role of H3K36me3 in yeast, where it promotes 
recruitment of the histone deacetylase complex Rpd3S to transcribed gene bodies (Carrozza et al., 
2005). Since histone acetylation is known to be an active marker for open chromatin and is 
directed by H3K36me3 in gene bodies (Zhang et al., 2015b), we performed accessibility analysis 
using ATAC-seq in WT and Setd2-/- NPCs (Figure 7C). We did not observe differentially accessible 
sites between WT and mutant NPCs, indicating that there is a slight increase of H4 acetylation in 
gene bodies, but it does not affect chromatin accessibility or Pol II occupancy.
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Figure 7 - Chromatin Environment in WT vs. Setd2-/- neuronal precursors.
(A) Clustered heatmaps showing antibody ChIP-seq signals for H3K36me3, total and Ser2-P Pol II, H4 panacetyl in 
gene bodies (2kb from TSS until transcription termination site) of WT vs. Setd2-/- NPCs. Signals were ranked 
according to H3K36me3 ChIP-seq signals in WT NP cells. (B) Smooth scatter plot of delta genic H4panacetyl ChIP-
seq signals (WT-Setd2-/-) over genic H3K36me3 ChIP-seq-signal in WT NPCs. All values are log2-transformed. There 
is a slight increase in acetylation at gene bodies that loose H3K36me3 in Setd2-/- cells. (C) Accessibility changes were 
assessed by ATAC-seq in WT vs. Setd2-/- NPCs. Shown is a MA plot for called ATAC-seq peaks in WT vs. Setd2-/- 
NPCs in dependence on average counts per million (CPM). All values are log2 transformed. Red dots show 
significantly different accessible sites (logFC > 0.5, FDR < 0.05). 
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3.8. Changes in Protein-Chromatin Interactions in Presence and 
Absence of SETD2/H3K36me3.
H3K36me3 could have a role as a bookmark to mark chromatin of transcribed genes and regulate 
recruitment of important factors to these sites (see chapter 1.3.2.). Thus, we wanted to investigate 
potential changes in the protein constitution on chromatin in absence of H3K36me3 and its enzyme 
SETD2 (Figure 8). First, we wanted to analyse potential changes of global chromatin interactions in 
absence/presence of H3K36me3 (Figure 8A). Towards this, we performed global chromatin mass 
spectrometry experiments in collaboration with the Stengel lab (University of Konstanz). Stable 
isotope labelling of WT and Setd2-/- mES cells with amino acids in cell culture (SILAC) followed by 
mass spectrometry (MS) analysis of cross-linked, chromatin-bound fractions (ChEP) (Kustatscher 
et al., 2014) were performed to obtain a quantitative and unbiased detection of protein-chromatin 
interaction changes in absence of SETD2 (Supplementary Figure S9A). The results revealed 
additional factors influenced by the lack of SETD2/H3K36me3, but less than expected from their 
potential role in RNA synthesis and genome function. As a control hit, we could rely on KDM5B a 
H3K4me2/3 demethylase that has been shown to associate to H3K36me3 sites in mES cells (Xie 
et al., 2011) and is depleted in the Setd2-/- background. In general, Pol II subunits were not 
differentially enriched between WT and Setd2-/- cells, suggesting that Pol II occupancy on 
chromatin itself is not altered upon H3K36me3 loss in ES cells. This was further validated by 
immunoblotting for Pol II protein levels in chromatin-bound fractions of WT and Setd2-/- mES cells 
(Supplementary Figure S9B). 
We next wanted to focus on the interactome of actively transcribed gene bodies, rather than the 
entire genome. Thus, we performed ChIP experiments against serine-2-phosphorylated (Ser2-P) 
Pol II followed by MS detection of associated proteins. Between wild-type ES and NP cells, the Pol 
II interactome only slightly changes by enrichment of neuronal-specific factors such as the 
Dihydropyrimidinase Like proteins 2 and 3 (DPYL2/3) in NPCs (Figure 8B). Changes between wild-
type and Setd2-/- NPCs could not be observed (Figure 8C), indicating that the interactome at 
actively transcribed genes is not altered upon H3K36me3 loss. However, this antibody-based 
approach holds limitations. It might not be representative for the protein-chromatin interactions 
around H3K36me3, as passaging by the elongating Pol II disrupts present chromatin states and 
potential interactions. Further, since this approach involves cross-linking with formaldehyde, 
capturing short-lived or dynamic changes in the chromatin-protein interactome might be limited 
(Solomon and Varshavsky, 1985). 
 73
3. Exploring the Functional Role of SETD2/H3K36me3 during Cellular Differentiation
Dissertation by Christina Ambrosi 
Due to these limitations, we utilised the recently established tool ChromID (Villasenor et al., 2020) 
and the SRI domain of SETD2 which binds to the Ser2-P CTD of the elongating Pol II. A 
promiscuous BirA* ligase from Bacillus subtilis (BASU) was added to the latter and successfully 
introduced into wild-type and Setd2-/- mES cell background for proximity labelling experiments 
using mass spectrometry. Biotinylation of proteins was sufficient leading to a count of about 4000 
peptides in the different samples (Supplementary Figure S9C). Enrichment analysis of SRI-BASU 
over a non-directed BASU control in wild-type ES cells showed an increase in the overall captured 
protein interactome (Figure 8D) in comparison to the previous Ser2-P-Pol II-MS run (Figure 8B), 
calling 39 significantly enriched proteins (Supplementary Figure S9D). Further, in the Setd2-/- 
background 18 of those significantly enriched proteins were lost besides SETD2 itself and 5 new 
interactions were gained, indicating a potential role for SETD2/H3K36me3 in facilitating 
interactions with the elongating RNA polymerase (Figure 8E). Next, we subjected a selection of 
these differentially enriched proteins, which are lost upon SETD2 depletion to GO term enrichment 
analysis (Supplementary Figure S9E) and to the STRING database (Figure 8F) (Szklarczyk et al., 
2019). We could find an enrichment of proteins being involved in 3’ RNA processing, particularly 
mRNA splicing. These results suggest that the observed transcriptome changes could be due to 
altered interactions between RNA processing factors and chromatin. 
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Figure 8 - Protein-Chromatin Interactome in Presence and Absence of SETD2/H3K36me3.
(A) Schematic overview of potential identification of known as well as unknown protein interactions facilitated by 
SETD2, H3K36me3 and the elongating Pol II. (B)-(C) Volcano plot showing Ser2-P Pol II ChIP-MS results obtained in 
(B) WT ES and NP cells or (C) WT and Setd2-/- NP cells. There are no statistically enriched proteins (FDR = 0.01, s0 = 
0.1, log2 FC > 0, n = 4). (D)-(E) Volcano plots indicating ChromID results from SETD2-SRI domain engineered 
chromatin reader-BASU fusion in comparison to a reader-free BASU control in (D) WT or (E) Setd2-/- ES cells. 
Statistically enriched proteins are indicated in blue (FDR = 0.01, s0 = 0.1, log2 FC > 0, n = 4). (F) Analysis of selected 
proteins lost in Setd2-/- SRI-BASU ES cells using the STRING database.
3. Exploring the Functional Role of SETD2/H3K36me3 during Cellular Differentiation




Dissertation by Christina Ambrosi 
4. Results - Supplementary Information
Supplementary Figure S1
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Supplementary Figure S1 - Generation of Setd2-/- ES cells in a Dnmt TKO background.
(A) CRISPR/Cas9 knock-out strategy for Setd2 in Dmnt TKO background (QKO). Two guide RNAs target exon 3, 
resulting in an out-of-frame deletion and a downstream premature STOP codon. (B) Immunoblot analysis for SETD2 
and H3K36me3 levels in nuclear (top) and histone (bottom) extracts of wild-type (WT) and QKO mES cells. LAMIN B 
and H1 serve as loading controls. (C) Representative genome browser view of a chromosome 19 locus exemplifying 
differences in signal for H3K36me3 between wild-type, Dnmt TKO, Setd2 -/-, and QKO mES cells. Shown are read 
counts per 100  bp for ChIP‐seq and input samples. (D) HPLC-MS measurement of methylcytosine to cytosine 
indicates absence of methylation in the QKO. Error bars denote standard deviation from three independent replicate 
measurements.
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Supplementary Figure S2  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Supplementary Figure S2 - Loss of chromatin marks does not impair self-renewal capacity and 
proliferation of mES cells. 
(A) Wild-type (WT), Setd2 -/-, Eed -/-, Dnmt TKO and QKO mES cells were cultured in media containing leukemia-
inhibitory factor (+LIF) over three passages. (B) Ki-67 and DAPI cell cycle analysis by FACS. Shown are percentages of 
the different phases of WT, Setd2 -/-, Eed -/-, Dnmt TKO and QKO mES cells, n = 3. (C) Exemplary FACS analysis for 
Ki-67 and DAPI levels in WT, Setd2 -/-, Eed -/-, Dnmt TKO and QKO mES cells. Highlighted are percentages of cells in 
Ki67+ (G1 phase) and Ki67+/DAPI+ (S/G2/M phase) clusters. (D) Microscopy images of Setd2 -/-, Eed -/-, Dnmt TKO 
and QKO mES cells in feeder-free culture. 100x magnification. (E) Real-time qPCR detection of pluripotency marker 
genes Nanog, Pou5f1 (Oct4), Klf4, and Sox2 in WT, Setd2 -/-, Eed -/-, Dnmt TKO and QKO mES cells. Hprt serves as 
an internal control.
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Supplementary Figure S3 - Differential Gene Expression in Wild-type, Setd2-/-, Eed-/-, Dnmt TKO 
and QKO mES cells. 
(A) Boxplot showing the number of detected genes per single cell in Wild-type (WT), Setd2-/-, Eed-/-, Dnmt TKO and 
QKO mES cells. Counts extracted after removal of cell cycle effects, of cells with high mitochondrial gene content, and 
of genes with no counts. (B) PCA plot showing cluster of Eed-/- mES cells in comparison to random spreading of WT, 
Setd2-/-, Eed-/-, Dnmt TKO and QKO mES cells. (C) Violin plots showing the log-transformed gene counts for selected 
genes in single WT, Setd2-/-, Eed-/-, Dnmt TKO and QKO mES cells.
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Supplementary Figure S4
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Supplementary Figure S4 - Differential Gene Expression in Wild-type, Setd2-/-, Eed-/-, Dnmt TKO 
and QKO mES cells. 
(A) PAGODA framework to adjust the variance for mean expression levels after calculation of the coefficient of 
variation for each gene in the individual cell lines. (B)-(C) Gene expression variability analysis integration with 
chromatin modifications data using normalised ChIP-seq data summarised by gene for signals at the TSS (+/- 2 kb 
from the transcriptional start site) and in gene bodies (+2 kb from transcriptional start site). (B) Heatmap presenting the 
correlation scores between gene expression variability and various ChIP-seq signals. (C) DNA methylation and 
H3K27me3 levels at promoters or H3K36me3 levels in gene bodies were quantilised into deciles (left). Normalised 
gene expression variability in wild-type and corresponding mutant mES cell lines across the obtained deciles is shown 
on the right.
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Supplementary Figure S5  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Supplementary Figure S5 - Eed-/-, Dmnt TKO and QKO lead to loss of differentiation potential.
(A) Wild-type (WT), Eed-/-, Dmnt TKO and QKO mES cells were cultured without leukemia-inhibitory factor (-LIF). 
Shown are percentages of survival based on life-dead stain after the first passage in three independent experiments. 
(B) Cell count assay using live-dead stain at CA day 4 and NPC stage. Depicted are percentages for survival in WT, 
Eed-/-, Dmnt TKO and QKO cells. (C) Exemplary microscopy images of in vitro-derived cellular aggregates (CA) at day 
4 for wild-type, Eed-/-, Dmnt TKO and QKO cells. 100x magnification. (D) Exemplary microscopy images of in vitro-
derived, terminal neurons of wild-type, Eed-/-, Dmnt TKO and QKO cells at day 14. Shown are percentages of survival 
(plated/attached); 100x magnification. (E) Cell count assay using live-dead stain at terminal neuron stage d14. 
Depicted are percentages for survival in WT, Eed-/-, Dmnt TKO and QKO cells.
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Supplementary Figure S6 - Neurodifferentiation upon induction of a Setd2 knockdown.
(A) Schematics depicting the neuronal differentiation protocol (Bibel et al. 2007). Red arrows indicate start of 1 µg/ml 
doxycycline (DOX) induction over time. (B) Real-time qPCR of Setd2 in Tet-inducible Setd2 knockdown cells, 
differentiated to terminal neurons (day d14). Cells were treated with 1 µg/ml doxycycline, always or from day d10 on. 
Hprt was used as an internal control. (C) Time-resolved microscopy images of in vitro differentiation of tet-inducible 
Setd2 knockdown cell lines, starting from cellular aggregates (CA) day 6 over neuronal progenitors at day 8 to terminal 
neurons at day 10 and 14. Treatment with 1 µg/ml doxycycline (DOX) was initiated at day 0, 6, 8, and 9; 100x 
magnification. (D) Representative genome browser view of a chromosome 7 locus exemplifying differences in ChIP-Rx 
signal for H3K36me3 between Wild-type (WT), Setd2-/-, and Tet-inducible shSetd2 cells at terminal neuron stage day 
d16. Shown are read counts per 100 bp for ChIP-seq samples. shRNA was induced at day d10 with 1 μg/ml 
doxycycline (DOX).
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Supplementary Figure S7 - Single-cell RNA-seq analysis of wild-type vs. Setd2-deficient neuronal 
progenitors.
(A) Genome-wide signals at the transcription start site (TSS, +/- 2kb) of ChIP-seq datasets generated in bulk 
neuronal progenitor cells were associated with the quantified adjusted variance to analyse gene expression noise 
relationships with chromatin marks in wild-type (WT) and Setd2-/- NPCs. (B) H3K27me3 ChIP-seq-centered analysis 
of adjusted variance in wild-type (WT) and Setd2-/- NPCs. H3K27me3-levels at TSS (+/- 2kb) were quantilised from 
lowest to highest, showing a mild dependency of the adjusted gene expression variance on H3K27me3 signal in 
NPCs. (C) Unsupervised detection of genes that separate WT and Setd2-/- NPCs based on single-cell RNA-seq. 
Shown are log-fold change ranges of the expression for each gene between the two cell lines. (D) Validation of 
differential expression of genes identified in single-cell RNA-seq data sets of WT and Setd2-/- NPCs by RT-qPCR 
analysis (n=3). Hprt served as internal control. Statistical significance assessed by Student’s t-test (p** < 0.01, p*** < 
0.0001). 
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Supplementary Figure S8 - Effects of prolonged cultivation in the late progenitor stage and 
overexpression of neuronal transcription factors on Setd2-deficient NPCs.
(A) Microscopy images of in vitro-derived neurons shows successful differentiation of neuronal cells derived from wild-
type (WT) control ES cells and a partial rescue of cell death in Setd2-deficient cells by prolonged cellular aggregate 
formation (CAd12 days instead of CAd8, 4 days longer in retinoic acid treatment). Similar results were obtained from 
two independent replicates. (B) Shown are percentages of survival after dissociation (plated/attached) of at least two 
independent experiments described in (A). (C) CD24 and CD56-marker flow cytometry measurements in WT and 
Setd2-/- NPCs after prolonged (day 12) retinoic acid treatment. Shown are percentages of CD24-/CD56- double 
negative cells. (D) Differential expression analysis of various marker genes in WT and Setd2-/- NPCs by RT-qPCR 
(n=3). Hprt served as housekeeping control. Statistical significance assessed by Student’s t-test (p** < 0.01, p*** < 
0.0001). (E) Schematic overview of the generation of an ES cell line harbouring a Tet-inducible Neurogenin2-
Neurogenin1 (iNgn) transcription factor cassette in a Setd2-/- background. RMCE - recombination-mediated cassette 
exchange. (F) RT-qPCR analysis for Neurog1 expression in two independent Tet-inducible iNgn ES cell lines (n = 2) in 
comparison to the parental Setd2-/- only ES cell line. Hprt served as housekeeping control. Cells were treated with 1 
µg/ml doxycycline (DOX). (G) Immunoblot analysis for Neurogenin 1 (NEUROG1) in two Tet-inducible Neurogenin2-
Neurogenin1 (iNgn) ES cells in comparison to the parental Setd2-/- cell line. LAMIN B served as loading control. Cells 
were treated either without or continuously with 1 µg/ml doxycycline (DOX) during in vitro differentiation.
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Supplementary Figure S9 - Changes in the protein-chromatin interactome upon H3K36me3 loss.
(A) Stable isotope labelling with amino acids in cell culture (SILAC) and subsequent mass spectrometry detection of 
chromatin-bound proteins in WT and Setd2-/- mES cells. grey dots - nonspecific protein interactions, blue dots - 
significant only in one experiment, red dots - significant in both experiments. (B) Immunoblotting for Ser2-P Pol II and 
PCNA (loading control) of chromatin-bound fractions in wild-type and Setd2-/- mES cells. (C) Quantification of unique 
MS peptide counts obtained using the SETD2-SRI domain engineered chromatin reader-BASU fusion in comparison to 
a reader-free nuclear BASU control in WT and Setd2-/- ES cell backgrounds. (D) Venn diagram showing the overlap 
and difference between significantly enriched proteins from SRI-BASU WT and Setd2-/- mES cells. (E) Gene ontology 
(PantherGO) enrichment analysis for all differentially enriched proteins in SETD2-SRI domain engineered chromatin 
reader-BASU fusion in Setd2-deficient mES cells.  
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Table 1 - Differentially expressed genes in different mES cell lines from single-cell RNA-seq 
data of ~300 cells each (p-value < 0.01, log2FC > I0.4I).
Setd2-/- vs. WT log2FC pct.1 pct.2 TKO vs. WT log2FC pct.1 pct.2
Grk4--chr5 -1.2 0.95 0.99 Erdr1--chrY -0.96 0.7 0.99
Kcnq1ot1--chr7 -1.19 1 1 Dnmt3a--chr12 -0.85 0.61 0.95
Gm17821--chr12 -1.12 0.99 1 Ifitm1--chr7 -0.73 0.92 0.98
Vmn2r55--chr7 -1.04 0.97 0.98 Dnmt3b--chr2 -0.7 0.54 0.9
A630089N07Rik--chr16 -1 0.99 1 Plac8--chr5 -0.67 0.21 0.81
Zfp71-rs1--chr13 -0.54 0.79 0.83 Map1b--chr13 -0.63 0.65 0.92
Erdr1--chrY -0.46 0.96 0.99 Dnmt1--chr9 -0.62 0.51 0.95
Upp1--chr11 0.41 0.97 0.9 Apoe--chr7 -0.57 0.92 0.98
8430410A17Rik--chr6 0.43 0.95 0.79 Grb10--chr11 -0.56 0.45 0.82
Bnip3--chr7 0.51 0.88 0.75 Phlda2--chr7 -0.55 0.78 0.94
Rn45s--chr17 -0.55 1 1
Eed-/- vs. WT log2FC pct.1 pct.2 Ftl1--chr7 -0.53 1 1
Ifitm1--chr7 -0.94 0.86 0.98 Tdrd12--chr7 -0.51 0.48 0.87
Apoe--chr7 -0.85 0.92 0.98 Gm10664--chr8 -0.5 0.85 0.97
Gpx4--chr10 -0.74 1 0.99 Mir5109--chr5 -0.5 0.85 0.89
Mycn--chr12 -0.73 0.87 0.97 Fxyd6--chr9 -0.47 0.63 0.87
Mif--chr10 -0.7 1 1 Eef2--chr10 -0.47 1 1
Fn1--chr1 -0.69 0.96 1 Malat1--chr19 -0.43 0.93 0.98
Chchd10--chr10 -0.68 0.98 1 Eif2s3y--chrY -0.42 0.05 0.49
Ldhb--chr6 -0.64 0.8 0.91 Mif--chr10 -0.4 1 1
Foxp1--chr6 -0.62 0.54 0.91 Aldoa--chr7 -0.4 1 1
Gm10664--chr8 -0.59 0.89 0.97 Mirg--chr12 0.4 0.65 0.03
Eed--chr7 -0.58 0.7 0.94 Ube2a--chrX 0.4 0.99 0.9
Usp28--chr9 -0.58 0.65 0.93 Rtp3--chr9 0.41 0.87 0.62
Map1b--chr13 -0.58 0.77 0.92 Marcksl1--chr4 0.41 1 1
Trh--chr6 -0.58 0.62 0.84 mtNd3--chrM 0.41 1 1
Tdrd12--chr7 -0.57 0.51 0.87 Sub1--chr15 0.42 1 1
Sars--chr3 -0.57 0.9 0.96 Sparc--chr11 0.43 0.99 0.96
Tpi1--chr6 -0.55 0.83 0.93 Adprh--chr16 0.45 0.95 0.9
Pgk1--chrX -0.54 1 1 Jarid2--chr13 0.45 1 0.99
Gab1--chr8 -0.52 0.85 0.98 Dazl--chr17 0.46 0.6 0.23
Ifitm3--chr7 -0.52 0.44 0.7 Peg10--chr6 0.49 0.8 0.48
Lima1--chr15 -0.51 0.41 0.84 Ccrn4l--chr3 0.49 0.95 0.88
Ftl1--chr7 -0.5 1 1 Aass--chr6 0.5 0.65 0.26
Bnip3--chr7 -0.5 0.42 0.75 Mt1--chr8 0.56 1 0.98
Rn45s--chr17 -0.48 1 1 Rhox5--chrX 0.57 0.81 0.43
Utrn--chr10 -0.47 0.62 0.93 Gabarapl2--chr8 0.59 0.97 0.94
Dhx16--chr17 -0.47 0.82 0.95 Khdc3--chr9 0.6 0.9 0.56
Fxyd6--chr9 -0.47 0.66 0.87 Mt2--chr8 0.61 1 0.97
Malat1--chr19 -0.47 0.94 0.98 Rpl39l--chr16 0.64 0.95 0.71
ERCC-00113 -0.46 0.99 1 Mest--chr6 0.65 0.97 0.85
Pdk1--chr2 -0.45 0.55 0.89 Hspb1--chr5 0.68 1 0.98
Psat1--chr19 -0.44 1 1 Meg3--chr12 1.52 0.99 0.15
Pla2g1b--chr5 -0.44 0.83 0.94
Nedd4--chr9 -0.43 1 1 QKO vs. WT log2FC pct.1 pct.2
Fam60a--chr6 -0.43 0.97 0.99 Dnmt3a--chr12 -0.85 0.63 0.95
Phc1--chr6 -0.43 0.92 0.98 Apoe--chr7 -0.75 0.9 0.98
Plac8--chr5 -0.43 0.65 0.81 Dnmt3b--chr2 -0.73 0.56 0.9
Rbpms2--chr9 -0.42 0.95 0.99 Dnmt1--chr9 -0.63 0.47 0.95
ERCC-00096 -0.42 1 1 Plac8--chr5 -0.63 0.32 0.81
Fabp3--chr4 -0.42 0.6 0.78 Gpx4--chr10 -0.57 0.99 0.99
Gpt2--chr8 -0.41 0.43 0.81 Tpi1--chr6 -0.55 0.79 0.93
Emb--chr13 -0.41 0.89 0.97 Map1b--chr13 -0.53 0.76 0.92
Alg13--chrX -0.4 0.93 0.96 Fabp3--chr4 -0.53 0.48 0.78
Tdh--chr14 -0.4 0.98 0.99 Grb10--chr11 -0.52 0.52 0.82
Aldoa--chr7 -0.4 1 1 Ftl1--chr7 -0.5 1 1
Acaa2--chr18 0.4 0.82 0.4 Ldhb--chr6 -0.49 0.81 0.91
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Dcaf12l1--chrX 0.4 0.79 0.35 Chchd10--chr10 -0.48 0.98 1
Ddah1--chr3 0.4 0.91 0.6 Phlda2--chr7 -0.46 0.81 0.94
Ciapin1--chr8 0.41 0.99 0.98 Ifitm1--chr7 -0.45 0.96 0.98
Ass1--chr2 0.41 0.9 0.7 Fxyd6--chr9 -0.43 0.61 0.87
Basp1--chr15 0.41 0.96 0.91 Eif2s3y--chrY -0.42 0.06 0.49
Krt8--chr15 0.41 0.52 0.23 Sars--chr3 -0.42 0.89 0.96
Tex13--chrX 0.42 0.63 0.03 Pgk1--chrX -0.4 1 1
Bzw1--chr1 0.43 0.99 0.97 Gm10664--chr8 -0.4 0.9 0.97
Ckap4--chr10 0.43 0.93 0.76 S100a10--chr3 0.4 0.95 0.81
Tubb3--chr8 0.44 0.94 0.87 Rhox13--chrX 0.41 0.72 0.32
Hmgn2--chr4 0.45 1 0.99 Efhc2--chrX 0.42 0.72 0.07
Peg10--chr6 0.45 0.84 0.48 Gm13247--chr4 0.42 0.87 0.52
Rtp3--chr9 0.45 0.82 0.62 Tubb3--chr8 0.42 0.95 0.87
Mylpf--chr7 0.46 0.92 0.68 mtNd3--chrM 0.42 1 1
Cdc5l--chr17 0.47 0.99 0.97 Syce1--chr7 0.43 0.87 0.48
Khdc3--chr9 0.47 0.93 0.56 Dusp9--chrX 0.44 0.92 0.73
Gjb3--chr4 0.47 0.91 0.61 Cenpm--chr15 0.44 0.95 0.9
Pcsk6--chr7 0.48 0.92 0.45 Mirg--chr12 0.46 0.74 0.03
Bmp4--chr14 0.48 0.76 0.39 Vim--chr2 0.47 0.88 0.7
Pmaip1--chr18 0.48 0.82 0.58 Ybey--chr10 0.48 0.9 0.69
Jam2--chr16 0.49 0.9 0.64 Gabarapl2--chr8 0.5 0.99 0.94
Gpx1--chr9 0.49 1 0.99 Stmn2--chr3 0.51 1 0.98
Arl6ip1--chr7 0.51 1 0.97 Hspb1--chr5 0.51 1 0.98
Tex19.1--chr11 0.51 0.92 0.81 1700013H16Rik--chrX 0.54 0.54 0.04
Id1--chr2 0.51 0.83 0.74 Rtp3--chr9 0.56 0.85 0.62
Col4a1--chr8 0.52 0.72 0.14 Mt1--chr8 0.56 0.99 0.98
Llgl2--chr11 0.52 0.95 0.8 Gpx1--chr9 0.57 1 0.99
Atp5g1--chr11 0.53 1 0.99 Sparc--chr11 0.61 1 0.96
Klf4--chr4 0.53 0.95 0.78 Mest--chr6 0.62 0.96 0.85
S100a10--chr3 0.54 0.98 0.81 Rpl39l--chr16 0.74 0.96 0.71
Hmga2--chr10 0.55 0.87 0.48 Mt2--chr8 0.75 1 0.97
Cycs--chr6 0.57 1 1 Dazl--chr17 0.81 0.8 0.23
S100a6--chr3 0.58 0.96 0.71 Calcoco2--chr11 0.82 0.83 0.5
Tbx3--chr5 0.59 0.88 0.28 Meg3--chr12 1.69 0.98 0.15
H19--chr7 0.6 0.67 0.48
Dusp9--chrX 0.62 0.95 0.73
E130012A19Rik--chr11 0.62 0.97 0.89
Mt2--chr8 0.65 1 0.97
Slc25a4--chr8 0.66 1 0.97
Sparc--chr11 0.68 0.99 0.96
Lefty2--chr1 0.7 0.77 0.6
Hspb1--chr5 0.73 1 0.98
Calcoco2--chr11 0.83 0.92 0.5
Gabarapl2--chr8 1.02 1 0.94
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Table 2 - Cell Lines.
Cell Line Source
RMCE-competent, BirA+ mES cells Baubec, et al., 2013
Dnmt1, Dnmt3a, Dnmt3b-/- (TKO) mES cells Domcke, et al. 2015
Eed-/- mES cells Villasenor, et al., 2020
Setd2-/- mES cells Baubec, et al., 2015
Setd2-/- in TKO background mES cells generated
constitutive shSetd2 mES cells generated
Tet-inducible shSetd2 mES cells generated
Tet-inducible Ngn2-Ngn1 mES cells generated
Tet-inducible shExosc3 mES cells generated
Mettl14-/- mES cells generated
BASU-SRI WT mES cells generated
BASU-SRImut Setd2-/- mES cells generated
Setd2 endogenously tagged C-terminal FLAG-bio mES cells generated
Setd2-/- SETmut addback mES cells generated
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Table 3 - Oligo Sequences.
Target Sequence 5’-3’
Setd2 -/- exon 3 sgRNA 5’ GTCGGTCCGAAAGAGATCGA
Setd2 -/- exon 3 sgRNA 3’ AGCGTGTCCTCTCACGATAA
Setd2 -/- genotyping GGGGAAATCATCAAGATCGAA
Setd2 -/- genotyping TTAGGTCTCTGTAGGAATGGG
Setd2 shRNA 1 ATAGTGTGACCTCGCCTTATT
Setd2 shRNA 2 ACTTTGTGAGGATAGTATAAA
RT-qPCR primer Setd2 forward TGGGGCCTTCGTGTGCTATG
RT-qPCR primer Setd2 forward GCAATCTTCTCCACATGCTACTT
RT-qPCR primer Hprt forward GGACCTCTCGAAGTGTTGGA 
RT-qPCR primer Hprt reverse CAACTTGCGCTCATCTTAGGC
RT-qPCR primer Oct4 forward AAGCGAACTAGCATTGAGAACC
RT-qPCR primer Oct4 reverse CATACTCGAACCACATCCTTCTC
RT-qPCR primer Nanog forward GAACTCTCCTCCATTCTGAACCT
RT-qPCR primer Nanog reverse GACCATTGCTAGTCTTCAACCAC
RT-qPCR primer Sox2 forward ACAGCATGTCCTACTCGCAG
RT-qPCR primer Sox2 reverse ATGCTGATCATGTCCCGGAG
RT-qPCR primer Klf4 forward GCAGTCACAAGTCCCCTCTC
RT-qPCR primer Klf4 reverse TTTGCCACAGCCTGCATAGT
RT-qPCR primer Gata6 forward ACAGTCCCCGTTCTTTTACTGAG
RT-qPCR primer Gata6 reverse GGTACAGGCGTCAAGAGTGTTAC
RT-qPCR primer Fgf4 forward CTACCGGATAGGAGACCCTTAGA
RT-qPCR primer Fgf4 reverse CCTCTTGTCCATTCCTAGTTCCT
RT-qPCR primer Gata4 forward TGGGGAGATTAGGTGAGGGG
RT-qPCR primer Gata4 reverse ATTAGCTGCACAACTGGGCT
RT-qPCR primer Cdx2 forward CTTTGTCAGTCCTCCGCAGT
RT-qPCR primer Cdx2 reverse CATTGAGACCGTGGGCTACC
RT-qPCR primer Sox17 forward ATGCATTCTGGACCCGCTAC
RT-qPCR primer Sox17 reverse AGCTCTCCTGCCTCTCAGAA
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RT-qPCR primer Nestin forward CCTTGCCTAATACCCTTGAGACT
RT-qPCR primer Nestin reverse TTTTAGGATAGGGAGCCTCAGAC
RT-qPCR primer Olig2 forward TGACTCCCTGTCTGGGCTTA
RT-qPCR primer Olig2 reverse AGTGCTTCTGATACCCACGC
RT-qPCR primer Neurod1 forward CCCTACTCCTACCAGTCCCC
RT-qPCR primer Neurod1 reverse GAGGGGTCCGTCAAAGGAAG
RT-qPCR primer Pax3 forward CATGCCCGGGTTCTCTCTTT
RT-qPCR primer Pax3 reverse GTCCCATGGTTGCGTCTCTA
RT-qPCR primer Pax6 forward GCCACCAGACTCACCTGACACC
RT-qPCR primer Pax6 reverse CTCACCGCCCTTGGTTAAAGTC
RT-qPCR primer Crabp1 forward AACTTCAAGGTCGGAGAGGG
RT-qPCR primer Crabp1 reverse GCTCTCGGGTCCAGTAAGTT
RT-qPCR primer Onecut2 forward CGGGCCATGACAAAATGCTC
RT-qPCR primer Onecut2 reverse CCAGGGTGGTGTAAGCCATT
RT-qPCR primer Foxd3 forward GCAACTACTGGACCCTGGAC
RT-qPCR primer Foxd3 reverse GCTCCGAAGCTCTGCATCAT
RT-qPCR primer Neurog1 forward ATTACATCTGGGCGCTCACC
RT-qPCR primer Neurog1 reverse GAAGGTGGAGAAGGGCTGTC
RT-qPCR primer Sox4 forward CACAACGCCGAGATCTCCAA
RT-qPCR primer Sox4 reverse CCGACTTCACCTTCTTTCGC
RT-qPCR primer Msx3 forward GAGTGCGCGACTGGAGG
RT-qPCR primer Msx3 reverse CACAGAGCACGGACCACTC
RT-qPCR primer Epha3 forward TTGGGGACTTGCAAGGAGAC
RT-qPCR primer Epha3 reverse TTCAGAATGCGATCCCCGAG
RT-qPCR primer Zic1 forward TTGAAAGCAGCGCTGGAGTA
RT-qPCR primer Zic1 reverse CCTTCAAGCTCAACCCCAGT
Setd2-SRI domain cDNA forward ACAGCAGAAGCAGACACCTC
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Table 4 - Omics data sets.
ChIP-seq ATAC-seq
ES WT H3K27me3 (2 replicates) ES WT
ES WT H3K4me3 (2 replicates) ES Setd2-/-
ES WT H3K9me3 NPC WT
ES WT H3K36me3 (2 replicates) NPC Setd2-/-
ES WT total Pol II (2 replicates) RNA-seq
ES WT Ser2-P Pol II (2 replicates) ES scRNA WT
ES WT H4 panacetyl (2 replicates) ES scRNA Setd2-/-
ES Setd2-/- H3K27me3 (2 replicates) ES scRNA Eed-/-
ES Setd2-/- H3K4me3 (2 replicates) ES scRNA TKO
ES Setd2-/- H3K9me3 ES scRNA Setd2-/- in QKO
ES Setd2-/- H3K36me3 (2 replicates) NP scRNA WT
ES Setd2-/- total Pol II (2 replicates) NP scRNA Setd2-/-
ES Setd2-/- Ser2-P Pol II (2 replicates) ES PolyA-RNA WT
ES Setd2-/- H4 panacetyl (2 replicates) ES PolyA-RNA Setd2-/- 
NP WT H3K27me3 (2 replicates) NP PolyA-RNA WT
NP WT H3K4me3 (2 replicates) NP PolyA-RNA Setd2-/- 
NP WT H3K36me3 (2 replicates) TN PolyA-RNA WT
NP WT total Pol II (2 replicates) Mass Spectrometry
NP WT Ser2-P Pol II (2 replicates) ES SILAC WT vs Setd2-/-
NP WT H4 panacetyl (2 replicates) ES Ser2-P Pol II ChIP WT
NP Setd2-/- H3K27me3 (2 replicates) ES Ser2-P Pol II ChIP Setd2-/-
NP Setd2-/- H3K4me3 (2 replicates) NP Ser2-P Pol II ChIP WT
NP Setd2-/- H3K36me3 (2 replicates) NP Ser2-P Pol II ChIP Setd2-/-
NP Setd2-/- total Pol II (2 replicates) ES SRI-BASU WT
NP Setd2-/- Ser2-P Pol II (2 replicates) ES SRI-BASU Setd2-/-
NP Setd2-/- H4 panacetyl (2 replicates) ES empty-BASU WT
TNd6 H3K36me3 + Active Motif Spike-In WT (2 replicates) ES empty-BASU Setd2-/-
TNd6 H3K36me3 + Active Motif Spike-In Setd2-/- Nascent RNA-seq
TNd6 H3K36me3 + Active Motif Spike-In shSetd2 -DOX ES PRO-seq WT
TNd6 H3K36me3 + Active Motif Spike-In shSetd2 +DOX ES PRO-seq Setd2-/-
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5. Discussion
Here, we addressed the contribution of chromatin modifications to gene expression noise and 
cellular identity. We further validated the essentiality of these different chromatin modifications to 
the establishment of new gene expression programs assayed by the differentiation of respective 
knock-out embryonic stem cell lines to neuroectoderm lineages using a well-established 
neurodifferentiation protocol (Bibel et al., 2007). We were able to identify a novel role of SETD2 in 
the establishment of correct transcriptional profiles upon terminal differentiation. Additional 
experiments indicate that this could be potentially influenced by altered interactions with the co-
transcriptional splicing machinery. 
We first confirmed that H3K27me3, H3K36me3 or DNA methylation are dispensable for the 
survival and maintenance of pluripotency of ES cells (Lei et al., 1996; OGEE database, 
Chamberlain et al., 2008; Zhang et al., 2014). We could further validate that chromatin 
modifications like H3K27me3 and H3K36me3 are predictive of gene expression noise (Faure et al., 
2017) in ES cells (Figure 1). However, they do not contribute to a cell-to-cell variation in ES cells, 
since their targeted depletion did not show additional differences. It is already well established that 
ES cells are highly amendable to changes. Thus, adaptation to the loss of chromatin modifications 
could be a result of their plasticity in the pluripotent state. 
Another reason for the lack of transcriptional changes in ES cells, could be the redundancy 
between different chromatin marks. For instance, DNA methylation loss is important to silence 
repetitive elements, but is dispensable in ES cells due to the additional presence of H3K9me3 at 
these sites (Rowe et al., 2010; Karimi et al., 2011). Moreover, H3K36me3 has been recently shown 
to maintain levels of Disruptor of telomeric silencing 1-like (DOT1L)-mediated H3K79me2 on target 
genes critical for cancer cell survival (Skucha et al., 2018). Thus, it will be necessary to elucidate 
such a combinatorial effect or interplay between chromatin factors and marks on cell survival in the 
pluripotent state or during differentiation in more detail. For this, CRISPR-Cas9 screens could be 
utilised to induce synthetic lethality in mES cells lacking different chromatin marks or to identify 
factors which promote cell survival in these compromised cells during differentiation. Positive hits 
could then be characterised in regards to their mechanism of action which might give insights into 
potential therapeutical advances, too. 
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In contrast to the lack of changes in the pluripotent state, differentiation experiments to 
neuroectoderm showed that loss of these modifications does influence development in a critical 
manner (Figure 2). Consequences of H3K27me3 and DNA methylation loss established early after 
exit from pluripotency, when silencing of developmental genes becomes crucial for the 
establishment of correct gene expression programs (Bracken et al., 2006; Ambrosi et al., 2017). 
TKO/QKO cells might be further compromised due to the upregulation of repetitive elements upon 
exit of pluripotency which can potentially harm genome stability (Walsh et al., 1998). In contrast, 
loss of the H3K36me3 mark was dispensable for early neuronal development stages. Only upon 
terminal differentiation, Setd2-/- cell survival was dramatically compromised in agreement with the 
Setd2-/- in vivo phenotype, showing lethality and neuronal tube closure defects at E10.5 (Hu et al., 
2010). 
With the help of inducible knockdown experiments, we could further elucidate that SETD2/
H3K36me3 is necessary for lineage commitment of neuronal precursors to post-mitotic neurons, 
but its loss does not impair lineage maintenance. This goes in line with the differential expression 
of Setd2 during mouse development and in adult tissues, as its highest expression is present 
during embryonic development in comparison to adult tissues as seen from mouse ENCODE 
transcriptome data (Yue et al., 2014). Furthermore, other studies have shown that loss of SETD2 
decreases the differentiation and terminal commitment potential to lineages of other germ-layers 
such as the primitive endoderm (Zhang et al., 2014), implying that the loss of H3K36me3 generally 
compromises terminal differentiation in a non-lineage specific fashion.
We were able to identify a change in transcriptional rewiring in Setd2-/- neuronal progenitors as the 
cause for the observed differentiation failure (Figure 3). Changes in transcription of Setd2-/- 
neuronal progenitors were minor as seen in other cellular models (Ho et al., 2016; Park et al., 
2016a; Tiedemann et al., 2016), but most differentially expressed genes indicated an impaired 
neuronal gene expression network. Setd2-/- NPCs also failed to control expression of other lineage 
marker or to completely downregulate pluripotency markers. However, this change in bulk gene 
expression could not be explained by increased transcriptional noise in single Setd2-/- NPCs, as it 
has been recently suggested based on the association of H3K36me3 with genes of low cell-to-cell 
variation in mES cells (Faure et al., 2017).
Instead, we suggest that the reduced differentiation into final lineages could partially caused by 
failure to establish accurate gene expression patterns in absence of SETD2. We were further able 
to partially bypass this inaccuracy by overexpression of a major transcriptional driver for neuronal 
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lineage determination (Figure 4). Its induced expression moderately reverted incorrect gene 
expression in the H3K36me3-deficient neuroprogenitors and let to an increased in survival. 
Nonetheless, we only investigated a subset of genes changed in the rescued cells which might not 
be representative for all transcriptome changes. Thus, additional bulk RNA-seq experiments of 
mutant cells expressing an induced neuronal transcription factor will shed light on an overall rescue 
of the SETD2/H3K36me3 deficiency. 
Since the correction of gene expression did not lead to a full reversion of the differentiation 
phenotype, we need to consider that there are other mechanisms in place which fail to operate 
correctly in the absence of SETD2. For instance, m6A on longer exons or towards the 3’ end of the 
gene correlates with the accumulation of H3K36me3 on actively transcribed genes in mES cells 
(Huang et al., 2019). Loss of H3K36me3 potentially leads to an impaired recruitment of the m6A 
machinery to the nascent mRNA. Reduced m6A levels can have various effects on mRNA 
processing such as a stabilisation of target transcripts or a failure in mRNA splicing and export, 
potentially influencing protein abundance (see chapter 1.1.4.3.). These effects could provide 
explanations for the differential expression in Setd2-/- NPCs, such as the insufficient 
downregulation of pluripotency marker genes. Thus, measuring global and genome-wide m6A level 
changes in the knock-out cell line by mass spectrometry will give insights into a potential 
relationship between mRNA methylation and the observed cell death. However, the direct 
relationship between METTL enzymes and H3K36me3 remains to be elucidated. Additionally, we 
did not observe differential transcript abundance of pluripotency genes in our analyses of knock-
out cells as suggested recently in mES cells (Huang et al., 2019).
Another alternative explanation might be the non-histone directed methyltransferase activity of 
SETD2. Neuronal progenitors have to undergo drastic morphology changes when committing to 
become post-mitotic neurons which is highly dependent on the precise arrangement of the 
cytoskeleton. SETD2 has been recently shown to methylate not only H3K36me3, but also the 
lysine 40 of α-tubulin (TubK40me3) (Park et al., 2016b), which is necessary for genomic stability. 
Thus, Setd2-deficient cells might not be able to adapt to the new structural requirements and 
induce cell death. Therefore, next steps will need to include TubK40me3 level analysis by 
immunoblot experiments and microtubule immunoflouresence staining in mutant neuronal 
progenitors and surviving post-mitotic neurons. However, since a defect in the cytoskeleton would 
be expected to impair all the cells to the same extent, α-tubulin methylation may not be sufficient to 
fully explain the remaining ~20 % surviving cells after terminal differentiation or the considerable 
rescue observed upon Neurogenin 1/2 expression.
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Differential gene expression can originate from many different variabilities in pathways, cues and 
machineries involved in the process of transcription and co-transcriptional processes. We explored 
several different possibilities to assess the gene expression changes upon SETD2/H3K36me3 loss 
in neuronal progenitor cells. First, we were not able to detect major changes in the chromatin 
landscape through ChIP-seq experiments of Pol II and other histone modifications, except for a 
known increase in acetylation upon H3K36me3 loss (Lee et al., 2013). Impaired compaction of 
chromatin after Pol II passage during transcription due to an hyperacetylated state can lead to an 
increase in spurious transcription from sites. Nonetheless, we did not observe any increase in 
spurious initiation, antisense transcription in absence of SETD2. Furthermore, ATAC-seq 
experiments did not suggest increased accessibility at transcribed gene bodies in absence of 
H3K36me3. However, the presence of spurious transcripts and initiation remains to be analysed 
using more sensitive assays such as PRO-seq or CAGE-seq (Shiraki et al., 2003).
Chromatin modifications stand in crosstalk to each other, are mutually exclusive and sometimes 
offer redundancy (Zhang et al., 2015). This could further explain the lack of changes in the 
H3K36me3-depleted chromatin environment in NPCs. Investigation of other chromatin marks need 
to be assessed to rule out their role in altering the transcriptional output. For instance, H3K27me1 
coincides with H3K36me3 to promote active transcription (Ferrari et al., 2014). In the absence of 
H3K36me3, H3K27me2 accumulates instead and represses gene transcription, potentially 
influencing the whole transcriptome. Additionally, technical draw-backs of ChIP sequencing need to 
taken into consideration. For instance, Pol II ChIP-seq only captures a static view at a point in time, 
which might not recapitulate dynamic changes in Pol II elongation behaviour that has been shown 
to be influenced by H3K36me3 (Jonkers et al., 2014; Wen et al., 2014). Dynamic methods that 
allow for this are nuclear run-on assays such as PRO-seq that map the genome-wide distribution 
of transcriptionally-engaged Pol II at base-pair resolution (Jonkers and Lis, 2015). Applying this to 
our cell system could help to elucidate transcriptional profiles in presence and absence of 
H3K36me3 at high resolution by globally mapping strand-specific Pol II density. 
The downstream effects of histone K36 methylation are facilitated by PWWP-domain reader 
proteins (Hyun et al., 2017). Thus, we decided to analyse the chromatin-protein interactome in 
presence or absence of SETD2/H3K36me3 using mass spectrometry. First analyses of chromatin-
bound fractions in WT and Setd2-/- mES cells using SILAC did not offer enough resolution to 
identify differential protein interactions at actively transcribed gene bodies. Therefore, we 
performed Ser2-P Pol II ChIP-MS in mES and neuronal progenitor cells to enrich for active 
chromatin sites. We could indeed identify proteins known to be involved in elongation such as Pol 
II subunits or elongation factors as well as proteins involved co-transcriptional processes, but there 
 96
5. Discussion
Dissertation by Christina Ambrosi 
were no significant differences between wild-type and Setd2-/- cells. Since ChIP involves cross-
linking and antibody-based enrichment, it might again not be the most optimal approach. Cross-
linking of DNA and protein by formaldehyde only covers proteins in a physical range of ~2 
angstrom (Hoffman et al., 2015). Thus, a pulldown for the elongating form of the multi-subunit 
complex Pol II might not be able to reveal changes caused by the lack histone modifications. This 
initial MS run will need repetition and optimisation, e.g. by increasing the range of interactions 
using the disuccinimidyl glutarate (DSG) cross-linker in addition to formaldehyde (Tian et al., 
2012). However, passaging of Pol II might generally disrupt the chromatin environment which is 
usually present at H3K36me3-rich sites, rendering this method less suitable for our purpose.
In order to avoid the disadvantages mentioned above, we utilised our recently described tool 
ChromID (Villasenor et al., 2020). The non-redundant SETD2 binds with its SRI-domain to the 
Ser2-P CTD of Pol II (Kizer et al., 2005). Fusing this domain to an active BirA ligase (BASU) and 
analysing the biotinylated, nuclear proteins helped to understand the chromatin interactome at 
H3K36me3 gene bodies. We were able to identify a small number of interactions in mES cells 
which were significantly lost in the Setd2-/- background. These proteins were amongst others 
enriched for the process of co-transcriptional splicing, indicating that lack of H3K36me3 indeed 
could influence the recruitment of splicing factors to chromatin (Luco et al., 2010; Zhu et al., 2017). 
In order to assess to what extent these factors play a role for the impaired progression to the 
terminal neuronal lineage, remains to be elucidated by repetition of the SRI-BASU experiments in 
neuronal progenitors. If the depletion of splicing factors holds true in NPCs, these protein hits need 
to be further characterised in order to find the link between observed gene expression changes 
and depletion of factors involved in splicing. 
Analysis centered on the differentially expressed genes in bulk RNA-seq data sets will also give 
further insights on how splicing or spurious transcription in Setd2-/- cells is altered. This can be 
extended by enriching for spurious transcripts in the cell through interference with the exosome 
complex, by utilising established inducible shExosc3 cell lines in wild-type and Setd2-/- 
backgrounds. Splicing defects can also generally alter the mRNA abundance which can highly vary 
between different cells in an isogenic population (La Manno et al., 2018). Thus, to quantitatively 
assess an effect of H3K36me3 loss on mRNA abundance and its time-resolved changes during 
lineage progression, referred to as RNA velocity, the single-cell RNA-seq data sets in hand need 
further exploration to examine differential kinetics of transcription in Setd2-/- cells.
It was recently shown that H3.3K36M mutants do not show an impaired differentiation potential 
towards neuroectoderm (Gehre et al., 2020). Even though the H3.3 incorporation at this stage is 
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not complete and canonical H3 histone is still present, the successful progression in lineage 
commitment hints to an individual role of SETD2 independent of its histone mark. We have recently 
generated Setd2-/- ES cells expressing a catalytic dead (SET domain) mutant in order to 
distinguish individual roles between the methylation mark and the enzyme. However, 
neurodifferentiation experiments as well as transcriptome and proteome analysis of these cells are 
still pending. 
In summary, we showed here that there is a connection between SETD2-mediated H3K36me3 and 
rewiring of gene expression circuits during terminal differentiation. However, it remains to be 
investigated how the establishment of transcriptional programs is specified by individual and 
combined roles of the enzyme, its mark and downstream signalling pathways. Dissecting their 
individual and overlapping contribution to transcription and RNA maturation could provide 
significant insights into gene regulation, and will help to understand processes which lead to 
altered gene expression in disease. Given the presence of the H3K36me3 mark on all transcribed 
genes of a cell, the concerted influence could potentially affect the entire transcriptional output and 
subsequently the whole identity of a cell. Accordingly, it is easily conceivable that analysing such 
factors and chromatin marks involved in cancer development with respect to their function in 
transcription can lead to the identification of new therapeutic targets and improved treatment.
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6. Material and Methods
Culturing and differentiation of ES cells to terminal neurons
Mouse embryonic stem cells (159-2) were cultured on 0.2 % gelatine-coated dishes in DMEM 
(Invitrogen) supplemented with 15 % fetal calf serum (Invitrogen), 1× non-essential amino acids 
(Invitrogen), 1x Glutamax (Invitrogen), homemade leukemia inhibitory factor (LIF), and 0.001 % b-
mercaptoethanol (Invitrogen) at 37°C in 7 % CO2. For -LIF experiments ES cells were cultured 
without LIF on gelatine-coated plates. Inducible knockdown as well as iNgn cell lines were treated 
with 1 µg/ml doxycycline (Sigma Aldrich). ES cell lines were differentiated as previously described 
(Bibel et al), except that no feeder cells were used. Microscopy images were taken with 100 x 
magnification. Cell count assays were performed using live/dead stain (BioRad) and TC20™ 
Automated Cell Counter (BioRad). For DNA damage analysis, cells were treated for 1 h with 1µM 
Camptothecin (Sigma Aldrich) and processed for QIBC as described previously (Teloni et al., 
2019).
Cell line generation
All generated cell lines are found in Table 2. Setd2-/- in Dnmts TKO mouse ES cell background 
(courtesy of Dirk Schübeler, FMI, Switzerland) was generated using CRISPR/Cas9. The sgRNAs 
target two parts the third exon, resulting in a deletion of approximately 200 bp. The Cas9 sgRNA 
sequences were cloned into the pX330-U6-Chimeric_BB-CBh-hSpCas9 (addgene 42230). 
Transfections together with pRR-Puro recombination reporter (Flemr and Buhler, 2015) (Addgene 
65853) were conducted using Lipofectamine 3000 reagent (L3000015, Thermo Fisher Scientific) at 
a 2:1 Lipofectamine/DNA ratio in OptiMEM (31985070, Thermo Fisher Scientific). 36 h later cells 
were treated with 2 μg/ml puromycin for another 36 h. Setd2-/- ES cells (Baubec et al., 2015) with 
an inducible neurotranscription factor (iNgn) were generated as described previously with 
adaptations (Busskamp et al., 2014). Doxycline-inducible rtTA3 system (addgene 61472) was 
randomly integrated into Setd2-/- ES cells (Baubec et al., 2015) using 20 µg of linearised plasmid 
with bleomycin resistance. Cells were treated with 200 µg/ml ZeocinTM (InvivoGen). The TetON-
inducible Ngn2-2A-Ngn1 Setd2-/- ES cells were then obtained by recombinase-mediated cassette 
exchange (RMCE) (Baubec et al., 2013), based on transfection of RMCE constructs (addgene 
61471 into pCAGbio_V6) with an expression plasmid for CRE recombinase in a 1:0.6 DNA ratio. 
Similarly, shRNA-inducible ES cells were generated using a TetON-inducible system for a shRNA, 
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expressed from the RMCE site, against Setd2. For ChromID cell line generation, BASU or 
TurboID-linked SRI domain was cloned into RMCE targeting vector parbit-v9 and SRI-ChromID ES 
cells in a wild-type as well as Setd2-/- background were generated as described previously 
(Villasenor et al., 2020). Positive clones were confirmed by Sanger sequencing, RT-qPCR and 
immunoblotting. Cloning strategies are available on request. Single guide RNA, shRNA and oligo 
sequences are collected in Table 3.
Immunoblotting
Crude nuclear extracts cells were obtained as described in (Manzo et al., 2018), histones were 
extracted acid extracted according to (Villasenor et al., 2020) and chromatin-bound fractions 
(chromatin enrichment for proteomics, ChEP) were obtained according to (Kustatscher et al., 
2014). Membranes were blocked with 5 % (wt/vol) milk in TBS-0.1 % Tween20 and incubated with 
primary antibodies against SETD2 (1:1000, A11271, ABclonal), Pol II (MABI0601, MBL), PCNA 
(sc-56, Santa Cruz Biotechnology), Phospho-H2A.X (Ser-139, 1:8000, #9718, Cell Signaling), 
H3K36me3 (1:5000, ab9050, abcam), anti-histone H1 (1:5000, 05-457, Millipore), anti-NEUROG1 
(1:1000, sc-100332, Santa Cruz Biotechnology), or anti-LAMIN B1 (1:1000, sc-374015, Santa Cruz 
Biotechnology) overnight at 4°C. Protein detection was facilitated using species-specific antibodies 
conjugated to horseradish peroxidase and Pierce® Peroxidase IHC Detection Kit (Thermo 
Scientific). 
RNA isolation, cDNA synthesis and RT-qPCR 
RNA was isolated from mouse ES cells, cellular aggregates at day 4 and NPCs using the RNeasy 
Plus mini kit (Qiagen). Coding DNA was synthesised from 2 μg isolated RNA with SuperScript III 
First-Strand Synthesis (Invitrogen) for 60 min at 50°C using Oligo(dT)18 (Thermo Fisher), followed 
by heat-inactivation for 10 min at 85°C. Residual RNA was digested with 2 units RNaseH (NEB) for 
20 min at 37°C. Target sequences were quantified by real-time qPCR analysis using a KAPA SYBR 
FAST qPCR Kit (Sigma Aldrich) on a QuantStudio 5 Real-Time PCR System (Applied Biosystems). 
Comparative quantification (ddCt) was used to determine transcript levels relative to the 
housekeeping gene Hprt. Each sample was at least run in technical triplicates. Oligo sequences 
available in Table 3.
Surface marker and cell cycle analysis using flow cytometry
For CD24 and CD56 measurements in mES cells and neuronal progenitors, single-cell 
suspensions were obtained through trypsinization and  filtered through 40-um cell strainers (BD 
Biosciences). For cell surface marker analysis, cells were stained for 30 min at 4° C with saturating 
concentration of anti-CD24a and anti-CD56 monoclonal antibodies  in the presence of anti-CD16/
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CD32 (eBioscience). For live dead cell exclusion,  LIVE/DEAD Fixable Near-IR Dead Cell Stain 
(Invitrogen) was used. For cell cycle and Ki-67 measurements, single-cell suspensions were fixed 
and permeabilised for 30 min at 4°C with Foxp3/Transcription Factor Staining Buffer set 
(eBioscience). Anti-Ki-67 or isotype control (eBioscience) was added and incubated for 45 min at 
RT in permeabilisation buffer. DAPI (5 µg/ml, Sigma) was added as a fluorescent DNA stain 5 min 
prior to FACS measurements and incubated at RT in the dark. Samples were acquired and data 
was analysed as in (Villasenor et al., 2020).
Chromatin immunoprecipitation (ChIP), -sequencing and read processing 
Histone ChIP experiments and sequencing were performed as previously described (Villasenor et 
al., 2020). Here, 100 µg chromatin were incubated with 5 µg of either total Pol II (MABI0601, MBL), 
Ser2-P RNA Pol II (ab5095, abcam), H3K36me3 (ab9050, abcam), H3K4me3 (ab8580, abcam), 
H4-panacetyl (B_2687872, ActiveMotif), H3K27me3 (C15410195, diagenode) antibody. Wiggle 
tracks were obtained with QuasR and visualised with the UCSC genome browser (https://
genome.ucsc.edu). For quantitative ChIP-Rx sequencing experiments, the Spike-in antibody 
(61686) and Drosophila melanogaster chromatin (53083) from Active Motif were used according to 
manufacturer’s instructions.
Genomic coordinates and analysis at gene bodies
Analysis were performed as described previously (Teloni et al., 2019), using the Mus musculus 
assembly version NCBI Build 37 mm9 from July 2007 and RefSeq gene predictions at NCBI from 
the annotation release: GCF_000001635.18. For genomic analyses, read counts overlapping with 
gene bodies (+2 kb from TSS) were used.
Assay for Transposase-Accessible Chromatin (ATAC)-sequencing
ATAC-seq experiments were performed in biological duplicates using wild-type and Setd2-/-mouse 
embryonic stem cells and neuronal progenitors. The tagmentation reaction was performed with 
50,000 cells as previously described (Buenrostro et al., 2013) with minor adjustments of the 
protocol, using the Nextera DNA Library Prep Kit (Illumina) together with the barcoded primers 
from the Nextera Index Kit (Illumina). In brief, an additional size selection step was performed after 
the first 5 cycles of library amplification. For this, the PCR reaction was incubated with 0.6 x 
volume of Ampure XP beads (Beckman Coulter) for 5 min to allow binding of high molecular weight 
fragments. Beads containing long DNA fragments were separated on a magnet and the 
supernatant containing only small DNA fragments below roughly 800 bp were cleaned up using 
MinElute PCR purification columns (Qiagen). All libraries were amplified for 12 cycles in total, 
visualised and quantified with a TapeStation2200 (Agilent), and sequenced as mentioned above. 
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ATAC-seq data processing and differential analysis
Raw sequencing reads were processed as discussed in (Villasenor et al., 2020) (TrimGalore, 
QuasR, Bowtie1, mm9, PCR duplicate removal). To call differentially open chromatin sites between 
the various conditions, the mapped reads of all conditions were merged into one alignment file. 
Peaks were called on the merged sample using MACS2 with --nomodel --shift -100 --extsize 200 --
keep-dup all, to obtain a consensus peak set with equal contribution of each sample independent 
of the respective biological treatment (Lun and Smyth, 2014). The combined peak set was used to 
build a count matrix using the aligned reads of the individual samples. Differential peaks between 
sample groups were identified using edgeR (Robinson et al., 2010). For this, the count matrix was 
filtered for peaks with low coverage across all samples based on a average CPM value < -1, 
resulting in a final set of 131271 peaks with p-values below 0.001266164. The remaining counts 
were normalised using the total library size as well as edgeR’s TMM derived normalisation factors. 
Between two sample groups, only regions with a log fold change above > 0.5 and a FDR value < 
0.05 were considered as differentially accessible for further analysis.
PolyA RNA-sequencing and differential gene expression analysis
Total RNA was isolated from NPCs using the RNeasy Plus mini kit (Qiagen). RNA integrity was 
measured using a model 2100 Bioanalyzer (Agilent). PolyA-tailed mRNAs were isolated and 
enriched using NEB Next Poly(A) mRNA Magnetic Isolation Module according to manufacturer’s 
instructions. Libraries for 1 µg mRNA were prepared using NEB Next UltraTM II Directional RNA 
Library Prep Kit for Illumina. Sequencing of library pools and read processing were performed as 
described above. Read counts per gene were generated using STAR (Dobin et al., 2013) based on 
the gene transcript annotation gencode.mouse.v1.annotation.gtf (NCBIM37, mm9). Differential 
gene expression was performed using the DESeq2 package with significance set to p-value < 0.05 
and log fold change > I1I (Love et al., 2014). Gene ontology enrichment analysis on differentially 
expressed was performed using Protein Analysis Through Evolutionary Relationships (PANTHER) 
classifications (Thomas et al., 2003).
Single-cell RNA-sequencing and processing
Dissociated ES cells and NPCs were sorted using a FACS Aria III cell sorter (BD Bioscience) with 
gates set based on size and forward scattering to exclude debris and doublets. The SORT-seq 
single-cell RNA-sequencing protocol was carried out as described previously (Hashimshony et al., 
2016; Muraro et al., 2016). Single cells were sorted in four 384-well plates (Biorad) provided by 
Single Cell Discoveries, containing 5 μl of CEL-Seq2 primer solution in mineral oil, further 
containing 24 bp polyT stretch, a 4 bp random molecular barcode (UMI), a cell-specific barcode, 
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the 5’Illumina TruSeq small RNA kit adaptor and a T7 promoter. After sorting, the plates were 
immediately placed on dry-ice and stored at -80°C until sent for sequencing. SORT-seq data from 
Single Cell Discoveries were delivered as tables with estimated original transcript counts by a 
Poisson correction (Grun et al., 2014). Cells were quality checked using scater v1.12.2 (McCarthy 
et al., 2017). Cells fulfilling the following attributes were subjected to downstream analysis: 
deviating less than three NMADS from the total reads, total features, and mitochondrial reads 
distributions; and on top of that, manually gated to have less than 15 % mitochondrial reads and 
more than 2000 features. Cell cycle phase was assigned using scran version 1.10.1 `cyclone` 
function with default parameters (Scialdone et al., 2015). Seurat v3.0.2 was used to normalise read 
counts, regress out the library size, the mitochondrial reads proportion per cell and cell cycle 
phase, find variable features with the `vst` method, integrate multiple plates as in, dimensionality 
reduce the data (PCA, t-SNE, UMAP), cluster cells and test for differentially expressed genes 
(Stuart et al., 2019). 
Variability analysis
Variability analysis was carried out using the PAGODA framework implemented within the `scde` 
package v1.99.1 (Fan et al., 2016). Briefly, we computed cell-specific error models and estimated 
the residual gene expression variance while attributing an adjusted (normalised) variability value to 
each gene within each genotype. This adjusted variability leverages the technical and intrinsic 
biological components of the variation, providing a score that is comparable across genes and 
independent from the gene expression level. Gene expression variability analysis integration with 
chromatin modifications data was carried out using normalised ChIP-seq data (Table 4) 
summarised by gene for signals at the TSS (+/- 2 kb from the transcriptional start site) and in gene 
bodies (+2 kb from transcriptional start site). ChIP-seq signals were quantilised into deciles to plot 
trends of  normalised gene expression variability. Data analysis was carried out in R v3.6.1. Source 
code for analysis is available upon request.
SRI-ChromID and ChIP-MS sample preparation
ChIP-MS samples were obtained by chromatin immunoprecipitation as described above. 150 µg 
chromatin from wild-type and Setd2 -/- ES cells and NPCs and 7.5 µg Ser2-P Pol II antibody 
(abcam) were used for the each IP. Instead of de-crosslinking, protein were eluted by boiling 
Protein-A beads in Laemmli buffer for 20 min. Proteins were run on a NuPAGE-Novex Bis-Tris 4-12 
% (Invitrogen), stained with InstantBlue™ Ultrafast Protein Stain (Sigma Aldrich) and each sample 
lane was cut into six equally-sized fractions excluding the antibody bands. Peptides were extracted 
according to (Rosenfeld et al., 1992). ChromID samples were prepared as previously described 
(Villasenor et al., 2020). In brief, nuclear extraction of SRI-ChromID mES cells of WT and Setd2-/- 
 103
6. Material and Methods
Dissertation by Christina Ambrosi 
background was performed after biotin incubation for 12h (BASU) and 1h (TurboID), followed by 
affinity purification through streptavidin beads, high-stringency washes and on-bead digestion. 
Label-free MS data acquisition and analysis
MS data acquisition was performed as described in (Villasenor et al., 2020). In brief, samples 
(quadruplicates per condition) were cleaned up by C18 StageTips. Peptides were detected by 
data-dependent acquisition via mass spectrometry. Proteins were identified and quantified from the 
raw acquisition data as well as processed using MaxQuant (Cox and Mann, 2008). The mouse 
reference proteome (UniProtKB/Swiss-Prot) version 2018_12 combined with manually annotated 
contaminant proteins was searched with protein and peptide false discovery rate (FDR) values set 
to 1% and the match-between-runs algorithm was enabled. Statistical analysis was conducted 
using Proteus (bioRxiv 416511). LFQ intensity values were log2-transformed and outlier samples 
determined based on low peptide or protein counts. Subsequently, Proteus’ limma-wrapper (Ritchie 
et al., 2015) was used to determine potential interactors in respective contrasts (bait vs. control of 
same genetic background) with an FDR of 0.05 as significance threshold. For gene ontology term 
analysis, differentially enriched proteins of bait conditions were combined and parsed to enrichr 
(Kuleshov et al., 2016).  
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Abstract
DNA methylation is one of the most extensively studied epigenetic marks. It is involved in transcriptional gene
silencing and plays important roles during mammalian development. Its perturbation is often associated with
human diseases. In mammalian genomes, DNA methylation is a prevalent modification that decorates the
majority of cytosines. It is found at the promoters and enhancers of inactive genes, at repetitive elements, and
within transcribed gene bodies. Its presence at promoters is dynamically linked to gene activity, suggesting
that it could directly influence gene expression patterns and cellular identity. The genome-wide distribution
and dynamic behaviour of this mark have been studied in great detail in a variety of tissues and cell lines,
including early embryonic development and in embryonic stem cells. In combination with functional studies,
these genome-wide maps of DNA methylation revealed interesting features of this mark and provided
important insights into its dynamic nature and potential functional role in genome regulation. In this review, we
discuss how these recent observations, in combination with insights obtained from biochemical and functional
genetics studies, have expanded our current knowledge about the regulation and context-dependent roles of
DNA methylation in mammalian genomes.
© 2017 Elsevier Ltd. All rights reserved.
Introduction
DNA methylation is a prevalent chemical modifi-
cation of cytosine bases (Fig. 1) and is found in
many eukaryotic genomes [1,2]. It is associated
with long-term transcriptional repression and is
faithfully propagated during mitosis, suggesting a
potential memory mechanism for transcriptional
regulation [3,4]. In mammals, this mark is involved
in the repression of gamete-specific genes during
development [5] or entire chromosomes, for exam-
ple, during mammalian X chromosome inactivation
[6], and is essential for genomic imprinting by
guiding allele-specific gene expression [7,8]. Fur-
thermore, DNA methylation is required for the
silencing of repetitive elements [9,10], thereby
maintaining genome stability [11]. It is also consid-
ered to be important for cellular differentiation as
well as identity and is of relevance to human health
[12].
Although DNA methylation is one of the best
mechanistically understood epigenetic modifica-
tions, the exact role of DNA methylation in regulating
genome function and how this differs from gene to
gene or genomic context need to be uncovered. To
date, it still remains to be fully understood how
specific DNA methylation patterns are precisely
generated, maintained, read, or erased along the
genome, in order to better understand its role as an
epigenetic signal that regulates biological process-
es. The promising emergence of high-throughput
sequencing has offered to explore this epigenetic
mark at a genome-wide scale and at high resolution.
DNA methylation measurements from various cell
types and developmental stages, in combination
with additional genome-wide datasets of chromatin
modifications and transcriptional activity, have gen-
erated a great amount of knowledge and offer
important insights into the dynamic regulation and
function of this relevant modification. Building up on
0022-2836/© 2017 Elsevier Ltd. All rights reserved. J Mol Biol (2017) 429, 1459–1475
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this knowledge, this review focuses on general
features of DNA methylation and how this modifica-
tion is regulated and discusses the dynamics of
genome-wide DNA methylation patterns in murine
embryonic stem (mES) cells and during early mouse
development.
DNA Methyltransferases (DNMTs), the
Writers of DNA Methylation
In mammals, three conserved enzymes are
responsible for the deposition of methyl mark to the
fifth carbon atom of cytosine bases and are essential
for normal development [13,14]. Therein, DNMT3A
and DNMT3B catalyse de novo DNA methylation,
whereas DNMT1 is the maintenance enzyme, which
restores the fully methylated state of DNA after
replication [15] (Fig. 1). In line with this role, DNMT1
prefers hemimethylated DNA as a substrate and is
localised to the replication foci, ensuring the inher-
itance of methylation patterns [16–18]. Functional
studies, however, have indicated that this distinction
does not fully reflect their activities in vivo. For
example, in mES cells lacking DNMT3A and
DNMT3B, DNMT1 alone is not sufficient to faithfully
maintain DNA methylation levels, indicating that the
de novo enzymes are involved in either filling up
gaps after DNA replication or are required to
counteract active demethylation [19–21]. Recently,
a new member of the DNMT family has been
identified: DNMT3C. This novel DNMT evolved as
a duplication of DNMT3B in rodents and is respon-
sible for DNA methylation of retrotransposons during
male germ cell development [22].
At a biochemical level, the structure of DNMTs and
the mechanisms of establishment or maintenance of
DNA methylation have been intensively studied over
the last decades, bringing considerable insights into
regulatory mechanisms that modulate their targeting
to the genome or their enzymatic activity (reviewed
in Refs. [23,24]) (Fig. 2a). All DNMTs share a similar,
multidomain architecture, which can be distin-
guished into a variable N-terminal part containing
regulatory domains and a C-terminal region harbour-
ing the catalytic methyltransferase domain. The
latter exhibits conserved amino acid motifs typical
for DNMTs described in bacteria and is responsible
for DNA binding and its chemical modification [15].
The N-terminal regulatory domains strongly differ
between DNMT1 and DNMT3 proteins and could
play an important role in specifying their activity
along the genome. Most notably, the N-terminal part
of DNMT1 contains domains that mediate anchoring
to the replication fork [18,25] or specify the prefer-
ence for hemimethylated substrates through auto-
inhibition upon binding to unmethylated DNA [26].
The N-terminal part of the DNMT3 methyltransfer-
ases contains two conserved domains. The
ATRX-DNMT3-DNMT3L domain of DNMT3A,
DNMT3B, and DNMT3L interacts with histone H3
tails and is blocked by the methylation of the lysine-4
residue (H3K4me3) [27–29], whereas the PWWP
domain of DNMT3A and DNMT3B contains a
conserved aromatic cage that recognises histone
H3 lysine-36 trimethylation (H3K36me3) in vitro and
in vivo [30–32] and is also required for the localisa-
tion to pericentromeric repeats [33]. In contrast,
DNMT3C and DNMT3L lack the PWWP domain
completely [22]. In addition to these conserved
Fig. 1. Key players in the DNA methylation pathway. In eukaryotes, DNA methylation predominantly occurs at the fifth
carbon atom of cytosine bases. Its deposition is catalysed by the de novo DNMTs DNMT3A and DNMT3B. Introduced
methylation patterns are preserved by the maintenance DNMT DNMT1 during replication. Passive DNA demethylation is
considered to be achieved across cell division in the absence of DNMT1 maintenance activity. Active removal includes the
mammalian TET1–3 proteins that are capable of converting 5-methylcytosine to its oxidised derivative 5-hydroxymethyl-
cytosine (5hmC) and further to 5-formylcytosine and 5-carboxylcytosine (not indicated here). These modifications are
removed through DNA repair processes or are passively lost through replication. In addition, DNA repair processes have
been involved in the direct removal of methylated cytosines.
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domains, the most N-terminal part of DNMT3A and
DNMT3B is highly variable and is involved in
interactions with DNA and nucleosomes [34,35].
The shorter isoform of DNMT3A that is predomi-
nantly expressed in embryonic stem (ES) cells,
DNMT3A2, lacks this variable part [36]. Understand-
ing whether and how these domains work together to
specify genomic localisation and activity of DNMTs
is still a matter of current investigations that should
bring valuable insights into the mechanisms that
establish cell-type-specific DNA methylation pat-
terns. Several biochemistry-based studies have
started to shed light on how these domains could
integrate chromatin information to guide DNMTs to
specific genomic sites (reviewed in Ref. [24]);
however, additional studies are required that incor-
porate this knowledge from a genomics perspective.
In addition, post-translational modifications [37,38]
and interactions with other proteins such as ubiqui-
tin-like with PHD and ring finger domains 1 (UHRF1)
[39], the ATP-dependent chromatin remodeller
lymphoid-specific helicase (LSH) [40], the inactive
DNMT3 family member, DNMT3L [41], or various
RNA molecules [42–44] have been implicated in
regulating DNMT-specific targeting preferences and
activities in vivo and in vitro (Fig. 2a). Most notably,
interactions between DNMT1 and UHRF1 are
essential for the maintenance of DNA methylation
during replication [39,45]. Immediately after DNA
replication, the newly synthesised DNA strand lacks
methylation. UHRF1 binds this hemimethylated DNA
through its SRA domain and recruits DNMT1 to the
replication fork [46,47]. Furthermore, UHRF1 has
been found to interact with histone H3 lysine 9
(H3K9) methylation via its tandem tudor domain,
linking H3K9 methylation to DNA methylation main-
tenance [48,49]. Interactions between de novo
DNMTs with their catalytic inactive family member
DNMT3L increase their enzymatic activity and
targeting specificity [50–52]. Most remarkably,
DNMT3L plays an essential role in regulating DNA
methylation in gametes, where it guides DNMT3A to
establish genomic imprints and grants genome
stability through the methylation of transposable
elements [11,53–55]. Despite its relevance during
gamete maturation, DNMT3L is dispensable during
early mouse development [56].
The catalytically active DNMT family members
play an essential role during mammalian develop-
ment, and Dnmt knockout mice are lethal (Table 1).
However, the basis for this lethality still remains to be
identified. Interestingly, the phenotypes of individual
Dnmt gene ablations differ significantly. Whereas
gene knockouts of Dnmt1 and Dnmt3b lead to
embryonic lethality, the knockout of Dnmt3a is
embryonic viable and only dies approximately
4 weeks after birth [13,14,57].
The observed phenotypes match the expression
patterns and essential roles of DNMTs in the
developing mouse embryo (Fig. 2b). ES cells
express different isoforms of DNMT3 proteins,
predominantly the isoforms DNMT3A2 and
DNMT3B1 [14,20,58]. During later development,
DNMT3A is transcribed from an alternative promoter
Fig. 2. DNMT targeting and activity. (a) Local and cell-type-specific patterns of DNA methylation can be achieved
through the recruitment or repulsion of DNMTs to specific genomic sites. Interactions with other proteins such as UHRF1 or
DNMT3L or various RNA molecules can promote or prevent DNMT targeting to genomic sites. Post-translational
modifications of histone H3 tails can also alter DNMT targeting preferences in vitro and in vivo, either directly or indirectly.
These mediate local DNMT activity through increased repulsion (H3K4me3) or retention (H3K9me3 and H3K36me3) to
sites enriched for these marks. Nucleosome positioning (accessibility), bound TFs, or engaged RNA polymerases II (Pol II)
can interfere with DNMT recruitment and thus decrease local DNMT activity. Densely methylated and unmethylated
CpG-rich regions (CpG islands) in the genome either promote or block DNMT recruitment and activity. (b) The DNA
methylation-modifying enzymes DNMTs and TETs and their major accessory proteins, DNMT3L and UHRF1, display
distinct activity patterns throughout early development.
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and produces the longer isoform DNMT3A1. This
becomes the predominant isoform of DNMT3A in
differentiated tissues [36]. Additionally, catalytically
inactive isoforms of DNMT3B are expressed at
various stages of development, which could poten-
tially influence methylation patterns through interac-
tions with catalytically active DNMT3A or DNMT3B
[52,59]. Although DNMT3A apparently plays a minor
role in the contribution of DNA methylation to the
developing embryo, DNMT3A, together with
DNMT3L, is essential for the establishment of DNA
methylation patterns in gametes, including maternal
and paternal genomic imprints [8,53,54,60]. Similar-
ly, DNMT3C regulates young retrotransposons in the
male germline and is required for mouse fertility [22].
DNMT3B, on the other hand, plays a more important
role in methylating target promoter regions during
embryonic development and in setting DNA methyl-
ation genome-wide, including repetitive elements
during implantation [5,14].
Erasure of DNA Methylation Patterns
Since DNA methylation is highly dynamic and
varies in a global and local context, DNA methyl-
ation removal is considered as an integral part of
the epigenetic regulatory network. DNA methyla-
tion can be removed through several mechanisms
(reviewed in Ref. [61]). Passive DNA demethyla-
tion is achieved via DNA replication in the absence
of DNMT1 activity (Fig. 1). During replication,
hemimethylated CpG intermediates are produced,
and DNMT1 copies the methylation state of the
mother strand onto the newly synthesised strand.
In absence of maintenance DNA methylation
activity, CpG methylation gets diluted during
replication and can be completely absent from a
locus after two cell divisions.
Alternatively, several processes have been
proposed to be involved in the active removal of
methylation in a site-specific or global manner,
such as DNA repair [62,63] or oxidation. The
mammalian Ten-Eleven Translocation (TET) pro-
teins are capable of converting 5-methylcytosine to
its oxidised derivative 5-hydroxymethylcytosine
(5hmC) and further to 5-formylcytosine and 5-car-
boxylcytosine [64–66]. These oxidised products of
5mC can be actively and passively removed by
DNA repair and through cell division, respectively
[67,68]. Three Tet family members exist in mam-
malian genomes, Tet1–3 [69]. All three TET
proteins are involved in various biological process-
es, ranging from embryonic development to gene
regulation and cancer (reviewed in more detail in
Ref. [70]). Based on their catalytic activity, TET
proteins contribute to the regulation of DNA
methylation patterns, and this requires precise
recruitment to genomic elements. TET1 and
TET3 contain N-terminal CXXC domains, and
TET2 interacts with the CXXC domain protein
IDAX [71,72]. CXXC domains preferentially bind
to unmethylated CpGs [73], providing a potential
mechanism of TET recruitment to unmethylated
CpG-rich promoters [72,74–76]. However, how
TETs are recruited to the genome and to what
extent CXXC domains contribute to their specificity
are still a matter of debate. Genome-wide studies
revealed the preference of TET proteins to bind to
CpG islands (CGIs) [77,78]. However, TETs also
prefer to bind to accessible and low methylated
sites in the genome with lower CpG densities [79],
and the abundance of 5hmC at enhancer elements
and methylated gene bodies [80,81] suggests that
additional factors could promote site-specific re-
cruitment of these proteins.
Individual knockouts of TET proteins have less
severe outcomes on development compared to
knockouts of DNMTs (Table 1). Tet1 and Tet2 are
expressed during early development in the inner cell
mass (ICM) and during implantation, whereas Tet3 is
expressed in the mouse oocyte and zygote until the
2-cell stage and has been suggested to contribute to
the demethylation of both parental genomes [82]
(Fig. 2b). Knockout of Tet1 and Tet2 in mice
generated from crosses between heterozygotes led
to viable progeny, whereas loss of TET1 results in
reduced litter size, and loss of TET2 promotes
leukaemias [83–84]. Tet3 knockouts generated by
conditional deletion in the germline lead to perinatal
death [85] (Table 1). Follow-up studies using Tet1–2
double-knockouts indicated that their removal is
compatible with development [86], while triple--
knockouts of Tet1–3 genes demonstrated defects
in chimera contribution and proper differentiation
Table 1. Relevance of DNA methylation writers and
erasers for mouse development
Genes Knockout studies in mice
Dnmt1 Embryonically lethal at E9.5, distorted neural tube, lacks
somites [13,57]
Dnmt3a Normal development until birth, postnatally (4 weeks)
rudimentary and fatal [14]
Dnmt3b Embryonically lethal at E 9.5–10.5, growth impairment,
neural tube defects [14]
TET1 Vital, reduced postnatal body size, mild developmental
delay [84]
TET 2 Normal development; at 20 weeks, defects in blood
differentiation and elevation of extramedullary
haematopoiesis [83]
TET3 Reduced litter size, arrest around E11.5, perinatal death
[85]
DNA methylation is known to be an essential and highly dynamic
feature throughout development and differentiation. Knockouts of
individual enzymes involved in the setting and removing of DNA
methylation display a wide range of phenotypes, ranging from
early lethality to reduced body size. This table summarises the
phenotypes obtained from mouse knockout studies.
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[87]. In mouse ES cells, Tet1,2-double and
Tet1,2,3-triple knockouts resulted in the global
depletion of 5hmC and increased DNA methylation
at enhancers, without apparent implications for
self-renewal [88,89].
Conservation, Global Distribution, and
Sequence Context of DNA Methylation
In contrast to plants and invertebrates, where
genome-wide DNA methylation patterns follow a
“mosaic” distribution, vertebrate methylation oc-
curs throughout the entire genome [1,2]. Methyla-
tion is present mainly in the context of CpG
dinucleotides, although non-CpG methylation is
evident in mammalian tissues, especially in ES and
neuronal cells [90,91]. In mammalian genomes,
60–80% of CpG sites are methylated, and roughly
10% occur in CGIs [92]. CGIs are marked by a
higher density of CpG dinucleotides than expected
by chance, and the majority of CGIs are associated
with active transcriptional units and, to a great
degree, are resistant to methylation [93–95].
Unmethylated CGIs are considered to prohibit
DNA methylation through various processes, in-
cluding engaged RNA polymerase II [96], tran-
scription factor (TF) binding [97], and H3K4me3
[27,29]. Furthermore, binding of proteins involved
in H3K4me3 deposition (CFP1/SET1, MLL1,2) or
removal of DNAmethylation by TETs could provide
a positive feedback loop that stabilises the
unmethylated state [76,98,99]. Approximately
60% of transcriptional start sites coincide with
CGIs. These include promoters of housekeeping
genes, which are active across various cell types
[100]; however, a small fraction of CGI promoters
that control imprinted and tissue-specific genes are
methylated [7,92].
Spontaneous and frequent deamination of meth-
ylated cytosines to thymine is the major cause of
global CpG depletion during the evolution of
mammalian genomes [101,102]. The retention of
a hypomethylated state at promoters can generally
be seen as a protective mechanism that prevents
the erosion of CpGs by methylation. Overall, the
distribution of CpGs in mammalian genomes is
h i g h l y s kewed and w i de l y s haped b y
methylcytosine deamination, selection pressure
(e.g., CpGs in codons), and active protection from
methylation through DNA-sequence-dependent
mechanisms [96,102–105]. This skewed CpG
distribution can influence the regulatory potential
of DNA methylation through local variation in
methylation density. For instance, methylated
CpG-rich promoters are more likely to be regulated
by DNAmethylation and are more frequently bound
by methyl-CpG-binding domain (MBD) proteins
[95,103,104].
A Genomics View on DNA Methylation
Dynamics
The last decade has generated a great amount of
information related to the distribution of methylated
cytosines in mammalian genomes. Fuelled by
increasing sequencing depth and decreasing se-
quencing costs, the first comprehensive mamma-
lian whole-genome bisulphite sequencing maps
were obtained from human ES, fibroblasts, and
sperm and haematopoietic cells [91,105,106],
followed by mES and neuronal progenitor cells
[79] and an entire panel of developmental transi-
tions in mouse and human [5,107,108]. These
datasets did not only measure the frequency and
distribution of individual methylated cytosines in
the mammalian genome but also greatly contribut-
ed towards understanding how the deposition of
DNA methylation is regulated and how it could
influence gene activity. Most importantly, compar-
ison of DNA methylation profiles to other genome--
wide datasets extracted from the same tissues and
cell types provided valuable insights about the
interplay among DNAmethylation, DNA sequence,
transcriptional activity, and other histone modifica-
tions. Many of these comparisons confirmed
previous findings at a genome-wide scale and
unprecedented resolution, generating useful re-
sources for the community, but also led to new
discoveries important for our current understand-
ing of DNA methylation and its function.
Profiles of DNA methylation obtained from early
developmental transitions or gamete maturation
revealed detailed insights into the dynamic nature
of DNA methylation during this important stage of
development, where global DNA methylation
reprogramming takes place (Fig. 3a). In addition,
studies using mES cells as cell culture models that
allow transitions between naïve and primed states
or terminal differentiation were used to dissect
numerous mechanisms that regulate DNA methyl-
ation deposition and erasure at a genome-wide
scale. Below, we will mainly discuss how these
recent genome-wide studies have contributed to
our current understanding about the regulation and
function of DNA methylation during these early
developmental stages and in ES cells.
Establishment of Gamete-Specific DNA
Methylation Patterns
The first wave of genome-wide DNA methylation
resetting takes place during primordial germ cell
(PGC) development. During PGC migration into the
genital ridge, DNA methylation marks are removed
from the entire genome, with the exception of a
subset of repetitive elements that retain elevated
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DNA methylation levels throughout the entire dura-
tion of PGC development [62,109–112]. After this
genome-wide erasure of DNA methylation, the
genome becomes remethylated. Remethylation
takes place in different cellular contexts and at
different developmental timepoints for female and
male gametes in mice. Therefore, rates and gener-
ated patterns of DNA methylation differ strongly
between sperm and oocyte [60,113,114] (Fig. 3a
and b). Remethylation in the male gametes initiates
in G1-arrested prospermatogonia and is largely
established around birth, resulting in the majority of
CpGs being remethylated in mature sperm, with the
exception of those overlapping CGIs, active pro-
moters, and active enhancers [105,115,116] (Fig.
3b). The majority of CpGs are already fully methyl-
ated in postnatal prospermatogonia, with little
additional increase in methylation until full matura-
tion [116]. However, during murine germ cell
development, numerous stage-specific, differentially
methylated regions were identified that overlap with
distal regulatory elements and contain binding sites
for stage-specific TFs. This finding is, however, in
contrast to an earlier study reporting little changes in
DNA methylation during spermatogonial stem cell
differentiation [115].
In mice, DNA methylation in female gametes
initiates around birth during follicular growth of
meiotically arrested oocytes [117]. Since no cell
division occurs during this global remethylation, the
DNA methylation patterns in the mature oocyte
largely reflect de novo DNA methylation activity of
DNMT3A, together with DNMT3L [8,53,60]. This
provides important insights about the regulatory
mechanisms involved in targeting de novo methyl-
ation to the genome during oocyte maturation.
Surprisingly, methylation in mature mouse oocytes
is mosaic and restricted to defined genomic regions
overlapping with transcribed genes and repetitive
elements, while the rest of the genome remains
hypomethylated, resulting in 40% CpGmethylation
overall [60,114,118] (Fig. 3b). Several studies in
mice suggest that histone modifications play an
important role in guiding de novo methylation in
oocytes. Increased methylation during oocyte
maturation coincides with actively transcribed
intragenic CGIs, suggesting a relationship be-
tween transcription and de novo methylation
Fig. 3. DNA methylation dynamics during early development. (a) A classical view on DNA methylation dynamics during
early mouse development indicating results obtained from bulk measurements of maternal (red) and paternal (blue)
methylation. This indicates the major wave of demethylation in preimplantation embryos that starts after zygote formation
and culminates at the blastocyst stage. DNA methylation is reestablished during implantation. (b) Representative view of
DNA methylation landscapes during early mouse developmental stages and in neurons as a comparison. Shown are DNA
methylation patterns at active and inactive genes, constitutive and tissue-specific enhancers, and endogenous
retroviruses (ERK) as a representative repetitive element that maintains DNA methylation during mouse preimplantation
development. Specific DNA methylation patterns that occur globally or during specific stages and cell types are indicated.
These include low methylated regions (LMRs) that coincide with active distal regulatory regions, unmethylated regions
(UMR) coinciding with active and CGI promoters, and methylated and unmethylated gene bodies of actively transcribed
genes. (c) mES cells cultivated in leukaemia-inhibitory factor and serum-containing media exhibit high levels of DNA
methylation (5mC; N80%) and are more “primed” towards a differentiated state. In the presence of Erk1/2 and GSK3beta
inhibitors (2i) ES cells can be maintained in a homogenous and naïve state, closely resembling the ICM. Adaptation to 2i
results in rapid global reduction of DNA methylation. Global and rapid demethylation is achieved through decreased DNA
methylation maintenance upon the degradation of UHRF1 and the transcriptional downregulation of the de novo DNMTs
DNMT3A and DNMT3B by PRDM14. Global demethylation is enhanced by the activity of TET dioxygenases, forming
5-hydroxymethylcytosine (5hmC) intermediates, which is further boosted in presence of vitamin C.
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[60,114]. Comparative analysis of co-transcription-
ally deposited H3K36me3 with DNA methylation in
growing murine oocytes further supports a direct
role of transcriptional elongation and H3K36me3 in
guiding de novo DNA methylation [119]. However,
a direct role for H3K36me3 in guiding methylation
patterns in oocytes remains to be shown. Regions
occupied by H3K4 di- and trimethylation are
protected from de novo methylation in oocytes,
supporting the antagonism between H3K4 methyl-
ation and DNMT3A/DNMT3L mediated by their
ATRX-DNMT3-DNMT3L domains [27,29]. Recent
genome-wide studies further identified broad
H3K4me3 domains in mature oocytes, which differ
in size and genomic localisation compared to the
canonical H3K4me3 peaks identified in mouse ES
and somatic cells. These domains overlap with
hypomethylated regions in oocytes, suggesting
that this unusual H3K4me3 distribution could be
involved in the large-scale genome hypomethyla-
tion observed in oocytes through preventing de
novo methylation [120,121]. However, since the
establishment of DNA methylation and non-canon-
ical H3K4me3 domains seems to be temporary
correlated during oocyte growth, additional func-
tional studies are required to uncover the causal
relationship between these marks. Here, it is
relevant to mention that while all H3K4me3
domains coincide with hypomethylated regions,
only 60% of hypomethylated regions reside within
the non-canonical H3K4me3 domains [120,121].
Therefore, additional mechanisms could exist that
protect the remaining regions from de novo
methylation.
Resetting DNA Methylation Patterns
during Early Embryogenesis
The pervasive, differential methylation established
in the mature gametes [60,114] is largely resolved by
the genome-wide removal of DNA methylation that
initiates after fertilisation (Fig. 3a). With a few
exceptions, the removal of DNA methylation seems
to occur at equal rates over the entire genome,
independent of the functional element annotation or
CpG density [122,123]. However, large differences
exist between the oocyte and sperm demethylation
rates. Early cytological work in mice indicated
differential DNA methylation reprogramming dynam-
ics of the parental genomes [124–126]. The paternal
genome displays active and almost complete de-
methylation after fertilisation and prior to replication,
whereas the maternal genome appears to become
demethylated passively during cell divisions, reach-
ing its minimum around the blastocyst stage before
implantation (Fig. 3a). How DNA methylation is
differentially removed from the parental genomes is
not completely elucidated, but similar to the demeth-
ylation processes during PGC development, a
combination of various pathways could facilitate
genome-wide removal. These include TET-me-
diated oxidation [85,127,128], DNA repair pathways
[63,129], and suppression of DNA methylation
[130,131]. Increased 5hmC localisation to the
paternal genome after zygote formation indicates
that TET-mediated oxidation could be accounted for
the active removal of DNA methylation [85,127,128].
However, these studies were based on immunoflu-
orescence detection, and more sensitive measure-
ments using mass spectrometry revealed that the
rate of paternal demethylation is not substantially
affected in absence of TET3-mediated oxidation
[132]. Surprisingly, the same study identified that the
occurrence of 5hmC on the paternal genome after
fertilisation depends on DNMT1 and DNMT3A,
suggesting that TET3-mediated oxidation is required
to prevent DNA methylation during this early stage.
Nevertheless, the exact mechanism that leads to the
active removal of methylation from the paternal
genome is still a matter of debate.
Due to this difference in demethylation rates, the
majority of DNA methylation patterns measured
through genomics assays in the early mouse embryo
are largely contributed by the inherited oocyte
methylation, although these patterns are diluted
with ongoing cleavage stage until full removal
[114,122,123] (Fig. 3a and b). While the bulk of
DNA methylation is removed during preimplantation,
some genomic sites remain protected from demeth-
ylation and carry the methylation state established in
the gametes into the late embryo [123]. These
include mostly endogenous retroviruses (ERVs) of
the intracisternal A-particle and differentially methyl-
ated imprinting control regions [5,110,133]. Mainte-
nance of DNA methylation at these regions requires
DNMT1 activity [14,57]. A maternally inherited,
shorter isoform of DNMT1, DNMT1o, prevents the
loss of methylation at intracisternal A-particles
during cleavage, while the embryonic full-length
DNMT1 contributes to methylation maintenance
during later stages [14,57,134].
Following this ground state of DNA methylation at
the blastocyst stage [135], de novo DNMTs are
upregulated, and DNA methylation is reestablished
genome-wide during the transition to the epiblast
stage [5,14,136,137] (Fig. 3). Absence of DNA
methyltranferases during this stage results in limited
remethylation and postimplantation lethality, where-
as de novo methy l t rans fe rases—main ly
DNMT3B—carry out the establishment of methyla-
tion, and DNMT1 is propagating the established
patterns during cell division [5,14,57]. As already
pointed out by Okano and colleagues [14], the de
novo methyltransferases display different expres-
sion patterns, activities, and targeting preferences
during postimplantation development. While
DNMT3B seems to be largely responsible for the
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majority of de novo methylation events during
implantation, DNMT3A is more relevant during later
differentiation [5,8,14,138,139]. During implantation
in mice, several promoters become de novo meth-
ylated, including pluripotency gene promoters, pro-
moters of gamete-specific genes, and numerous
promoters associated with tissue-specific genes that
are active during later development [5,140]. DNA
methylation at CpG-dense, gamete-specific gene
promoters is maintained through the later stages of
development, and interference with DNA methyla-
tion during gastrulation or in various other cell types
results in their transcriptional reactivation
[5,141,142]. This indicates that the high density of
methylation at these genes could play an important
role in preventing aberrant transcription [95,103]. In
addition, the promoters of pluripotency genes,
including Oct4 and Nanog, become de novo
methylated in a stage-dependent manner, suggest-
ing a role for DNA methylation in coordinating
transcriptional programs during exit from pluripo-
tency [5,140,143].
DNA Methylation and Pluripotency
ES cells are derived from the ICM, can be
cultivated for unlimited passages, have the unique
property to differentiate to various cell types and
contribute to all germ layers [144]. This self-renewal
capacity and pluripotency make them a valuable
model for studying the role of epigenetic modifica-
tions during early development. mES cells cultivated
in leukaemia-inhibitory factor and serum-containing
media display high levels of DNA methylation
(N80%) [79,91]. This state of full-genome methyla-
tion is in contrast to the hypomethylated genome of
the ICM (Fig. 3). Cultivation of mES cells in a
defined, serum-free medium and in the presence of
Erk1/2 and GSK3beta inhibitors (2i) allows mES
cells to maintain a state that, based on transcription
and DNA methylation, closely resembles the ICM
[135,145–149] (Fig. 3c). It is widely accepted that
mES cells cultivated in presence of serum are more
“primed” towards a differentiated state and constant-
ly cycle between self-renewal and differentiation--
prone states, while 2i-grown mES cells resemble a
homogenous, naïve state [145,146]. Recent single--
cell gene expression analysis identified that serum--
grown mES cells display increased variation of
pluripotency gene expression, confirming previous
findings [150], whereas this variation is not observed
in 2i cells [151].
This heterogeneity in the presence of serum also
affects DNA methylation. Serum-grown mES cells
show reduced clonal transmission of DNA methyl-
ation patterns, which could be attributed to in-
creased turnover rates of DNA methylation at
regulatory elements [152,153]. This creates in-
creased heterogeneity in DNA methylation, which
can be observed from bulk or single-cell whole--
genome bisulphite sequencing data [79,154]. These
sites of heterogeneity often coincide with distal
regulatory elements enriched for pluripotency and
differentiation factors. Despite these correlations, it
remains to be clarified if heterogeneity of DNA
methylation at these sites could play any role in
regulating the dynamic activity of pluripotency and
differentiation factors. While global interference with
DNA methylation has been reported to reduce the
gene expression variability of pluripotency genes
[155], additional studies are required to fully
substantiate a role for methylation in regulating
expression dynamics of pluripotency genes. Impor-
tantly, complete depletion of DNA methylation in the
absence of DNMT1, DNMT3A, and DNMT3B
(Dnmt-triple-KO) does not alter the morphological
features or self-renewal properties of mouse ES
cells, suggesting that methylation is not generally
required for the maintenance of an ES cell state
[141,156]. However, comprehensive single-cell
RNA sequencing experiments are required to
identify if pluripotency genes in mouse Dnmt-tri-
ple-KO ES cells recapitulate the transcriptional
heterogeneity of serum mES cells or are more
similar to mES cells grown in 2i conditions.
The transition between naïve and primed states of
mES cells can be easily controlled in cell culture,
providing a useful tool to study the mechanism of
DNA methylation deposition and removal (Fig. 3c).
Adaptation of serum-grown ES cells to 2i or vice
versa results in rapid global reduction or reestab-
lishment of DNA methylation after 10 days, respec-
tively [148]. How this rapid removal of cytosine
methylation is facilitated was the focus of numerous
recent studies (Fig. 3c). Earlier studies suggested
that the transcriptional downregulation of Dnmt3a
and Dnmt3b by PRDM14 upon cultivation in 2i
medium could be responsible for the global demeth-
ylation [135,148,149,157]. However, this hypothesis
was contradicting reports using Dnmt3a and Dnmt3b
double-KO mES cells, where global reduction of
DNA methylation required extensive passaging
[20,21]. A potential explanation to this discrepancy
involved the enhanced TET-mediated removal of
DNA methylation during cultivation in 2i [158].
Interestingly, addition of vitamin C further accelerat-
ed DNA methylation removal through boosting the
activity of TET enzymes and temporally increasing
5hmC [159]. Surprisingly, recent findings indicate
that TET enzymes do not substantially contribute to
the global removal of methylation during the transi-
tion from serum to 2i, but rather that the decreased
DNA methylation maintenance through downregula-
tion of UHRF1 is responsible for the global reduction
[160], in line with the role of UHRF1 in the
recruitment of DNMT1 to hemimethylated DNA
[39,45].
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DNA Methylation during Exit from Plur-
ipotency and Differentiation
The ability of ES cells to differentiate to various
cell types provides a useful model to study the
regulation of DNA methylation dynamics during
lineage commitment and terminal differentiation,
as well as the requirement of DNA methylation for
exit from pluripotency and differentiation. Earlier
studies comparing DNA methylation profiles of
mouse ES cells to differentiated cell types, and
during in vitro differentiation, detected dynamic
changes of this mark at numerous promoters and
enhancers [79,107,143,161]. Similar to de novo
methylation events during gastrulation, promoters
and enhancers of pluripotency genes become de
novo methylated, suggesting that methylation
could contribute to exit from pluripotency or prevent
dedifferentiation. This establishes the model that
DNA methylation, similar to other epigenetic
modifications, could serve as a barrier to cellular
reprogramming and could contribute to the low
efficiency of induced pluripotent stem cell genera-
tion [162]. Along these lines, successfully repro-
grammed induced pluripotent stem cell cells are
characterised by hypomethylated pluripotency
gene promoters, and interference with DNA meth-
ylation has been reported to improve reprogram-
ming efficiency [163,164]. This suggests that DNA
methylation at promoters and enhancers of plur-
ipotency genes could block the accessibility of the
pluripotency factors OCT4, KLF4, SOX2, and
cMYC to the DNA and therefore interfere with the
establishment of a pluripotency gene regulatory
network. The requirement of de novo DNA meth-
ylation at promoters of pluripotency genes during
exit from pluripotency is, however, less clear.
Strikingly, early passage mouse ES cells lacking
Dnmt3a and Dnmt3b are able to terminally differ-
entiate in vitro, suggesting that de novo methyla-
tion of pluripotency genes is dispensable for exit
from pluripotency and further commitment [21]. In
contrast, mouse ES cells lacking DNMT1 fail to
differentiate, suggesting that the maintenance of
methylation patterns, rather than de novo estab-
lishment, is required for differentiation [21,165]. A
similar failure to differentiate is also observed for
late-passage Dnmt3a and Dnmt3b double-knock-
out mES cells, which progressively lose methyla-
tion due to their involvement in “backing up”
maintenance methylation [20,21]. Why the mainte-
nance of methylation is more important than de
novo methylation during differentiation is not fully
understood, but it could be required to maintain
transcriptional repression at either gamete-specific
gene promoters or repetitive elements
Strikingly, mES cells retain their self-renewing
capacity in the absence of DNA methylation in
Dnmt-TKO cells [141,156]. While several imprinted
and gamete-specific genes become derepressed in
Dnmt-TKO mES cells, repetitive elements remain
largely inactive [141,166]. This is in contrast to
somatic and gametic cells, where the lack of DNA
methylation leads to the upregulation of ERVs,
resulting in genome instability [10,11]. DNA methyl-
ation is therefore dispensable for the maintenance of
genome integrity in mouse ES cells, but upon exit
from pluripotency, the absence of DNA methylation
could trigger the reactivation of repetitive elements,
resulting in interference with transcriptional pro-
grams and genome instability [10,166]. Genome
stability in mES cells could be due to a dual backup
scheme that involves H3K9me3. Removal of
H3K9me3 in mES cells through the ablation of
ESET, the responsible histone methyltransferase, or
KAP1, a factor involved in the recruitment of various
repressive factors to ERVs, leads to drastic upreg-
ulation of ERV-specific transcripts and rapid cell
death, suggesting that H3K9me3 is the major
protective mechanism in mES cells [166–169]. In
line with a role for histone modifications in the
maintenance of genome integrity, recent studies
using the transition of mES cells from serum to 2i in
the presence of vitamin C identified a transient
upregulation of numerous repetitive elements upon
rapid removal of DNA methylation, followed by a
reconfiguration to H3K9me3- and H3K27me3-based
repressive mechanisms [170]. This remarkable
adaptation potential of mES cells in the absence of
DNA methylation could reflect the epigenetic plas-
ticity that takes place during this unique window of
early mouse development. Further epigenetic per-
turbation experiments in ES cells are expected to
reveal additional mechanistic insights into the
regulation and crosstalk of DNA methylation with
other histone modifications.
DNA Methylation - Instructive or Ensu-
ing?
Generally, the regulation of gene expression is
encoded in cis and is mediated by spatiotemporal
interactions of TFs with their recognition sites within
proximal and distal regulatory elements [171].
Nevertheless, gene expression can also be directed
and modulated by epigenetic modifications through
“overriding” genetically encoded programs in order
to configure developmental decisions [172]. DNA
and histone modifications correlate with transcrip-
tional processes and are generally viewed to be
involved in gene regulation. However, evidence for
the direct contribution of epigenetic marks is still
sparse. In the case of DNA methylation, presence of
this mark at promoters is associated with the lack of
gene activity, which could be mediated either
through attraction or repulsion of regulatory factors
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[104]. This correlative observation is true for the
entire genome, but it does not imply that every
methylated promoter is indeed repressed by DNA
methylation (Fig. 4). For example, knockout of all
DNMTs, and therefore, the complete removal of
DNA methylation in mouse ES cells, results in the
reactivation of only a small fraction of methylated
promoters [141,156,166]. On the other hand, mES
cells lacking DNA methylation are unable to differ-
entiate [21,173]. These findings suggest that DNA
methylation-mediated regulation could be largely
dependent on genomic context, such as variation in
CpGs or TF sites at promoters, and/or cellular
context, such as abundance of transcriptional
regulators at different developmental stages.
DNAmethylation at promoter sites is considered to
lock genes in a stable silent state. Several studies
have shown that methylated CpGs influence TF
binding at their recognition site [174–177]. However,
repulsion by DNAmethylation seems to vary from TF
to TF, and more comprehensive in vivo studies are
required to uncover if methylated CpGs can gener-
ally block TF accessibility. Numerous TF recognition
sites do not contain CpGs in their recognition
sequence; therefore, direct repulsion is not expected
to be a universal mechanism. It has to be further
noted that this “traditional” antagonism between TF
binding and DNA methylation has been blurred by
recent reports that identified in vitro affinities of
numerous TF to methylated DNA [178–180]. How-
ever, a direct requirement for DNA methylation in the
recruitment of these TFs in vivo awaits confirmation.
DNA methylation can attract MBD proteins in a
sequence-independent fashion [181,182]. Binding of
MBD proteins could directly prevent TFs from
binding through steric interference or through re-
cruitment of chromatin remodelers and repressors
[183–185]. However, this requires a high local
density of methylated CpGs, which might also
explain the observed repressive activity of methyla-
tion at CpG-rich promoters [95,103,186]. Despite the
preference of MBD proteins for methyl-CpG-rich
regions in the genome [184,186], it remains to be
tested if MBD-interacting chromatin regulators in-
deed colocalise to the same genomic regions. In
general, the role of MBD proteins in mediating
methylation readout and gene regulation remains
to be explored in more detail through genetic and
genomic approaches. So far, studies of individual
and combined genetic deletions of MBD family
members did not show an expected reactivation of
methylated promoters and left many questions about
their role and redundancy in embryonic development
unanswered [187,188].
Synthetic tools to directly manipulate DNA meth-
ylation at specific loci have already been described
in 1997 [189], and more recently, with the develop-
ments of CRISPR/Cas9, site-specific targeting of
DNA methylation writers and erasers can be easily
achieved. For example, synthetic TFs engineered
Fig. 4. DNA methylation, instructive or ensuing? DNA methylation at gene promoters is associated with transcriptional
repression. However, whether the presence of methylation is the cause or consequence of gene inactivity is not always
clear and could be mainly mediated by local context. For example, increased CpG density at methylated promoters is often
found at gamete-specific genes that are reactivated in the absence of methylation. In this case, the density of methylated
CpGs could directly or indirectly block TF binding and therefore lead to gene repression (left route). On the other hand, the
presence of TF binding sites and the affinity and abundance of TFs to their recognition sites have been shown to influence
DNA methylation at CpG-poor promoters and enhancers. In this case, the absence of an activating signal (i.e., TF activity)
would render a gene inactive, and its promoter will become methylated by default (right route). Changes in DNA
methylation patterns during biological processes, such as responses to stimuli or cellular differentiation, are often
associated with changes in gene expression (blue box). For the repressed gene, removal of DNA methylation is required
for TF binding and gene activation. In case of the inactive gene, changes in TF activity would result in enhanced TF binding
to its recognition sequence and removal of DNA methylation through active or passive processes.
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from enzymatically inactive Cas9 fused to DNMT3A
or TET1 could be utilised to target DNA methylation
or demethylation to specific genes and regulate their
transcription [190–192]. Furthermore, a similar sys-
tem could be used to assess the effects of
combinatorial recruitment of epigenetic regulators
on genomic sites [193]. In this study, the authors
could further show that DNA methylation-mediated
silencing was maintained upon the removal of the
synthetic TF. However, the extent of downregulation
differed between different targeted genes, indicating
a context-dependent effect of transcriptional silenc-
ing [193]. Such synthetic approaches provide an
excellent opportunity to test the direct contribution of
DNA methylation to gene regulation in a locus-spe-
cific manner. However, more comprehensive studies
that query multiple sites in the genome are needed in
order to understand the context-dependent influence
of DNA methylation on transcription.
Protein–DNA Interactions Influence DNA
Methylation Patterns
As noted above, how transcription factors are
influenced by DNA methylation is not fully under-
stood and can vary from factor to factor. On the other
hand, single-locus and genome-wide studies have
indicated that TF binding can protect from DNA
methylation at proximal and distal regulatory regions
in a tissue-specific manner [79,91,194,195]. Human
and mouse ES cell data identified that binding sites
of pluripotency factors show reduced DNA methyl-
ation [79,91]. Unbiased analysis over the entire
genome identified the occurrence of low methylated
regions that overlap with distal regulatory sites [79]
(Fig. 3b). These regions display average DNA
methylation values of 15–50%, increased conser-
vation scores, DNaseI hypersensitivity, and TF
binding sites. These observations gave rise to
several important questions. Does this reduction in
methylation at TF binding sites reflect a requirement
for the removal of methylation prior to binding or a
footprint of TF binding? Is removal mediated through
the recruitment of active demethylation mecha-
nisms to TF binding sites or through a consequence
of decreased accessibility of the methylation ma-
chinery to these sites? 5hmC levels are drastically
enriched at distal regulatory sites [79,196], implicat-
ing TET proteins in facilitating the removal of
methylation upon or prior to TF binding. The role of
TET proteins in promoting 5hmC at mES cell
enhancers has been confirmed through knockout
studies [88,89], but the requirement for this oxida-
tion step in mediating TF binding remains to be
tested. Nevertheless, the presence of 5hmC at TF
binding sites suggests that constant methylation
and demethylation take place at these regions,
keeping DNA modifications highly dynamic. Based
on these observations, targeted removal of DNA
methylation, as described above, could indeed
predefine which of the numerous TF motifs that
usually occur throughout the entire genome should
be occupied and which should not. Surprisingly, in
mouse ES cells lacking DNAmethylation, chromatin
accessibility measured by DNaseI hypersensitivity
is not drastically changed, suggesting that the
majority of TFs expressed in mES cells are not
sensitive to DNA methylation and/or that demethyl-
ation is not a prerequisite for their initial binding to
methylated sites [177,197]. However, notable ex-
ceptions exist, as these studies identified that the
binding of NRF1, GABPA, and MYCN to various
genomic sites is blocked by the presence of DNA
methylation in their binding motifs. These sites are
only accessible in a methylation-free state or upon
the binding of pioneering TF in the vicinity [177],
again exemplifying how local context influences the
role of DNA methylation in guiding TF binding to the
genome. Nevertheless, more systematic experi-
ments are required to understand the complex
involvement of DNA methylation in restricting TF
accessibility in ES cells and beyond.
Conclusions and Future Outlook
The genomics revolution that we have experi-
enced in the past decade had a great influence on
DNA methylation research, not only through the
generation of a large panel of high-resolution
resources from various cell lines and healthy as
well as diseased tissues but also, to a great extent,
through the novel insights that have been obtained
from the genome-wide analysis of this important
mark. These revealed, for example, sequences and
genomic features decorated or protected from
methylation, and further uncovered unexpected
dynamics during cellular processes responsible for
the resetting and redistribution of methylation at
defined genomic sites. Furthermore, the discovery of
hydroxymethylation and TET enzymes as important
players in the active turnover of DNA methylation
unravelled that this modification is not as inert as
previously thought. It will be of great importance to
understand how this cycle is regulated and its
significance for gene regulation.
Genome-wide profiles further facilitated the com-
parison of DNA methylation patterns to other maps
of chromatin modifications, transcriptional activity,
and DNA sequence composition. These compari-
sons provided valuable information on the crosstalk
to histone modifications that positively or negatively
influence the deposition of DNA methylation and the
dynamic interplay with TF binding at regulatory
elements. While these comparative approaches
were already very insightful, there is still a large
amount of open questions that need to be answered
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and various observations that require a more
detailed exploration in order to fully understand the
role of DNA methylation in genome regulation. Most
notably, we still lack a comprehensive understanding
on how DNA methylation regulates gene activity and
how this function depends on local context. Methyl-
ation can prevent transcriptional activation through
inhibiting binding of TFs to their recognition sites in
regulatory sequences. This ability, however, is likely
to depend on the local concentration of methylated
cytosines and can be further influenced by the
expression levels and DNA-binding affinities of
individual or multiple TFs. The ability of methylated
cytosines to inhibit TF binding could furthermore be
amplified by factors that specifically recognise and
bind to this modification. The key players that have
been involved in the readout of methylation, the MBD
proteins, still remain enigmatic in their function as
translators of DNA methylation into transcriptional
repressors, and more detailed in vivo studies are
required to understand their role. The possibility that
additional tissue-specific factors could exist that read
DNAmethylation in a sequence-specific manner and
contribute to a context-dependent readout of this
pervasive mark provides an attractive hypothesis
that needs to be explored in more detail using
genomics, biochemistry, and genetics approaches.
A comprehensive understanding of the mechanisms
that are influenced by DNA methylation, in combi-
nation with the detailed knowledge about the
distribution and frequency of methylated cytosines
along the genomes of various cell and tissue types,
will allow us to generate quantitative models that
could predict if the presence of DNA methylation at
promoters of interest is indeed a mark of repression.
Furthermore, it remains to be fully elucidated how
the deposition or removal of DNA methylation is
mediated at specific genomic regions. Understand-
ing which processes drive or block methylation to
certain sites will provide valuable insight into the
mechanisms that regulate the deposition of DNA
methylation in a context-specific manner. Addition-
ally, it could elucidate the order of events that
distinguish if methylation acts upstream or down-
stream of gene activity. A careful dissection of the
molecular mechanisms that regulate methylation
along the genome is therefore a required step
towards identifying the hierarchy of this mark in
transcriptional regulation. Histone modifications
such as H3K4, H3K9, or H3K36 methylation have
been already implicated in repulsion or recruitment
of methylation to specific genomic sites, including
CGIs, repetitive elements, or transcribed gene
bodies. However, there is still more to be explored,
ranging from nucleosome positioning to remodelling
activities of various factors, transcriptional process-
es, nuclear organisation, and protein–protein inter-
actions of the writers and erasers of DNA
methylation.
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mES, murine embryonic stem; DNMT, DNA methyltrans-
ferase; DNMT3A, DNA methyltransferase 3A; DNMT3B,
DNA methyltransferase 3B; DNMT1, DNA methyltrans-
ferase 1; H3K36me3, histone H3 lysine-36 trimethylation;
ES, embryonic stem; UHRF1, ubiquitin-like with PHD and
ring finger domains 1; H3K9, histone H3 lysine 9; TET,
ten-eleven translocation; 5hmC, 5-hydroxymethylcyto-
sine; CGI, CpG island; ICM, inner cell mass; TF,
transcription factor; PGC, primordial germ cell; ERV,
endogenous retrovirus; MBD, methyl-CpG-binding do-
main; 2i, two inhibitor ES medium; H3K4me3, histone H3
lysine-4 trimethylation; TKO, Dnmt-triple-KO.
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Summary: Here, we describe a method to investigate the binding preferences of mammalian DNA 
methyltransferases (DNMT). Using prior biotin-tagging of DNMTs in engineered cells, stringent 
ChIP-seq based on biotin-avidin interactions circumvents limitations arising from the lack of high 
specificity of commercially available antibodies. This ensures reproducible results in a high-
throughput manner. Follow-up bioinformatic analyses allow specific and reliable determination of 
DNMT genome-wide binding.
Author contribution: I participated in the writing and figure preparation. I contributed to the editing 
and revision of this book chapter. 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Genome-Wide Profiling of DNA Methyltransferases
in Mammalian Cells
Massimiliano Manzo, Christina Ambrosi, and Tuncay Baubec
Abstract
Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) is currently the
method of choice to determine binding sites of chromatin-associated factors in a genome-wide manner.
Here, we describe a method to investigate the binding preferences of mammalian DNA methyltransferases
(DNMT) based on ChIP-seq using biotin-tagging. Stringent ChIP of DNMT proteins based on the strong
interaction between biotin and avidin circumvents limitations arising from low antibody specificity and
ensures reproducible enrichment. DNMT-bound DNA fragments are ligated to sequencing adaptors,
amplified and sequenced on a high-throughput sequencing instrument. Bioinformatic analysis gives valu-
able information about the binding preferences of DNMTs genome-wide and around promoter regions.
This method is unconventional due to the use of genetically engineered cells; however, it allows specific and
reliable determination of DNMT binding.
Key words ChIP-seq, Immunoprecipitation, In vivo biotinylation, Next-generation sequencing,
DNA methyltransferases, CpG islands
1 Introduction
Methylation of cytosine bases is one of the best mechanistically
understood epigenetic modifications and plays various roles in
genome regulation. Three conserved enzymes are responsible for
the deposition of methyl groups to cytosine bases in mammals—the
de novo DNA methyltransferases 3A (DNMT3A) and DNMT3B,
as well as the maintenance DNA methyltransferase 1 (DNMT1)
[1, 2]. In mammals, DNA methylation occurs at the majority of
CpG dinucleotides throughout the entire genome, only CpG
islands remain largely protected from methylation [3]. Based on
biochemical studies, the mechanism of DNA methylation has been
largely elucidated, but how DNAmethylation patterns are precisely
set along the genome and to what extent these cause further
regulation remains to be understood in full detail.
Tanya Vavouri and Miguel A. Peinado (eds.), CpG Islands: Methods and Protocols, Methods in Molecular Biology, vol. 1766,
https://doi.org/10.1007/978-1-4939-7768-0_9, © Springer Science+Business Media, LLC, part of Springer Nature 2018
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8.1. ChromID identifies the protein interactome at chromatin marks
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Elana Bryan, Thomas W. Sheahan, Annika L. Gable, Nina Schmolka, Massimiliano Manzo, Joël 
Wirz, Christian Feller, Christian von Mering, Ruedi Aebersold, Philipp Voigt and Tuncay Baubec.
Published: Nature Biotechnology, 2020; doi: 10.1038/s41587-020-0434-2 
        https://www.nature.com/articles/s41587-020-0434-2 
Summary: This part contains the published article titled ChromID identifies the protein interactome 
at chromatin marks. Here, we describe ChromID, a new tool to attain a detailed overview of 
chromatin-dependent protein interaction networks using engineered chromatin readers (eCRs) in 
combination with a biotin ligase BASU for proximity biotinylation. In particular, we uncovered the 
interactome of bivalent promoters carrying the histone modifications H3K4me3 and H3K27me3.
Author contribution: I performed ChIP-seq experiments for trimethylation of lysine 4, 27, and 9 
on histone 3 in murine embryonic stem (mES) cells. Obtained data was used in Figure 1 D and G, 
2 A-C, 4 A-C, 5 B and Supplementary Figure S4, S5, S7 D-E, S9 C-D, S11 D-F, S12, and S14 B. I 
further generated an Eed-/- mES cell line via CRISPR-Cas9 and conducted immunoblotting for 
total histone 1, histone 3, and trimethylation of lysine 27 on histone 3 to control for a depletion of 
the named chromatin mark in these knock-out cells, seen in Supplementary Figure 6E. Additionally, 
I performed PolyA-RNA-seq experiments in various mES cell lines containing engineered 
chromatin readers (not included in the final manuscript). I contributed to the writing of the methods 
part and to the revisions.
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C
hromatin and many chemical modifications on histones 
and DNA play critical roles in organismal development 
and human health1. These modifications are recognized by 
specialized reader domains in regulatory proteins and multipro-
tein complexes2,3. Depending on the presence and composition of 
modifications at genomic sites, regulatory factors can associate with 
chromatin in a spatiotemporal manner4. However, a major challenge 
in the field remains understanding how this chemical language on 
chromatin defines the protein interactome of the genome.
In recent years, proteomics-based assays have helped measure 
the affinity of proteins for chromatin marks. Current methods probe 
the cellular proteome using synthetic histone peptides, methylated 
DNA probes or in vitro-reconstituted nucleosomes5–9. In addition, 
proteins bound to specific genomic segments can be identified 
using enrichment via antibodies, DNA-sequence-specific probes 
or, more recently, engineered dCas9 fusion proteins10–14. Although 
these studies have greatly enhanced current knowledge about 
interactions between proteins and chromatin marks, the available 
methods rely on artificial chromatin, protein–protein cross-linking 
or methods that require access to the underlying DNA, leading to 
chromatin disruption. Therefore, new approaches are required that 
enable detection of dynamic interactions between proteins and 
physiological chromatin in living cells.
In this study, we developed ChromID to identify the local pro-
tein composition at individual and combinatorial chromatin marks. 
To this end, we used the reader domains of well-established chro-
matin regulators as modules to build eCRs. We first quantified and 
functionally validated the genome-wide binding and/or histone 
post-translational modification (PTM) interaction preferences of 
individual eCRs toward DNA methylation, H3K9me3, H3K4me3 
and H3K27me3, demonstrating their applicability as selective bind-
ers in mouse stem cells. Finally, we used the specificity of eCRs to 
recruit promiscuous biotin ligases to detect proteins associated with 
these individual chromatin modifications in mouse embryonic 
stem cells (mESCs), revealing similarities and differences in the 
protein composition between these marks. By coupling ChromID 
to a synthetic dual-modification reader, we also detected proteins 
associated with genomic regions marked bivalently with H3K4me3 
and H3K27me3 modifications.
Results
Generation and characterization of eCRs in mESCs. We first 
assembled well-characterized chromatin reader domains into 
synthetic reporter proteins to test their affinity and specificity for 
individual chromatin modifications in living cells. We used the 
chromodomains specific for H3K27me3 from CBX7 and Drosophila 
Polycomb (dPC)15,16, the H3K9me3-specific chromodomain from 
CBX1 (refs. 17,18), the Phd domain specific for H3K4me3 from TAF3 
(ref. 19) and the MBD domains from the DNA methylation read-
ers MBD1 and MeCP2 (refs. 20,21) (Fig. 1a). cDNA sequences were 
assembled as either single- or dual-domain constructs in a protein 
expression cassette containing a biotin acceptor site for biochemi-
cal purification, a nuclear localization signal (NLS) and enhanced 
green fluorescent protein (eGFP) for live-cell imaging and detection 
(Fig. 1a and Supplementary Fig. 1a). All constructs were integrated 
into a defined site in the mouse genome via recombinase-mediated 
cassette exchange (RMCE)22, enabling fast generation of mESC lines 
stably expressing the proteins from the same genomic location and 
under the control of the same promoter (Fig. 1b). Measurements of 
eGFP fluorescence and protein levels indicated that all generated cell 
ChromID identifies the protein interactome at 
chromatin marks
Rodrigo Villaseñor! !1, Ramon Pfaendler! !1, Christina Ambrosi1,2, Stefan Butz1,2, Sara Giuliani1, 
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Joël Wirz1, Christian Feller5, Christian von Mering! !4, Ruedi Aebersold! !5,6, Philipp Voigt3 and 
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Chromatin modifications regulate genome function by recruiting proteins to the genome. However, the protein composition at 
distinct chromatin modifications has yet to be fully characterized. In this study, we used natural protein domains as modular 
building blocks to develop engineered chromatin readers (eCRs) selective for DNA methylation and histone tri-methylation at 
H3K4, H3K9 and H3K27 residues. We first demonstrated their utility as selective chromatin binders in living cells by stably 
expressing eCRs in mouse embryonic stem cells and measuring their subnuclear localization, genomic distribution and histone-
modification-binding preference. By fusing eCRs to the biotin ligase BASU, we established ChromID, a method for identify-
ing the chromatin-dependent protein interactome on the basis of proximity biotinylation, and applied it to distinct chromatin 
modifications in mouse stem cells. Using a synthetic dual-modification reader, we also uncovered the protein composition at 
bivalently modified promoters marked by H3K4me3 and H3K27me3. These results highlight the ability of ChromID to obtain a 
detailed view of protein interaction networks on chromatin.
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Authors: Federico Teloni, Jone Michelena, Aleksandra Lezaja, Sinan Kilic, Christina Ambrosi, 
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Summary: Here, my contribution to published article titled Efficient Pre-mRNA Cleavage Prevents 
Replication Stress-Associated Genome Instability is described. Through a multi-screening strategy 
we identified the polyadenylation-complex member WDR33 to allow replication stress resilience. 
We described that impaired pre-mRNA cleavage leads to replication fork stalling, elevated origin 
firing and subsequent replication stress-associated genome instability.
Author contribution: I performed and analysed ChIP-qPCR and -seq experiments for RNA-
Polymerase II phosphorylated on serine 2 in siControl and siWDR33 knock-down U2OS cell lines. 
ChIP-seq data analysis is shown in Figure 5 A-C. ChIP-qPCR experiments were not included in the 
final manuscript. I contributed to the completion of methods part and to the revisions.
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d A convergent multi-screening approach reveals modulators
of replication stress (RS)
d Efficient WDR33-mediated pre-mRNA cleavage confers RS
resilience
d RNA:DNA-hybrid formation occurs upon RS-induced DNA
breakage
d THO nuclear export complex drives RS sensitivity of WDR33-
depleted cells
Authors
Federico Teloni, Jone Michelena,
Aleksandra Lezaja, ..., Pavel Janscak,




Replication stress is a hallmark of many
cancers. Teloni et al. identify the pre-
mRNA cleavage factor WDR33 as
regulator of replication stress resilience
and demonstrate that, when WDR33
function is impaired, unreleased nascent
transcripts and genomic loci re-localize
toward the nuclear periphery, where they
cause replication stress and DNA
damage.
Teloni et al., 2019, Molecular Cell 73, 670–683
February 21, 2019 ª 2018 The Author(s). Published by Elsevier Inc.
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methylation fidelity at bivalent CpG islands
Authors: Massimiliano Manzo, Joël Wirz, Christina Ambrosi, Rodrigo Villaseñor, Bernd Roschitzki
 
and Tuncay Baubec.
Published: EMBO, 2017; doi: 10.15252/embj.201797038 
        https://www.embopress.org/doi/full/10.15252/embj.201797038
Summary: This part comprises my contribution to the published article entitled Isoform-specific 
localisation of DNMT3A regulates DNA methylation fidelity at bivalent CpG islands. Here, we 
studied the individual genomic binding of DNMT3A isoforms in mES cells as well as NPCs and 
identified that the longer isoform DNMT3A1 localises to and de novo - methylates CpG island 
shores of Polycomb‐regulated, bivalent promoters of developmental genes in order to regulate the 
turnover of 5mC at these sites.
Author contribution: I performed RT-qPCR experiments for gene expression analysis of Dnmt3 
genes and Hprt housekeeping control in mES cells, seen in Appendix Figure S1 B, 10 C. I helped 
to extract genomic DNA from various mES cell lines for subsequent DNA methylation level 
measurements by mass spectrometry (Supplementary Figure S1 C). I also contributed to the 
writing of methods part and the revision of the manuscript.
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Isoform-specific localization of DNMT3A regulates
DNA methylation fidelity at bivalent CpG islands
Massimiliano Manzo1,2, Joël Wirz1, Christina Ambrosi1,2, Rodrigo Villaseñor1, Bernd Roschitzki3 &
Tuncay Baubec1,*
Abstract
DNA methylation is a prevalent epigenetic modification involved in
transcriptional regulation and essential for mammalian develop-
ment. While the genome-wide distribution of this mark has been
studied to great detail, the mechanisms responsible for its correct
deposition, as well as the cause for its aberrant localization in
cancers, have not been fully elucidated. Here, we have compared
the activity of individual DNMT3A isoforms in mouse embryonic
stem and neuronal progenitor cells and report that these isoforms
differ in their genomic binding and DNA methylation activity at
regulatory sites. We identify that the longer isoform DNMT3A1
preferentially localizes to the methylated shores of bivalent CpG
island promoters in a tissue-specific manner. The isoform-specific
targeting of DNMT3A1 coincides with elevated hydroxymethylcy-
tosine (5-hmC) deposition, suggesting an involvement of this
isoform in mediating turnover of DNA methylation at these sites.
Through genetic deletion and rescue experiments, we demonstrate
that this isoform-specific recruitment plays a role in de novo DNA
methylation at CpG island shores, with potential implications on
H3K27me3-mediated regulation of developmental genes.
Keywords CpG islands; DNA methylation; DNMT3A; H3K27me3; Polycomb
Subject Categories Chromatin, Epigenetics, Genomics & Functional
Genomics; Transcription
DOI 10.15252/embj.201797038 | Received 29 March 2017 | Revised 1 October
2017 | Accepted 3 October 2017
Introduction
DNA methylation is a well-established epigenetic mark involved in
gene regulation and genome stability. The importance of DNA
methylation for mammalian genome function is apparent by the
lethal phenotypes observed upon individual and combined knock-
out of DNA methyltransferases, whereas DNMT1 and DNMT3B
knock-outs are embryonic lethal and DNMT3A knock-outs are lethal
4 weeks after birth (Lei et al, 1996; Okano et al, 1999; Chen et al,
2003). Furthermore, aberrant deposition of DNA methylation is
frequently observed in cancers (Baylin, 2005; Yan et al, 2011).
Recent genome-wide initiatives explored the distribution of methy-
lated CpGs in various cell types and tissues at single-base pair reso-
lution (Lister et al, 2009; Stadler et al, 2011; Hon et al, 2013). These
datasets were crucial in identifying the frequency and localization of
methylated cytosines, and also to monitor changes in methylation
during cellular transitions, including differentiation in healthy indi-
viduals (Schultz et al, 2015) or cellular transformation (Akalin et al,
2012; Hovestadt et al, 2014). Furthermore, the discovery of 5-hydro-
xymethylcytosine (5-hmC) as an additional modification of mamma-
lian genomes and the characterization of TET-mediated DNA
methylation removal (Kriaucionis & Heintz, 2009; Tahiliani et al,
2009; Kohli & Zhang, 2013) provide compelling evidence that DNA
methylation is highly dynamic and undergoes constant turnover at
regulatory sites (Stroud et al, 2011; Feldmann et al, 2013; Kohli &
Zhang, 2013).
The de novo enzymes DNMT3A and DNMT3B are responsible
for establishing DNA methylation, while DNMT1 is the mainte-
nance methyltransferase responsible for propagation of this mark
at CpG dinucleotides after DNA replication. In addition, the de
novo DNMTs are responsible for the frequently occurring non-CpG
methylation in mammalian genomes and contribute to mainte-
nance of CpG methylation through filling up gaps after DNMT1 or
counteracting active demethylation (Ramsahoye et al, 2000; Liang
et al, 2002; Jackson et al, 2004; Arand et al, 2012). Recently,
DNMT3C, a novel rodent-specific member of the de novo DNMT
family, has been identified to regulate DNA methylation in the
male germline (Barau et al, 2016). How DNMTs are correctly
recruited to the genome in order to establish and maintain DNA
methylation is not completely understood. In addition, splicing
and alternative promoter usage gives rise to various catalytically
active and inactive DNMT isoforms with tissue- and cancer-
specific expression preferences (Chen et al, 2002; La Salle &
Trasler, 2006; Gopalakrishnan et al, 2009; Duymich et al, 2016),
revealing a complex regulation of DNA methylation through
isoform variation. Previous studies have measured subcellular
localization, catalytic activity, and targeting specificities of these
isoforms in various cell types and in vitro (Chen et al, 2002, 2003;
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3 Functional Genomics Center Zurich, ETH and University of Zurich, Zurich, Switzerland
*Corresponding author. Tel: +41 44 635 5438; E-mail: tuncay.baubec@uzh.ch
ª 2017 The Authors. Published under the terms of the CC BY 4.0 license The EMBO Journal 1
Published online: October 26, 2017 
9. References
Dissertation by Christina Ambrosi 
9. References
Adelman, K., and Lis, J.T. (2012). Promoter-proximal pausing of RNA polymerase II: emerging 
roles in metazoans. Nat Rev Genet 13, 720-731.
Ahn, S.H., Kim, M., and Buratowski, S. (2004). Phosphorylation of serine 2 within the RNA 
polymerase II C-terminal domain couples transcription and 3' end processing. Mol Cell 13, 67-76.
Alberts, B.J., A.; Lewis, A.; Raff, M.; Roberts, K.; Walter, P. (2002). Molecular Biology of the Cell, 
4th edition (New York: Garland Science).
Allen, B.L., and Taatjes, D.J. (2015). The Mediator complex: a central integrator of transcription. 
Nat Rev Mol Cell Biol 16, 155-166.
Altmeyer, M., Toledo, L., Gudjonsson, T., Grofte, M., Rask, M.B., Lukas, C., Akimov, V., Blagoev, 
B., Bartek, J., and Lukas, J. (2013). The chromatin scaffold protein SAFB1 renders chromatin 
permissive for DNA damage signaling. Mol Cell 52, 206-220.
Ambrosi, C., Manzo, M., and Baubec, T. (2017). Dynamics and Context-Dependent Roles of DNA 
Methylation. J Mol Biol 429, 1459-1475.
Amrani, N., Ganesan, R., Kervestin, S., Mangus, D.A., Ghosh, S., and Jacobson, A. (2004). A faux 
3'-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature 432, 
112-118.
Ardehali, M.B., Yao, J., Adelman, K., Fuda, N.J., Petesch, S.J., Webb, W.W., and Lis, J.T. (2009). 
Spt6 enhances the elongation rate of RNA polymerase II in vivo. EMBO J 28, 1067-1077.
Arents, G., Burlingame, R.W., Wang, B.C., Love, W.E., and Moudrianakis, E.N. (1991). The 
nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-
handed superhelix. Proc Natl Acad Sci U S A 88, 10148-10152.
Aymard, F., Bugler, B., Schmidt, C.K., Guillou, E., Caron, P., Briois, S., Iacovoni, J.S., Daburon, V., 
Miller, K.M., Jackson, S.P., et al. (2014). Transcriptionally active chromatin recruits homologous 
recombination at DNA double-strand breaks. Nat Struct Mol Biol 21, 366-374.
Balazsi, G., van Oudenaarden, A., and Collins, J.J. (2011). Cellular decision making and biological 
noise: from microbes to mammals. Cell 144, 910-925.
Balbo, P.B., and Bohm, A. (2007). Mechanism of poly(A) polymerase: structure of the enzyme-
MgATP-RNA ternary complex and kinetic analysis. Structure 15, 1117-1131.




Dissertation by Christina Ambrosi 
Bannister, A.J., Schneider, R., Myers, F.A., Thorne, A.W., Crane-Robinson, C., and Kouzarides, T. 
(2005). Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes. J Biol Chem 
280, 17732-17736.
Bannister, A.J., Zegerman, P., Partridge, J.F., Miska, E.A., Thomas, J.O., Allshire, R.C., and 
Kouzarides, T. (2001). Selective recognition of methylated lysine 9 on histone H3 by the HP1 
chromo domain. Nature 410, 120-124.
Bar-Nahum, G., Epshtein, V., Ruckenstein, A.E., Rafikov, R., Mustaev, A., and Nudler, E. (2005). A 
ratchet mechanism of transcription elongation and its control. Cell 120, 183-193.
Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., and 
Zhao, K. (2007). High-resolution profiling of histone methylations in the human genome. Cell 129, 
823-837.
Bartkowiak, B., and Greenleaf, A.L. (2011). Phosphorylation of RNAPII: To P-TEFb or not to P-
TEFb? Transcription 2, 115-119.
Bartkowiak, B., Liu, P., Phatnani, H.P., Fuda, N.J., Cooper, J.J., Price, D.H., Adelman, K., Lis, J.T., 
and Greenleaf, A.L. (2010). CDK12 is a transcription elongation-associated CTD kinase, the 
metazoan ortholog of yeast Ctk1. Genes Dev 24, 2303-2316.
Batista, P.J., Molinie, B., Wang, J., Qu, K., Zhang, J., Li, L., Bouley, D.M., Lujan, E., Haddad, B., 
Daneshvar, K., et al. (2014). m(6)A RNA modification controls cell fate transition in mammalian 
embryonic stem cells. Cell Stem Cell 15, 707-719.
Baubec, T., Colombo, D.F., Wirbelauer, C., Schmidt, J., Burger, L., Krebs, A.R., Akalin, A., and 
Schubeler, D. (2015). Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in 
genic methylation. Nature 520, 243-247.
Baubec, T., Ivanek, R., Lienert, F., and Schubeler, D. (2013). Methylation-dependent and -
independent genomic targeting principles of the MBD protein family. Cell 153, 480-492.
Behjati, S., Tarpey, P.S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., Wedge, D.C., Cooke, 
S.L., Gundem, G., Davies, H., et al. (2013). Distinct H3F3A and H3F3B driver mutations define 
chondroblastoma and giant cell tumor of bone. Nat Genet 45, 1479-1482.
Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W.J., Mattick, J.S., and Haussler, D. 
(2004). Ultraconserved elements in the human genome. Science 304, 1321-1325.
Bentley, D.L. (2014). Coupling mRNA processing with transcription in time and space. Nat Rev 
Genet 15, 163-175.
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Meissner, A., 
Wernig, M., Plath, K., et al. (2006). A bivalent chromatin structure marks key developmental genes 
in embryonic stem cells. Cell 125, 315-326.
Bertero, A., Brown, S., Madrigal, P., Osnato, A., Ortmann, D., Yiangou, L., Kadiwala, J., Hubner, 
N.C., de Los Mozos, I.R., Sadee, C., et al. (2018). The SMAD2/3 interactome reveals that TGFbeta 
controls m(6)A mRNA methylation in pluripotency. Nature 555, 256-259.
Bibel, M., Richter, J., Lacroix, E., and Barde, Y.A. (2007). Generation of a defined and uniform 




Dissertation by Christina Ambrosi 
Bienroth, S., Keller, W., and Wahle, E. (1993). Assembly of a processive messenger RNA 
polyadenylation complex. EMBO J 12, 585-594.
Bird, A. (2007). Perceptions of epigenetics. Nature 447, 396-398.
Bird, A.P. (1980). DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 8, 
1499-1504.
Black, B.E., Jansen, L.E., Maddox, P.S., Foltz, D.R., Desai, A.B., Shah, J.V., and Cleveland, D.W. 
(2007). Centromere identity maintained by nucleosomes assembled with histone H3 containing the 
CENP-A targeting domain. Mol Cell 25, 309-322.
Blackledge, N.P., Zhou, J.C., Tolstorukov, M.Y., Farcas, A.M., Park, P.J., and Klose, R.J. (2010). 
CpG islands recruit a histone H3 lysine 36 demethylase. Mol Cell 38, 179-190.
Blank, A., Gallant, J.A., Burgess, R.R., and Loeb, L.A. (1986). An RNA polymerase mutant with 
reduced accuracy of chain elongation. Biochemistry 25, 5920-5928.
Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I., Levine, S.S., Wernig, 
M., Tajonar, A., Ray, M.K., et al. (2006). Polycomb complexes repress developmental regulators in 
murine embryonic stem cells. Nature 441, 349-353.
Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H., and Helin, K. (2006). Genome-wide mapping 
of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20, 1123-1136.
Brandman, O., Stewart-Ornstein, J., Wong, D., Larson, A., Williams, C.C., Li, G.W., Zhou, S., King, 
D., Shen, P.S., Weibezahn, J., et al. (2012). A ribosome-bound quality control complex triggers 
degradation of nascent peptides and signals translation stress. Cell 151, 1042-1054.
Brien, G.L., Gambero, G., O'Connell, D.J., Jerman, E., Turner, S.A., Egan, C.M., Dunne, E.J., 
Jurgens, M.C., Wynne, K., Piao, L., et al. (2012). Polycomb PHF19 binds H3K36me3 and recruits 
PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation. Nat Struct Mol 
Biol 19, 1273-1281.
Brueckner, F., and Cramer, P. (2007). DNA photodamage recognition by RNA polymerase II. FEBS 
Lett 581, 2757-2760.
Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y., and Greenleaf, W.J. (2013). Transposition 
of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding 
proteins and nucleosome position. Nat Methods 10, 1213-1218.
Buschbeck, M., and Hake, S.B. (2017). Variants of core histones and their roles in cell fate 
decisions, development and cancer. Nat Rev Mol Cell Biol 18, 299-314.
Busskamp, V., Lewis, N.E., Guye, P., Ng, A.H., Shipman, S.L., Byrne, S.M., Sanjana, N.E., Murn, 
J., Li, Y., Li, S., et al. (2014). Rapid neurogenesis through transcriptional activation in human stem 
cells. Mol Syst Biol 10, 760.
Cai, L., Rothbart, S.B., Lu, R., Xu, B., Chen, W.Y., Tripathy, A., Rockowitz, S., Zheng, D., Patel, 
D.J., Allis, C.D., et al. (2013). An H3K36 methylation-engaging Tudor motif of polycomb-like 
proteins mediates PRC2 complex targeting. Mol Cell 49, 571-582.




Dissertation by Christina Ambrosi 
Cao, Z., and Grima, R. (2020). Analytical distributions for detailed models of stochastic gene 
expression in eukaryotic cells. Proc Natl Acad Sci U S A 117, 4682-4692.
Carrozza, M.J., Li, B., Florens, L., Suganuma, T., Swanson, S.K., Lee, K.K., Shia, W.J., Anderson, 
S., Yates, J., Washburn, M.P., et al. (2005). Histone H3 methylation by Set2 directs deacetylation 
of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123, 581-592.
Carvalho, S., Raposo, A.C., Martins, F.B., Grosso, A.R., Sridhara, S.C., Rino, J., Carmo-Fonseca, 
M., and de Almeida, S.F. (2013). Histone methyltransferase SETD2 coordinates FACT recruitment 
with nucleosome dynamics during transcription. Nucleic Acids Res 41, 2881-2893.
Carvalho, S., Vitor, A.C., Sridhara, S.C., Martins, F.B., Raposo, A.C., Desterro, J.M., Ferreira, J., 
and de Almeida, S.F. (2014). SETD2 is required for DNA double-strand break repair and activation 
of the p53-mediated checkpoint. Elife 3, e02482.
Chamberlain, S.J., Yee, D., and Magnuson, T. (2008). Polycomb repressive complex 2 is 
dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells 26, 1496-1505.
Chan, R.T., Peters, J.K., Robart, A.R., Wiryaman, T., Rajashankar, K.R., and Toor, N. (2018). 
Structural basis for the second step of group II intron splicing. Nat Commun 9, 4676.
Chang, H.H.Y., Pannunzio, N.R., Adachi, N., and Lieber, M.R. (2017). Non-homologous DNA end 
joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol 18, 495-506.
Chen, K., Liu, J., Liu, S., Xia, M., Zhang, X., Han, D., Jiang, Y., Wang, C., and Cao, X. (2017). 
Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity. 
Cell 170, 492-506 e414.
Chen, M., and Manley, J.L. (2009). Mechanisms of alternative splicing regulation: insights from 
molecular and genomics approaches. Nat Rev Mol Cell Biol 10, 741-754.
Chen, R., Zhao, W.Q., Fang, C., Yang, X., and Ji, M. (2020). Histone methyltransferase SETD2: a 
potential tumor suppressor in solid cancers. J Cancer 11, 3349-3356.
Cheng, B., and Price, D.H. (2007). Properties of RNA polymerase II elongation complexes before 
and after the P-TEFb-mediated transition into productive elongation. J Biol Chem 282, 
21901-21912.
Chow, C.M., Georgiou, A., Szutorisz, H., Maia e Silva, A., Pombo, A., Barahona, I., Dargelos, E., 
Canzonetta, C., and Dillon, N. (2005). Variant histone H3.3 marks promoters of transcriptionally 
active genes during mammalian cell division. EMBO Rep 6, 354-360.
Clapier, C.R., Iwasa, J., Cairns, B.R., and Peterson, C.L. (2017). Mechanisms of action and 
regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol 18, 407-422.
Clerici, M., Faini, M., Muckenfuss, L.M., Aebersold, R., and Jinek, M. (2018). Structural basis of 
AAUAAA polyadenylation signal recognition by the human CPSF complex. Nat Struct Mol Biol 25, 
135-138.
Cortez, D., Wang, Y., Qin, J., and Elledge, S.J. (1999). Requirement of ATM-dependent 




Dissertation by Christina Ambrosi 
Cox, J., and Mann, M. (2008). MaxQuant enables high peptide identification rates, individualized 
p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26, 
1367-1372.
Cramer, P. (2004). Structure and function of RNA polymerase II. Adv Protein Chem 67, 1-42.
Crick, F. (1970). Central dogma of molecular biology. Nature 227, 561-563.
Czudnochowski, N., Bosken, C.A., and Geyer, M. (2012). Serine-7 but not serine-5 
phosphorylation primes RNA polymerase II CTD for P-TEFb recognition. Nat Commun 3, 842.
D'Alessandro, G., and d'Adda di Fagagna, F. (2017). Transcription and DNA Damage: Holding 
Hands or Crossing Swords? J Mol Biol 429, 3215-3229.
Dalgliesh, G.L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., 
Hardy, C., Latimer, C., et al. (2010). Systematic sequencing of renal carcinoma reveals inactivation 
of histone modifying genes. Nature 463, 360-363.
Dasgupta, M., Dermawan, J.K., Willard, B., and Stark, G.R. (2015). STAT3-driven transcription 
depends upon the dimethylation of K49 by EZH2. Proc Natl Acad Sci U S A 112, 3985-3990.
Daugaard, M., Baude, A., Fugger, K., Povlsen, L.K., Beck, H., Sorensen, C.S., Petersen, N.H., 
Sorensen, P.H., Lukas, C., Bartek, J., et al. (2012). LEDGF (p75) promotes DNA-end resection and 
homologous recombination. Nat Struct Mol Biol 19, 803-810.
De La Fuente, R., Baumann, C., Fan, T., Schmidtmann, A., Dobrinski, I., and Muegge, K. (2006). 
Lsh is required for meiotic chromosome synapsis and retrotransposon silencing in female germ 
cells. Nat Cell Biol 8, 1448-1454.
de la Mata, M., Alonso, C.R., Kadener, S., Fededa, J.P., Blaustein, M., Pelisch, F., Cramer, P., 
Bentley, D., and Kornblihtt, A.R. (2003). A slow RNA polymerase II affects alternative splicing in 
vivo. Mol Cell 12, 525-532.
Deaton, A.M., and Bird, A. (2011). CpG islands and the regulation of transcription. Genes Dev 25, 
1010-1022.
Di Giammartino, D.C., Nishida, K., and Manley, J.L. (2011). Mechanisms and consequences of 
alternative polyadenylation. Mol Cell 43, 853-866.
Dillon, S.C., Zhang, X., Trievel, R.C., and Cheng, X. (2005). The SET-domain protein superfamily: 
protein lysine methyltransferases. Genome Biol 6, 227.
Dixon, J.R., Gorkin, D.U., and Ren, B. (2016). Chromatin Domains: The Unit of Chromosome 
Organization. Mol Cell 62, 668-680.
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., 
and Gingeras, T.R. (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21.
Doma, M.K., and Parker, R. (2006). Endonucleolytic cleavage of eukaryotic mRNAs with stalls in 
translation elongation. Nature 440, 561-564.
Domcke, S., Bardet, A.F., Adrian Ginno, P., Hartl, D., Burger, L., and Schubeler, D. (2015). 




Dissertation by Christina Ambrosi 
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, 
S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012). Topology of the human 
and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201-206.
Dreyfus, M., and Regnier, P. (2002). The poly(A) tail of mRNAs: bodyguard in eukaryotes, 
scavenger in bacteria. Cell 111, 611-613.
Du, H., Zhao, Y., He, J., Zhang, Y., Xi, H., Liu, M., Ma, J., and Wu, L. (2016). YTHDF2 destabilizes 
m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat 
Commun 7, 12626.
Duns, G., van den Berg, E., van Duivenbode, I., Osinga, J., Hollema, H., Hofstra, R.M., and Kok, 
K. (2010). Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell 
renal cell carcinoma. Cancer Res 70, 4287-4291.
Eberharter, A., and Becker, P.B. (2002). Histone acetylation: a switch between repressive and 
permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 3, 224-229.
Ecco, G., Imbeault, M., and Trono, D. (2017). KRAB zinc finger proteins. Development 144, 
2719-2729.
Edmunds, J.W., Mahadevan, L.C., and Clayton, A.L. (2008). Dynamic histone H3 methylation 
during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J 27, 406-420.
Egger, G., Liang, G., Aparicio, A., and Jones, P.A. (2004). Epigenetics in human disease and 
prospects for epigenetic therapy. Nature 429, 457-463.
Ellis, R.J. (2006). Molecular chaperones: assisting assembly in addition to folding. Trends Biochem 
Sci 31, 395-401.
Elowitz, M.B., Levine, A.J., Siggia, E.D., and Swain, P.S. (2002). Stochastic gene expression in a 
single cell. Science 297, 1183-1186.
Escribano-Diaz, C., Orthwein, A., Fradet-Turcotte, A., Xing, M., Young, J.T., Tkac, J., Cook, M.A., 
Rosebrock, A.P., Munro, M., Canny, M.D., et al. (2013). A cell cycle-dependent regulatory circuit 
composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol Cell 49, 
872-883.
Fahey, C.C., and Davis, I.J. (2017). SETting the Stage for Cancer Development: SETD2 and the 
Consequences of Lost Methylation. Cold Spring Harb Perspect Med 7.
Falck, J., Coates, J., and Jackson, S.P. (2005). Conserved modes of recruitment of ATM, ATR and 
DNA-PKcs to sites of DNA damage. Nature 434, 605-611.
Fan, J., Salathia, N., Liu, R., Kaeser, G.E., Yung, Y.C., Herman, J.L., Kaper, F., Fan, J.B., Zhang, 
K., Chun, J., et al. (2016). Characterizing transcriptional heterogeneity through pathway and gene 
set overdispersion analysis. Nat Methods 13, 241-244.
Fang, D., Gan, H., Lee, J.H., Han, J., Wang, Z., Riester, S.M., Jin, L., Chen, J., Zhou, H., Wang, J., 




Dissertation by Christina Ambrosi 
Fant, C.B., Levandowski, C.B., Gupta, K., Maas, Z.L., Moir, J., Rubin, J.D., Sawyer, A., Esbin, 
M.N., Rimel, J.K., Luyties, O., et al. (2020). TFIID Enables RNA Polymerase II Promoter-Proximal 
Pausing. Mol Cell.
Faure, A.J., Schmiedel, J.M., and Lehner, B. (2017). Systematic Analysis of the Determinants of 
Gene Expression Noise in Embryonic Stem Cells. Cell Syst 5, 471-484 e474.
Feng, Y.Q., Seibler, J., Alami, R., Eisen, A., Westerman, K.A., Leboulch, P., Fiering, S., and 
Bouhassira, E.E. (1999). Site-specific chromosomal integration in mammalian cells: highly efficient 
CRE recombinase-mediated cassette exchange. J Mol Biol 292, 779-785.
Ferrari, K.J., Scelfo, A., Jammula, S., Cuomo, A., Barozzi, I., Stutzer, A., Fischle, W., Bonaldi, T., 
and Pasini, D. (2014). Polycomb-dependent H3K27me1 and H3K27me2 regulate active 
transcription and enhancer fidelity. Mol Cell 53, 49-62.
Ficz, G., Hore, T.A., Santos, F., Lee, H.J., Dean, W., Arand, J., Krueger, F., Oxley, D., Paul, Y.L., 
Walter, J., et al. (2013). FGF signaling inhibition in ESCs drives rapid genome-wide demethylation 
to the epigenetic ground state of pluripotency. Cell Stem Cell 13, 351-359.
Fischle, W., Tseng, B.S., Dormann, H.L., Ueberheide, B.M., Garcia, B.A., Shabanowitz, J., Hunt, 
D.F., Funabiki, H., and Allis, C.D. (2005). Regulation of HP1-chromatin binding by histone H3 
methylation and phosphorylation. Nature 438, 1116-1122.
Flemr, M., and Buhler, M. (2015). Single-Step Generation of Conditional Knockout Mouse 
Embryonic Stem Cells. Cell Rep 12, 709-716.
Fousteri, M., and Mullenders, L.H. (2008). Transcription-coupled nucleotide excision repair in 
mammalian cells: molecular mechanisms and biological effects. Cell Res 18, 73-84.
Fradet-Turcotte, A., Canny, M.D., Escribano-Diaz, C., Orthwein, A., Leung, C.C., Huang, H., 
Landry, M.C., Kitevski-LeBlanc, J., Noordermeer, S.M., Sicheri, F., et al. (2013). 53BP1 is a reader 
of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature 499, 50-54.
Frietze, S., and Farnham, P.J. (2011). Transcription factor effector domains. Subcell Biochem 52, 
261-277.
Fujisawa, T., and Filippakopoulos, P. (2017). Functions of bromodomain-containing proteins and 
their roles in homeostasis and cancer. Nat Rev Mol Cell Biol 18, 246-262.
Fujita, K., Iwaki, M., and Yanagida, T. (2016). Transcriptional bursting is intrinsically caused by 
interplay between RNA polymerases on DNA. Nat Commun 7, 13788.
Fuks, F., Hurd, P.J., Deplus, R., and Kouzarides, T. (2003). The DNA methyltransferases associate 
with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31, 2305-2312.
Fulton, D.L., Sundararajan, S., Badis, G., Hughes, T.R., Wasserman, W.W., Roach, J.C., and 
Sladek, R. (2009). TFCat: the curated catalog of mouse and human transcription factors. Genome 
Biol 10, R29.
Gansen, A., Toth, K., Schwarz, N., and Langowski, J. (2015). Opposing roles of H3- and H4-




Dissertation by Christina Ambrosi 
Gao, Z., Zhang, J., Bonasio, R., Strino, F., Sawai, A., Parisi, F., Kluger, Y., and Reinberg, D. (2012). 
PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol 
Cell 45, 344-356.
Garneau, N.L., Wilusz, J., and Wilusz, C.J. (2007). The highways and byways of mRNA decay. Nat 
Rev Mol Cell Biol 8, 113-126.
Gehre, M., Bunina, D., Sidoli, S., Lubke, M.J., Diaz, N., Trovato, M., Garcia, B.A., Zaugg, J.B., and 
Noh, K.M. (2020). Lysine 4 of histone H3.3 is required for embryonic stem cell differentiation, 
histone enrichment at regulatory regions and transcription accuracy. Nat Genet 52, 273-282.
Goldberg, A.D., Allis, C.D., and Bernstein, E. (2007). Epigenetics: a landscape takes shape. Cell 
128, 635-638.
Gong, F., Chiu, L.Y., Cox, B., Aymard, F., Clouaire, T., Leung, J.W., Cammarata, M., Perez, M., 
Agarwal, P., Brodbelt, J.S., et al. (2015). Screen identifies bromodomain protein ZMYND8 in 
chromatin recognition of transcription-associated DNA damage that promotes homologous 
recombination. Genes Dev 29, 197-211.
Graham, T.G., Walter, J.C., and Loparo, J.J. (2016). Two-Stage Synapsis of DNA Ends during Non-
homologous End Joining. Mol Cell 61, 850-858.
Grun, D., Kester, L., and van Oudenaarden, A. (2014). Validation of noise models for single-cell 
transcriptomics. Nat Methods 11, 637-640.
Hacker, K.E., Fahey, C.C., Shinsky, S.A., Chiang, Y.J., DiFiore, J.V., Jha, D.K., Vo, A.H., Shavit, 
J.A., Davis, I.J., Strahl, B.D., et al. (2016). Structure/Function Analysis of Recurrent Mutations in 
SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining 
Protein Stability and Histone H3 Lys-36 Trimethylation. J Biol Chem 291, 21283-21295.
Hall, I.M., Shankaranarayana, G.D., Noma, K., Ayoub, N., Cohen, A., and Grewal, S.I. (2002). 
Establishment and maintenance of a heterochromatin domain. Science 297, 2232-2237.
Hamperl, S., and Cimprich, K.A. (2016). Conflict Resolution in the Genome: How Transcription and 
Replication Make It Work. Cell 167, 1455-1467.
Hanawalt, P.C., and Spivak, G. (2008). Transcription-coupled DNA repair: two decades of progress 
and surprises. Nat Rev Mol Cell Biol 9, 958-970.
Hansen, K.H., Bracken, A.P., Pasini, D., Dietrich, N., Gehani, S.S., Monrad, A., Rappsilber, J., 
Lerdrup, M., and Helin, K. (2008). A model for transmission of the H3K27me3 epigenetic mark. Nat 
Cell Biol 10, 1291-1300.
Hashimoto, H., Liu, Y., Upadhyay, A.K., Chang, Y., Howerton, S.B., Vertino, P.M., Zhang, X., and 
Cheng, X. (2012). Recognition and potential mechanisms for replication and erasure of cytosine 
hydroxymethylation. Nucleic Acids Res 40, 4841-4849.
Hashimshony, T., Senderovich, N., Avital, G., Klochendler, A., de Leeuw, Y., Anavy, L., Gennert, D., 
Li, S., Livak, K.J., Rozenblatt-Rosen, O., et al. (2016). CEL-Seq2: sensitive highly-multiplexed 
single-cell RNA-Seq. Genome Biol 17, 77.




Dissertation by Christina Ambrosi 
Heidemann, M., Hintermair, C., Voss, K., and Eick, D. (2013). Dynamic phosphorylation patterns of 
RNA polymerase II CTD during transcription. Biochim Biophys Acta 1829, 55-62.
Hellen, C.U., and Sarnow, P. (2001). Internal ribosome entry sites in eukaryotic mRNA molecules. 
Genes Dev 15, 1593-1612.
Hidalgo, I., Herrera-Merchan, A., Ligos, J.M., Carramolino, L., Nunez, J., Martinez, F., Dominguez, 
O., Torres, M., and Gonzalez, S. (2012). Ezh1 is required for hematopoietic stem cell maintenance 
and prevents senescence-like cell cycle arrest. Cell Stem Cell 11, 649-662.
Hirose, Y., and Manley, J.L. (1998). RNA polymerase II is an essential mRNA polyadenylation 
factor. Nature 395, 93-96.
Ho, T.H., Park, I.Y., Zhao, H., Tong, P., Champion, M.D., Yan, H., Monzon, F.A., Hoang, A., Tamboli, 
P., Parker, A.S., et al. (2016). High-resolution profiling of histone h3 lysine 36 trimethylation in 
metastatic renal cell carcinoma. Oncogene 35, 1565-1574.
Hoffman, E.A., Frey, B.L., Smith, L.M., and Auble, D.T. (2015). Formaldehyde crosslinking: a tool 
for the study of chromatin complexes. J Biol Chem 290, 26404-26411.
Holliday, R., and Pugh, J.E. (1975). DNA modification mechanisms and gene activity during 
development. Science 187, 226-232.
Hu, M., Sun, X.J., Zhang, Y.L., Kuang, Y., Hu, C.Q., Wu, W.L., Shen, S.H., Du, T.T., Li, H., He, F., et 
al. (2010). Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular 
remodeling. Proc Natl Acad Sci U S A 107, 2956-2961.
Huang, H., Weng, H., Zhou, K., Wu, T., Zhao, B.S., Sun, M., Chen, Z., Deng, X., Xiao, G., Auer, F., 
et al. (2019). Histone H3 trimethylation at lysine 36 guides m(6)A RNA modification co-
transcriptionally. Nature 567, 414-419.
Huang, Y., Gu, L., and Li, G.M. (2018). H3K36me3-mediated mismatch repair preferentially 
protects actively transcribed genes from mutation. J Biol Chem 293, 7811-7823.
Huh, D., and Paulsson, J. (2011). Non-genetic heterogeneity from stochastic partitioning at cell 
division. Nat Genet 43, 95-100.
Huh, I., Zeng, J., Park, T., and Yi, S.V. (2013). DNA methylation and transcriptional noise. 
Epigenetics Chromatin 6, 9.
Husmann, D., and Gozani, O. (2019). Histone lysine methyltransferases in biology and disease. 
Nat Struct Mol Biol 26, 880-889.
Hustedt, N., and Durocher, D. (2016). The control of DNA repair by the cell cycle. Nat Cell Biol 19, 
1-9.
Hyun, K., Jeon, J., Park, K., and Kim, J. (2017). Writing, erasing and reading histone lysine 
methylations. Exp Mol Med 49, e324.
Illingworth, R.S., Gruenewald-Schneider, U., Webb, S., Kerr, A.R., James, K.D., Turner, D.J., 
Smith, C., Harrison, D.J., Andrews, R., and Bird, A.P. (2010). Orphan CpG islands identify 
numerous conserved promoters in the mammalian genome. PLoS Genet 6, e1001134.
Inoue, A., Jiang, L., Lu, F., Suzuki, T., and Zhang, Y. (2017). Maternal H3K27me3 controls DNA 
methylation-independent imprinting. Nature 547, 419-424.
 139
9. References
Dissertation by Christina Ambrosi 
International Human Genome Sequencing, C. (2004). Finishing the euchromatic sequence of the 
human genome. Nature 431, 931-945.
Jackson, M., Krassowska, A., Gilbert, N., Chevassut, T., Forrester, L., Ansell, J., and Ramsahoye, 
B. (2004). Severe global DNA hypomethylation blocks differentiation and induces histone 
hyperacetylation in embryonic stem cells. Mol Cell Biol 24, 8862-8871.
Jackson, S.P., and Bartek, J. (2009). The DNA-damage response in human biology and disease. 
Nature 461, 1071-1078.
Jacquier, A. (2009). The complex eukaryotic transcriptome: unexpected pervasive transcription and 
novel small RNAs. Nat Rev Genet 10, 833-844.
Jambhekar, A., Dhall, A., and Shi, Y. (2019). Roles and regulation of histone methylation in animal 
development. Nat Rev Mol Cell Biol 20, 625-641.
Jensen, T.H., Jacquier, A., and Libri, D. (2013). Dealing with pervasive transcription. Mol Cell 52, 
473-484.
Joazeiro, C.A.P. (2019). Mechanisms and functions of ribosome-associated protein quality control. 
Nat Rev Mol Cell Biol 20, 368-383.
Jolma, A., Yin, Y., Nitta, K.R., Dave, K., Popov, A., Taipale, M., Enge, M., Kivioja, T., Morgunova, E., 
and Taipale, J. (2015). DNA-dependent formation of transcription factor pairs alters their binding 
specificity. Nature 527, 384-388.
Jones, M.J., Goodman, S.J., and Kobor, M.S. (2015). DNA methylation and healthy human aging. 
Aging Cell 14, 924-932.
Jonkers, I., Kwak, H., and Lis, J.T. (2014). Genome-wide dynamics of Pol II elongation and its 
interplay with promoter proximal pausing, chromatin, and exons. Elife 3, e02407.
Jonkers, I., and Lis, J.T. (2015). Getting up to speed with transcription elongation by RNA 
polymerase II. Nat Rev Mol Cell Biol 16, 167-177.
Kanu, N., Gronroos, E., Martinez, P., Burrell, R.A., Yi Goh, X., Bartkova, J., Maya-Mendoza, A., 
Mistrik, M., Rowan, A.J., Patel, H., et al. (2015). SETD2 loss-of-function promotes renal cancer 
branched evolution through replication stress and impaired DNA repair. Oncogene 34, 5699-5708.
Kaplan, C.D., Laprade, L., and Winston, F. (2003). Transcription elongation factors repress 
transcription initiation from cryptic sites. Science 301, 1096-1099.
Kar, G., Kim, J.K., Kolodziejczyk, A.A., Natarajan, K.N., Torlai Triglia, E., Mifsud, B., Elderkin, S., 
Marioni, J.C., Pombo, A., and Teichmann, S.A. (2017). Flipping between Polycomb repressed and 
active transcriptional states introduces noise in gene expression. Nat Commun 8, 36.
Karimi, M.M., Goyal, P., Maksakova, I.A., Bilenky, M., Leung, D., Tang, J.X., Shinkai, Y., Mager, 
D.L., Jones, S., Hirst, M., et al. (2011). DNA methylation and SETDB1/H3K9me3 regulate 
predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem 
Cell 8, 676-687.
Kim, T.W., Kang, B.H., Jang, H., Kwak, S., Shin, J., Kim, H., Lee, S.E., Lee, S.M., Lee, J.H., Kim, 
J.H., et al. (2015). Ctbp2 Modulates NuRD-Mediated Deacetylation of H3K27 and Facilitates 
 140
9. References
Dissertation by Christina Ambrosi 
PRC2-Mediated H3K27me3 in Active Embryonic Stem Cell Genes During Exit from Pluripotency. 
Stem Cells 33, 2442-2455.
Kizer, K.O., Phatnani, H.P., Shibata, Y., Hall, H., Greenleaf, A.L., and Strahl, B.D. (2005). A novel 
domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation 
with transcript elongation. Mol Cell Biol 25, 3305-3316.
Kolasinska-Zwierz, P., Down, T., Latorre, I., Liu, T., Liu, X.S., and Ahringer, J. (2009). Differential 
chromatin marking of introns and expressed exons by H3K36me3. Nat Genet 41, 376-381.
Kornberg, R.D., and Thomas, J.O. (1974). Chromatin structure; oligomers of the histones. Science 
184, 865-868.
Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705.
Krecic, A.M., and Swanson, M.S. (1999). hnRNP complexes: composition, structure, and function. 
Curr Opin Cell Biol 11, 363-371.
Krejci, L., Altmannova, V., Spirek, M., and Zhao, X. (2012). Homologous recombination and its 
regulation. Nucleic Acids Res 40, 5795-5818.
Krogan, N.J., Kim, M., Tong, A., Golshani, A., Cagney, G., Canadien, V., Richards, D.P., Beattie, 
B.K., Emili, A., Boone, C., et al. (2003). Methylation of histone H3 by Set2 in Saccharomyces 
cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol Cell Biol 23, 
4207-4218.
Kuleshov, M.V., Jones, M.R., Rouillard, A.D., Fernandez, N.F., Duan, Q., Wang, Z., Koplev, S., 
Jenkins, S.L., Jagodnik, K.M., Lachmann, A., et al. (2016). Enrichr: a comprehensive gene set 
enrichment analysis web server 2016 update. Nucleic Acids Res 44, W90-97.
Kumar, N., Singh, A., and Kulkarni, R.V. (2015). Transcriptional Bursting in Gene Expression: 
Analytical Results for General Stochastic Models. PLoS Comput Biol 11, e1004292.
Kuo, A.J., Cheung, P., Chen, K., Zee, B.M., Kioi, M., Lauring, J., Xi, Y., Park, B.H., Shi, X., Garcia, 
B.A., et al. (2011). NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. 
Mol Cell 44, 609-620.
Kurosaki, T., Popp, M.W., and Maquat, L.E. (2019). Quality and quantity control of gene expression 
by nonsense-mediated mRNA decay. Nat Rev Mol Cell Biol 20, 406-420.
Kustatscher, G., Wills, K.L., Furlan, C., and Rappsilber, J. (2014). Chromatin enrichment for 
proteomics. Nat Protoc 9, 2090-2099.
Kwak, H., Fuda, N.J., Core, L.J., and Lis, J.T. (2013). Precise maps of RNA polymerase reveal how 
promoters direct initiation and pausing. Science 339, 950-953.
La Manno, G., Soldatov, R., Zeisel, A., Braun, E., Hochgerner, H., Petukhov, V., Lidschreiber, K., 
Kastriti, M.E., Lonnerberg, P., Furlan, A., et al. (2018). RNA velocity of single cells. Nature 560, 
494-498.
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., and Jenuwein, T. (2001). Methylation of histone 
H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116-120.
Lawrence, M., Daujat, S., and Schneider, R. (2016). Lateral Thinking: How Histone Modifications 
Regulate Gene Expression. Trends Genet 32, 42-56.
 141
9. References
Dissertation by Christina Ambrosi 
Lawrence, M.S., Stojanov, P., Mermel, C.H., Robinson, J.T., Garraway, L.A., Golub, T.R., 
Meyerson, M., Gabriel, S.B., Lander, E.S., and Getz, G. (2014). Discovery and saturation analysis 
of cancer genes across 21 tumour types. Nature 505, 495-501.
Lee, C.H., Wu, J., and Li, B. (2013). Chromatin remodelers fine-tune H3K36me-directed 
deacetylation of neighbor nucleosomes by Rpd3S. Mol Cell 52, 255-263.
Lee, T.I., and Young, R.A. (2013). Transcriptional regulation and its misregulation in disease. Cell 
152, 1237-1251.
Lee, Y., and Rio, D.C. (2015). Mechanisms and Regulation of Alternative Pre-mRNA Splicing. Annu 
Rev Biochem 84, 291-323.
Lei, H., Oh, S.P., Okano, M., Juttermann, R., Goss, K.A., Jaenisch, R., and Li, E. (1996). De novo 
DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122, 
3195-3205.
Li, B., Howe, L., Anderson, S., Yates, J.R., 3rd, and Workman, J.L. (2003). The Set2 histone 
methyltransferase functions through the phosphorylated carboxyl-terminal domain of RNA 
polymerase II. J Biol Chem 278, 8897-8903.
Li, E. (2002). Chromatin modification and epigenetic reprogramming in mammalian development. 
Nat Rev Genet 3, 662-673.
Li, F., Mao, G., Tong, D., Huang, J., Gu, L., Yang, W., and Li, G.M. (2013). The histone mark 
H3K36me3 regulates human DNA mismatch repair through its interaction with MutSalpha. Cell 
153, 590-600.
Li, G.M. (2008). Mechanisms and functions of DNA mismatch repair. Cell Res 18, 85-98.
Liu, H., Jin, T., Guan, J., and Zhou, S. (2014). Histone modifications involved in cassette exon 
inclusions: a quantitative and interpretable analysis. BMC Genomics 15, 1148.
Liu, X., Gao, Q., Li, P., Zhao, Q., Zhang, J., Li, J., Koseki, H., and Wong, J. (2013). UHRF1 targets 
DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated 
H3K9. Nat Commun 4, 1563.
Ljungman, M., and Lane, D.P. (2004). Transcription - guarding the genome by sensing DNA 
damage. Nat Rev Cancer 4, 727-737.
Lord, C.J., and Ashworth, A. (2012). The DNA damage response and cancer therapy. Nature 481, 
287-294.
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion 
for RNA-seq data with DESeq2. Genome Biol 15, 550.
Luco, R.F., and Misteli, T. (2011). More than a splicing code: integrating the role of RNA, chromatin 
and non-coding RNA in alternative splicing regulation. Curr Opin Genet Dev 21, 366-372.
Luco, R.F., Pan, Q., Tominaga, K., Blencowe, B.J., Pereira-Smith, O.M., and Misteli, T. (2010). 
Regulation of alternative splicing by histone modifications. Science 327, 996-1000.
Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F., and Richmond, T.J. (1997). Crystal 
structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-260.
 142
9. References
Dissertation by Christina Ambrosi 
Luijsterburg, M.S., Acs, K., Ackermann, L., Wiegant, W.W., Bekker-Jensen, S., Larsen, D.H., 
Khanna, K.K., van Attikum, H., Mailand, N., and Dantuma, N.P. (2012). A new non-catalytic role for 
ubiquitin ligase RNF8 in unfolding higher-order chromatin structure. EMBO J 31, 2511-2527.
Lun, A.T., and Smyth, G.K. (2014). De novo detection of differentially bound regions for ChIP-seq 
data using peaks and windows: controlling error rates correctly. Nucleic Acids Res 42, e95.
Luo, W., and Bentley, D. (2004). A ribonucleolytic rat torpedoes RNA polymerase II. Cell 119, 
911-914.
Luo, W., Johnson, A.W., and Bentley, D.L. (2006). The role of Rat1 in coupling mRNA 3'-end 
processing to transcription termination: implications for a unified allosteric-torpedo model. Genes 
Dev 20, 954-965.
Luo, Z., Lin, C., Guest, E., Garrett, A.S., Mohaghegh, N., Swanson, S., Marshall, S., Florens, L., 
Washburn, M.P., and Shilatifard, A. (2012). The super elongation complex family of RNA 
polymerase II elongation factors: gene target specificity and transcriptional output. Mol Cell Biol 32, 
2608-2617.
Lutz, C.S. (2008). Alternative polyadenylation: a twist on mRNA 3' end formation. ACS Chem Biol 
3, 609-617.
Lynch, M.D., Smith, A.J., De Gobbi, M., Flenley, M., Hughes, J.R., Vernimmen, D., Ayyub, H., 
Sharpe, J.A., Sloane-Stanley, J.A., Sutherland, L., et al. (2012). An interspecies analysis reveals a 
key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment. EMBO J 
31, 317-329.
Mailand, N., Bekker-Jensen, S., Faustrup, H., Melander, F., Bartek, J., Lukas, C., and Lukas, J. 
(2007). RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of 
repair proteins. Cell 131, 887-900.
Malys, N., and McCarthy, J.E. (2011). Translation initiation: variations in the mechanism can be 
anticipated. Cell Mol Life Sci 68, 991-1003.
Manzo, M., Ambrosi, C., and Baubec, T. (2018). Genome-Wide Profiling of DNA 
Methyltransferases in Mammalian Cells. Methods Mol Biol 1766, 157-174.
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Kranz, A., 
Stewart, A.F., Smith, A., et al. (2012). The transcriptional and epigenomic foundations of ground 
state pluripotency. Cell 149, 590-604.
Martinez-Rucobo, F.W., and Cramer, P. (2013). Structural basis of transcription elongation. Biochim 
Biophys Acta 1829, 9-19.
Mason, P.B., and Struhl, K. (2003). The FACT complex travels with elongating RNA polymerase II 
and is important for the fidelity of transcriptional initiation in vivo. Mol Cell Biol 23, 8323-8333.
Mattiroli, F., D'Arcy, S., and Luger, K. (2015). The right place at the right time: chaperoning core 
histone variants. EMBO Rep 16, 1454-1466.
Matys, V., Kel-Margoulis, O.V., Fricke, E., Liebich, I., Land, S., Barre-Dirrie, A., Reuter, I., 
Chekmenev, D., Krull, M., Hornischer, K., et al. (2006). TRANSFAC and its module TRANSCompel: 
transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34, D108-110.
 143
9. References
Dissertation by Christina Ambrosi 
Maunakea, A.K., Nagarajan, R.P., Bilenky, M., Ballinger, T.J., D'Souza, C., Fouse, S.D., Johnson, 
B.E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010). Conserved role of intragenic DNA methylation in 
regulating alternative promoters. Nature 466, 253-257.
Maurano, M.T., Haugen, E., Sandstrom, R., Vierstra, J., Shafer, A., Kaul, R., and 
Stamatoyannopoulos, J.A. (2015). Large-scale identification of sequence variants influencing 
human transcription factor occupancy in vivo. Nat Genet 47, 1393-1401.
Maze, I., Wenderski, W., Noh, K.M., Bagot, R.C., Tzavaras, N., Purushothaman, I., Elsasser, S.J., 
Guo, Y., Ionete, C., Hurd, Y.L., et al. (2015). Critical Role of Histone Turnover in Neuronal 
Transcription and Plasticity. Neuron 87, 77-94.
McCarthy, D.J., Campbell, K.R., Lun, A.T., and Wills, Q.F. (2017). Scater: pre-processing, quality 
control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics 33, 
1179-1186.
McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S.D., 
Wickens, M., and Bentley, D.L. (1997). The C-terminal domain of RNA polymerase II couples 
mRNA processing to transcription. Nature 385, 357-361.
McDaniel, S.L., and Strahl, B.D. (2017). Shaping the cellular landscape with Set2/SETD2 
methylation. Cell Mol Life Sci.
McKittrick, E., Gafken, P.R., Ahmad, K., and Henikoff, S. (2004). Histone H3.3 is enriched in 
covalent modifications associated with active chromatin. Proc Natl Acad Sci U S A 101, 1525-1530.
Meers, M.P., Henriques, T., Lavender, C.A., McKay, D.J., Strahl, B.D., Duronio, R.J., Adelman, K., 
and Matera, A.G. (2017). Histone gene replacement reveals a post-transcriptional role for H3K36 in 
maintaining metazoan transcriptome fidelity. Elife 6.
Meinhart, A., and Cramer, P. (2004). Recognition of RNA polymerase II carboxy-terminal domain by 
3'-RNA-processing factors. Nature 430, 223-226.
Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., 
Brockman, W., Kim, T.K., Koche, R.P., et al. (2007). Genome-wide maps of chromatin state in 
pluripotent and lineage-committed cells. Nature 448, 553-560.
Millar, A.H., Heazlewood, J.L., Giglione, C., Holdsworth, M.J., Bachmair, A., and Schulze, W.X. 
(2019). The Scope, Functions, and Dynamics of Posttranslational Protein Modifications. Annu Rev 
Plant Biol 70, 119-151.
Mitchell, P.J., and Tjian, R. (1989). Transcriptional regulation in mammalian cells by sequence-
specific DNA binding proteins. Science 245, 371-378.
Mohandas, T., Sparkes, R.S., and Shapiro, L.J. (1981). Reactivation of an inactive human X 
chromosome: evidence for X inactivation by DNA methylation. Science 211, 393-396.
Mohn, F., Weber, M., Rebhan, M., Roloff, T.C., Richter, J., Stadler, M.B., Bibel, M., and Schubeler, 
D. (2008). Lineage-specific polycomb targets and de novo DNA methylation define restriction and 
potential of neuronal progenitors. Mol Cell 30, 755-766.
Moore, M.J., and Proudfoot, N.J. (2009). Pre-mRNA processing reaches back to transcription and 
ahead to translation. Cell 136, 688-700.
 144
9. References
Dissertation by Christina Ambrosi 
Morselli, M., Pastor, W.A., Montanini, B., Nee, K., Ferrari, R., Fu, K., Bonora, G., Rubbi, L., Clark, 
A.T., Ottonello, S., et al. (2015). In vivo targeting of de novo DNA methylation by histone 
modifications in yeast and mouse. Elife 4, e06205.
Muraro, M.J., Dharmadhikari, G., Grun, D., Groen, N., Dielen, T., Jansen, E., van Gurp, L., 
Engelse, M.A., Carlotti, F., de Koning, E.J., et al. (2016). A Single-Cell Transcriptome Atlas of the 
Human Pancreas. Cell Syst 3, 385-394 e383.
Musselman, C.A., Lalonde, M.E., Cote, J., and Kutateladze, T.G. (2012). Perceiving the epigenetic 
landscape through histone readers. Nat Struct Mol Biol 19, 1218-1227.
Nechaev, S., Fargo, D.C., dos Santos, G., Liu, L., Gao, Y., and Adelman, K. (2010). Global analysis 
of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila. 
Science 327, 335-338.
Neri, F., Rapelli, S., Krepelova, A., Incarnato, D., Parlato, C., Basile, G., Maldotti, M., Anselmi, F., 
and Oliviero, S. (2017). Intragenic DNA methylation prevents spurious transcription initiation. 
Nature 543, 72-77.
Ng, H.H., Robert, F., Young, R.A., and Struhl, K. (2003). Targeted recruitment of Set1 histone 
methylase by elongating Pol II provides a localized mark and memory of recent transcriptional 
activity. Mol Cell 11, 709-719.
Nicolas, D., Zoller, B., Suter, D.M., and Naef, F. (2018). Modulation of transcriptional burst 
frequency by histone acetylation. Proc Natl Acad Sci U S A 115, 7153-7158.
Nojima, T., Gomes, T., Grosso, A.R.F., Kimura, H., Dye, M.J., Dhir, S., Carmo-Fonseca, M., and 
Proudfoot, N.J. (2015). Mammalian NET-Seq Reveals Genome-wide Nascent Transcription 
Coupled to RNA Processing. Cell 161, 526-540.
Nudler, E. (2012). RNA polymerase backtracking in gene regulation and genome instability. Cell 
149, 1438-1445.
Okano, M., Bell, D.W., Haber, D.A., and Li, E. (1999). DNA methyltransferases Dnmt3a and 
Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257.
Orphanides, G., LeRoy, G., Chang, C.H., Luse, D.S., and Reinberg, D. (1998). FACT, a factor that 
facilitates transcript elongation through nucleosomes. Cell 92, 105-116.
Orsi, G.A., Couble, P., and Loppin, B. (2009). Epigenetic and replacement roles of histone variant 
H3.3 in reproduction and development. Int J Dev Biol 53, 231-243.
Osheim, Y.N., Proudfoot, N.J., and Beyer, A.L. (1999). EM visualization of transcription by RNA 
polymerase II: downstream termination requires a poly(A) signal but not transcript cleavage. Mol 
Cell 3, 379-387.
Papai, G., Frechard, A., Kolesnikova, O., Crucifix, C., Schultz, P., and Ben-Shem, A. (2020). 
Structure of SAGA and mechanism of TBP deposition on gene promoters. Nature 577, 711-716.
Park, I.Y., Powell, R.T., Tripathi, D.N., Dere, R., Ho, T.H., Blasius, T.L., Chiang, Y.-C., Davis, I.J., 
Fahey, C.C., Hacker, K.E., et al. (2016a). Dual Chromatin and Cytoskeletal Remodeling by SETD2. 
Cell 166, Pages 950–962.
 145
9. References
Dissertation by Christina Ambrosi 
Park, I.Y., Powell, R.T., Tripathi, D.N., Dere, R., Ho, T.H., Blasius, T.L., Chiang, Y.C., Davis, I.J., 
Fahey, C.C., Hacker, K.E., et al. (2016b). Dual Chromatin and Cytoskeletal Remodeling by SETD2. 
Cell 166, 950-962.
Pasini, D., Bracken, A.P., Jensen, M.R., Lazzerini Denchi, E., and Helin, K. (2004). Suz12 is 
essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 23, 
4061-4071.
Pasini, D., Malatesta, M., Jung, H.R., Walfridsson, J., Willer, A., Olsson, L., Skotte, J., Wutz, A., 
Porse, B., Jensen, O.N., et al. (2010). Characterization of an antagonistic switch between histone 
H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target 
genes. Nucleic Acids Res 38, 4958-4969.
Passarge, E. (1979). Emil Heitz and the concept of heterochromatin: longitudinal chromosome 
differentiation was recognized fifty years ago. Am J Hum Genet 31, 106-115.
Paull, T.T., Rogakou, E.P., Yamazaki, V., Kirchgessner, C.U., Gellert, M., and Bonner, W.M. (2000). 
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. 
Curr Biol 10, 886-895.
Peterlin, B.M., and Price, D.H. (2006). Controlling the elongation phase of transcription with P-
TEFb. Mol Cell 23, 297-305.
Pfister, S.X., Ahrabi, S., Zalmas, L.P., Sarkar, S., Aymard, F., Bachrati, C.Z., Helleday, T., Legube, 
G., La Thangue, N.B., Porter, A.C., et al. (2014). SETD2-dependent histone H3K36 trimethylation 
is required for homologous recombination repair and genome stability. Cell Rep 7, 2006-2018.
Phatnani, H.P., and Greenleaf, A.L. (2006). Phosphorylation and functions of the RNA polymerase 
II CTD. Genes Dev 20, 2922-2936.
Pillutla, R.C., Yue, Z., Maldonado, E., and Shatkin, A.J. (1998). Recombinant human mRNA cap 
methyltransferase binds capping enzyme/RNA polymerase IIo complexes. J Biol Chem 273, 
21443-21446.
Ping, X.L., Sun, B.F., Wang, L., Xiao, W., Yang, X., Wang, W.J., Adhikari, S., Shi, Y., Lv, Y., Chen, 
Y.S., et al. (2014). Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine 
methyltransferase. Cell Res 24, 177-189.
Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H., de la Cruz, C.C., 
Otte, A.P., Panning, B., and Zhang, Y. (2003). Role of histone H3 lysine 27 methylation in X 
inactivation. Science 300, 131-135.
Porrua, O., Boudvillain, M., and Libri, D. (2016). Transcription Termination: Variations on Common 
Themes. Trends Genet 32, 508-522.
Pradeepa, M.M., Sutherland, H.G., Ule, J., Grimes, G.R., and Bickmore, W.A. (2012). Psip1/Ledgf 
p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of 
alternative splicing. PLoS Genet 8, e1002717.
Ptashne, M., and Gann, A. (1997). Transcriptional activation by recruitment. Nature 386, 569-577.
Pu, M., Ni, Z., Wang, M., Wang, X., Wood, J.G., Helfand, S.L., Yu, H., and Lee, S.S. (2015). 
Trimethylation of Lys36 on H3 restricts gene expression change during aging and impacts life 
span. Genes Dev 29, 718-731.
 146
9. References
Dissertation by Christina Ambrosi 
Rae, M.M., and Franke, W.W. (1972). The interphase distribution of satellite DNA-containing 
heterochromatin in mouse nuclei. Chromosoma 39, 443-456.
Rainier, S., and Feinberg, A.P. (1994). Genomic imprinting, DNA methylation, and cancer. J Natl 
Cancer Inst 86, 753-759.
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B.D., Sun, Z.W., Schmid, M., Opravil, S., Mechtler, K., 
Ponting, C.P., Allis, C.D., et al. (2000). Regulation of chromatin structure by site-specific histone H3 
methyltransferases. Nature 406, 593-599.
Reddington, J.P., Perricone, S.M., Nestor, C.E., Reichmann, J., Youngson, N.A., Suzuki, M., 
Reinhardt, D., Dunican, D.S., Prendergast, J.G., Mjoseng, H., et al. (2013). Redistribution of 
H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes. 
Genome Biol 14, R25.
Reiter, F., Wienerroither, S., and Stark, A. (2017). Combinatorial function of transcription factors 
and cofactors. Curr Opin Genet Dev 43, 73-81.
Reynolds, N., Salmon-Divon, M., Dvinge, H., Hynes-Allen, A., Balasooriya, G., Leaford, D., 
Behrens, A., Bertone, P., and Hendrich, B. (2012). NuRD-mediated deacetylation of H3K27 
facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. EMBO J 31, 
593-605.
Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., and Smyth, G.K. (2015). limma 
powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids 
Res 43, e47.
Robinson, M.D., McCarthy, D.J., and Smyth, G.K. (2010). edgeR: a Bioconductor package for 
differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140.
Rondelet, G., Dal Maso, T., Willems, L., and Wouters, J. (2016). Structural basis for recognition of 
histone H3K36me3 nucleosome by human de novo DNA methyltransferases 3A and 3B. J Struct 
Biol 194, 357-367.
Rosenfeld, J., Capdevielle, J., Guillemot, J.C., and Ferrara, P. (1992). In-gel digestion of proteins 
for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 
203, 173-179.
Rosonina, E., Kaneko, S., and Manley, J.L. (2006). Terminating the transcript: breaking up is hard 
to do. Genes Dev 20, 1050-1056.
Roundtree, I.A., Evans, M.E., Pan, T., and He, C. (2017). Dynamic RNA Modifications in Gene 
Expression Regulation. Cell 169, 1187-1200.
Rowe, H.M., Jakobsson, J., Mesnard, D., Rougemont, J., Reynard, S., Aktas, T., Maillard, P.V., 
Layard-Liesching, H., Verp, S., Marquis, J., et al. (2010). KAP1 controls endogenous retroviruses 
in embryonic stem cells. Nature 463, 237-240.
Sakaue, M., Ohta, H., Kumaki, Y., Oda, M., Sakaide, Y., Matsuoka, C., Yamagiwa, A., Niwa, H., 
Wakayama, T., and Okano, M. (2010). DNA methylation is dispensable for the growth and survival 
of the extraembryonic lineages. Curr Biol 20, 1452-1457.
 147
9. References
Dissertation by Christina Ambrosi 
Santos-Rosa, H., Schneider, R., Bannister, A.J., Sherriff, J., Bernstein, B.E., Emre, N.C., Schreiber, 
S.L., Mellor, J., and Kouzarides, T. (2002). Active genes are tri-methylated at K4 of histone H3. 
Nature 419, 407-411.
Scharer, O.D. (2013). Nucleotide excision repair in eukaryotes. Cold Spring Harb Perspect Biol 5, 
a012609.
Schmitges, F.W., Prusty, A.B., Faty, M., Stutzer, A., Lingaraju, G.M., Aiwazian, J., Sack, R., Hess, 
D., Li, L., Zhou, S., et al. (2011). Histone methylation by PRC2 is inhibited by active chromatin 
marks. Mol Cell 42, 330-341.
Schuettengruber, B., Bourbon, H.M., Di Croce, L., and Cavalli, G. (2017). Genome Regulation by 
Polycomb and Trithorax: 70 Years and Counting. Cell 171, 34-57.
Schuller, A.P., and Green, R. (2018). Roadblocks and resolutions in eukaryotic translation. Nat Rev 
Mol Cell Biol 19, 526-541.
Schultz, D.C., Ayyanathan, K., Negorev, D., Maul, G.G., and Rauscher, F.J., 3rd (2002). SETDB1: 
a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-
mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16, 919-932.
Schwartzentruber, J., Korshunov, A., Liu, X.Y., Jones, D.T., Pfaff, E., Jacob, K., Sturm, D., 
Fontebasso, A.M., Quang, D.A., Tonjes, M., et al. (2012). Driver mutations in histone H3.3 and 
chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231.
Scialdone, A., Natarajan, K.N., Saraiva, L.R., Proserpio, V., Teichmann, S.A., Stegle, O., Marioni, 
J.C., and Buettner, F. (2015). Computational assignment of cell-cycle stage from single-cell 
transcriptome data. Methods 85, 54-61.
Sen, P., Dang, W., Donahue, G., Dai, J., Dorsey, J., Cao, X., Liu, W., Cao, K., Perry, R., Lee, J.Y., 
et al. (2015). H3K36 methylation promotes longevity by enhancing transcriptional fidelity. Genes 
Dev 29, 1362-1376.
Shandilya, J., and Roberts, S.G. (2012). The transcription cycle in eukaryotes: from productive 
initiation to RNA polymerase II recycling. Biochim Biophys Acta 1819, 391-400.
Shatkin, A.J. (1976). Capping of eucaryotic mRNAs. Cell 9, 645-653.
Sheridan, R.M., Fong, N., D'Alessandro, A., and Bentley, D.L. (2019). Widespread Backtracking by 
RNA Pol II Is a Major Effector of Gene Activation, 5' Pause Release, Termination, and Transcription 
Elongation Rate. Mol Cell 73, 107-118 e104.
Shiraki, T., Kondo, S., Katayama, S., Waki, K., Kasukawa, T., Kawaji, H., Kodzius, R., Watahiki, A., 
Nakamura, M., Arakawa, T., et al. (2003). Cap analysis gene expression for high-throughput 
analysis of transcriptional starting point and identification of promoter usage. Proc Natl Acad Sci U 
S A 100, 15776-15781.
Shukla, S., Kavak, E., Gregory, M., Imashimizu, M., Shutinoski, B., Kashlev, M., Oberdoerffer, P., 
Sandberg, R., and Oberdoerffer, S. (2011). CTCF-promoted RNA polymerase II pausing links DNA 
methylation to splicing. Nature 479, 74-79.
Sigurdsson, S., Dirac-Svejstrup, A.B., and Svejstrup, J.Q. (2010). Evidence that transcript cleavage 
is essential for RNA polymerase II transcription and cell viability. Mol Cell 38, 202-210.
 148
9. References
Dissertation by Christina Ambrosi 
Simon, J.A., and Kingston, R.E. (2009). Mechanisms of polycomb gene silencing: knowns and 
unknowns. Nat Rev Mol Cell Biol 10, 697-708.
Simon, J.M., Hacker, K.E., Singh, D., Brannon, A.R., Parker, J.S., Weiser, M., Ho, T.H., Kuan, P.F., 
Jonasch, E., Furey, T.S., et al. (2014). Variation in chromatin accessibility in human kidney cancer 
links H3K36 methyltransferase loss with widespread RNA processing defects. Genome Res 24, 
241-250.
Skucha, A., Ebner, J., Schmollerl, J., Roth, M., Eder, T., Cesar-Razquin, A., Stukalov, A., Vittori, S., 
Muhar, M., Lu, B., et al. (2018). MLL-fusion-driven leukemia requires SETD2 to safeguard genomic 
integrity. Nat Commun 9, 1983.
Sledz, P., and Jinek, M. (2016). Structural insights into the molecular mechanism of the m(6)A 
writer complex. Elife 5.
Sleeth, K.M., Sorensen, C.S., Issaeva, N., Dziegielewski, J., Bartek, J., and Helleday, T. (2007). 
RPA mediates recombination repair during replication stress and is displaced from DNA by 
checkpoint signalling in human cells. J Mol Biol 373, 38-47.
Slobodin, B., Han, R., Calderone, V., Vrielink, J., Loayza-Puch, F., Elkon, R., and Agami, R. (2017). 
Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine 
Methylation. Cell 169, 326-337 e312.
Smith, Z.D., and Meissner, A. (2013). DNA methylation: roles in mammalian development. Nat Rev 
Genet 14, 204-220.
Solomon, M.J., and Varshavsky, A. (1985). Formaldehyde-mediated DNA-protein crosslinking: a 
probe for in vivo chromatin structures. Proc Natl Acad Sci U S A 82, 6470-6474.
Sonenberg, N., and Hinnebusch, A.G. (2009). Regulation of translation initiation in eukaryotes: 
mechanisms and biological targets. Cell 136, 731-745.
Squazzo, S.L., Costa, P.J., Lindstrom, D.L., Kumer, K.E., Simic, R., Jennings, J.L., Link, A.J., 
Arndt, K.M., and Hartzog, G.A. (2002). The Paf1 complex physically and functionally associates 
with transcription elongation factors in vivo. EMBO J 21, 1764-1774.
Stewart, M. (2019). Polyadenylation and nuclear export of mRNAs. J Biol Chem 294, 2977-2987.
Strasser, K., Masuda, S., Mason, P., Pfannstiel, J., Oppizzi, M., Rodriguez-Navarro, S., Rondon, 
A.G., Aguilera, A., Struhl, K., Reed, R., et al. (2002). TREX is a conserved complex coupling 
transcription with messenger RNA export. Nature 417, 304-308.
Streubel, G., Watson, A., Jammula, S.G., Scelfo, A., Fitzpatrick, D.J., Oliviero, G., McCole, R., 
Conway, E., Glancy, E., Negri, G.L., et al. (2018). The H3K36me2 Methyltransferase Nsd1 
Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells. Mol 
Cell 70, 371-379 e375.
Struhl, K. (2007). Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat Struct 
Mol Biol 14, 103-105.




Dissertation by Christina Ambrosi 
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W.M., 3rd, Hao, Y., 
Stoeckius, M., Smibert, P., and Satija, R. (2019). Comprehensive Integration of Single-Cell Data. 
Cell 177, 1888-1902 e1821.
Stucki, M., Clapperton, J.A., Mohammad, D., Yaffe, M.B., Smerdon, S.J., and Jackson, S.P. (2005). 
MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-
strand breaks. Cell 123, 1213-1226.
Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.A., Jones, D.T., Konermann, C., Pfaff, E., 
Tonjes, M., Sill, M., Bender, S., et al. (2012). Hotspot mutations in H3F3A and IDH1 define distinct 
epigenetic and biological subgroups of glioblastoma. Cancer Cell 22, 425-437.
Sun, X.J., Wei, J., Wu, X.Y., Hu, M., Wang, L., Wang, H.H., Zhang, Q.H., Chen, S.J., Huang, Q.H., 
and Chen, Z. (2005). Identification and characterization of a novel human histone H3 lysine 36-
specific methyltransferase. J Biol Chem 280, 35261-35271.
Surova, O., and Zhivotovsky, B. (2013). Various modes of cell death induced by DNA damage. 
Oncogene 32, 3789-3797.
Suzuki, M.M., and Bird, A. (2008). DNA methylation landscapes: provocative insights from 
epigenomics. Nat Rev Genet 9, 465-476.
Szklarczyk, D., Gable, A.L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., 
Doncheva, N.T., Morris, J.H., Bork, P., et al. (2019). STRING v11: protein-protein association 
networks with increased coverage, supporting functional discovery in genome-wide experimental 
datasets. Nucleic Acids Res 47, D607-D613.
Tachibana, M., Sugimoto, K., Nozaki, M., Ueda, J., Ohta, T., Ohki, M., Fukuda, M., Takeda, N., 
Niida, H., Kato, H., et al. (2002). G9a histone methyltransferase plays a dominant role in 
euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 
16, 1779-1791.
Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Kodama, T., 
Hamakubo, T., and Shinkai, Y. (2005). Histone methyltransferases G9a and GLP form heteromeric 
complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19, 815-826.
Teissandier, A., and Bourc'his, D. (2017). Gene body DNA methylation conspires with H3K36me3 
to preclude aberrant transcription. EMBO J 36, 1471-1473.
Teloni, F., Michelena, J., Lezaja, A., Kilic, S., Ambrosi, C., Menon, S., Dobrovolna, J., Imhof, R., 
Janscak, P., Baubec, T., et al. (2019). Efficient Pre-mRNA Cleavage Prevents Replication-Stress-
Associated Genome Instability. Mol Cell 73, 670-683 e612.
Terzo, E.A., Lim, A.R., Chytil, A., Chiang, Y.C., Farmer, L., Gessner, K.H., Walker, C.L., Jansen, 
V.M., and Rathmell, W.K. (2019). SETD2 loss sensitizes cells to PI3Kbeta and AKT inhibition. 
Oncotarget 10, 647-659.
Teves, S.S., Weber, C.M., and Henikoff, S. (2014). Transcribing through the nucleosome. Trends 
Biochem Sci 39, 577-586.
Thattai, M., and van Oudenaarden, A. (2001). Intrinsic noise in gene regulatory networks. Proc Natl 
Acad Sci U S A 98, 8614-8619.
 150
9. References
Dissertation by Christina Ambrosi 
Thomas, P.D., Campbell, M.J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., 
Muruganujan, A., and Narechania, A. (2003). PANTHER: a library of protein families and 
subfamilies indexed by function. Genome Res 13, 2129-2141.
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and 
Jones, J.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 
1145-1147.
Tian, B., Yang, J., and Brasier, A.R. (2012). Two-step cross-linking for analysis of protein-chromatin 
interactions. Methods Mol Biol 809, 105-120.
Tiedemann, R.L., Hlady, R.A., Hanavan, P.D., Lake, D.F., Tibes, R., Lee, J.H., Choi, J.H., Ho, T.H., 
and Robertson, K.D. (2015). Dynamic reprogramming of DNA methylation in SETD2-deregulated 
renal cell carcinoma. Oncotarget.
Tiedemann, R.L., Hlady, R.A., Hanavan, P.D., Lake, D.F., Tibes, R., Lee, J.H., Choi, J.H., Ho, T.H., 
and Robertson, K.D. (2016). Dynamic reprogramming of DNA methylation in SETD2-deregulated 
renal cell carcinoma. Oncotarget 7, 1927-1946.
Tilgner, H., Nikolaou, C., Althammer, S., Sammeth, M., Beato, M., Valcarcel, J., and Guigo, R. 
(2009). Nucleosome positioning as a determinant of exon recognition. Nat Struct Mol Biol 16, 
996-1001.
Toledo, L.I., Altmeyer, M., Rask, M.B., Lukas, C., Larsen, D.H., Povlsen, L.K., Bekker-Jensen, S., 
Mailand, N., Bartek, J., and Lukas, J. (2013). ATR prohibits replication catastrophe by preventing 
global exhaustion of RPA. Cell 155, 1088-1103.
Trievel, R.C., Beach, B.M., Dirk, L.M., Houtz, R.L., and Hurley, J.H. (2002). Structure and catalytic 
mechanism of a SET domain protein methyltransferase. Cell 111, 91-103.
Tsai, K.L., Yu, X., Gopalan, S., Chao, T.C., Zhang, Y., Florens, L., Washburn, M.P., Murakami, K., 
Conaway, R.C., Conaway, J.W., et al. (2017). Mediator structure and rearrangements required for 
holoenzyme formation. Nature 544, 196-201.
Tsumura, A., Hayakawa, T., Kumaki, Y., Takebayashi, S., Sakaue, M., Matsuoka, C., Shimotohno, 
K., Ishikawa, F., Li, E., Ueda, H.R., et al. (2006). Maintenance of self-renewal ability of mouse 
embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. 
Genes Cells 11, 805-814.
Turinetto, V., and Giachino, C. (2015). Multiple facets of histone variant H2AX: a DNA double-
strand-break marker with several biological functions. Nucleic Acids Res 43, 2489-2498.
van Hoof, A., Frischmeyer, P.A., Dietz, H.C., and Parker, R. (2002). Exosome-mediated recognition 
and degradation of mRNAs lacking a termination codon. Science 295, 2262-2264.
van Nimwegen, E. (2003). Scaling laws in the functional content of genomes. Trends Genet 19, 
479-484.
Vaquerizas, J.M., Kummerfeld, S.K., Teichmann, S.A., and Luscombe, N.M. (2009). A census of 
human transcription factors: function, expression and evolution. Nat Rev Genet 10, 252-263.
Venkatesh, S., Smolle, M., Li, H., Gogol, M.M., Saint, M., Kumar, S., Natarajan, K., and Workman, 
J.L. (2012). Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed 
genes. Nature 489, 452-455.
 151
9. References
Dissertation by Christina Ambrosi 
Vermeulen, M., Eberl, H.C., Matarese, F., Marks, H., Denissov, S., Butter, F., Lee, K.K., Olsen, J.V., 
Hyman, A.A., Stunnenberg, H.G., et al. (2010). Quantitative interaction proteomics and genome-
wide profiling of epigenetic histone marks and their readers. Cell 142, 967-980.
Villasenor, R., Pfaendler, R., Ambrosi, C., Butz, S., Giuliani, S., Bryan, E., Sheahan, T.W., Gable, 
A.L., Schmolka, N., Manzo, M., et al. (2020). ChromID identifies the protein interactome at 
chromatin marks. Nat Biotechnol.
Viphakone, N., Sudbery, I., Griffith, L., Heath, C.G., Sims, D., and Wilson, S.A. (2019). Co-
transcriptional Loading of RNA Export Factors Shapes the Human Transcriptome. Mol Cell 75, 
310-323 e318.
Vo, N., and Goodman, R.H. (2001). CREB-binding protein and p300 in transcriptional regulation. J 
Biol Chem 276, 13505-13508.
Voigt, P., LeRoy, G., Drury, W.J., 3rd, Zee, B.M., Son, J., Beck, D.B., Young, N.L., Garcia, B.A., and 
Reinberg, D. (2012). Asymmetrically modified nucleosomes. Cell 151, 181-193.
Vos, S.M., Pollmann, D., Caizzi, L., Hofmann, K.B., Rombaut, P., Zimniak, T., Herzog, F., and 
Cramer, P. (2016). Architecture and RNA binding of the human negative elongation factor. Elife 5.
Waddington, C.H. (1957). The Strategy of the Genes; a Discussion of Some Aspects of Theoretical 
Biology (London: Allen & Unwin).
Wagner, E.J., and Carpenter, P.B. (2012). Understanding the language of Lys36 methylation at 
histone H3. Nat Rev Mol Cell Biol 13, 115-126.
Wahl, M.C., Will, C.L., and Luhrmann, R. (2009). The spliceosome: design principles of a dynamic 
RNP machine. Cell 136, 701-718.
Walsh, C.P., Chaillet, J.R., and Bestor, T.H. (1998). Transcription of IAP endogenous retroviruses is 
constrained by cytosine methylation. Nat Genet 20, 116-117.
Wang, W.Y., Pan, L., Su, S.C., Quinn, E.J., Sasaki, M., Jimenez, J.C., Mackenzie, I.R., Huang, 
E.J., and Tsai, L.H. (2013). Interaction of FUS and HDAC1 regulates DNA damage response and 
repair in neurons. Nat Neurosci 16, 1383-1391.
Wang, X., Lu, Z., Gomez, A., Hon, G.C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. 
(2014). N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505, 
117-120.
Wang, X., Zhao, B.S., Roundtree, I.A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., and 
He, C. (2015). N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell 161, 
1388-1399.
Weber, M., Davies, J.J., Wittig, D., Oakeley, E.J., Haase, M., Lam, W.L., and Schubeler, D. (2005). 
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in 
normal and transformed human cells. Nat Genet 37, 853-862.
Wei, X., Samarabandu, J., Devdhar, R.S., Siegel, A.J., Acharya, R., and Berezney, R. (1998). 




Dissertation by Christina Ambrosi 
Weinberger, L., Voichek, Y., Tirosh, I., Hornung, G., Amit, I., and Barkai, N. (2012). Expression 
noise and acetylation profiles distinguish HDAC functions. Mol Cell 47, 193-202.
Wells, S.E., Hillner, P.E., Vale, R.D., and Sachs, A.B. (1998). Circularization of mRNA by eukaryotic 
translation initiation factors. Mol Cell 2, 135-140.
Wen, H., Li, Y., Xi, Y., Jiang, S., Stratton, S., Peng, D., Tanaka, K., Ren, Y., Xia, Z., Wu, J., et al. 
(2014). ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression. 
Nature 508, 263-268.
Wen, Y., Yue, Z., and Shatkin, A.J. (1998). Mammalian capping enzyme binds RNA and uses 
protein tyrosine phosphatase mechanism. Proc Natl Acad Sci U S A 95, 12226-12231.
Williams, A.S., and Marzluff, W.F. (1995). The sequence of the stem and flanking sequences at the 
3' end of histone mRNA are critical determinants for the binding of the stem-loop binding protein. 
Nucleic Acids Res 23, 654-662.
Wirbelauer, C., Bell, O., and Schubeler, D. (2005). Variant histone H3.3 is deposited at sites of 
nucleosomal displacement throughout transcribed genes while active histone modifications show a 
promoter-proximal bias. Genes Dev 19, 1761-1766.
Wong, K.H., Jin, Y., and Struhl, K. (2014). TFIIH phosphorylation of the Pol II CTD stimulates 
mediator dissociation from the preinitiation complex and promoter escape. Mol Cell 54, 601-612.
Wood, A., and Shilatifard, A. (2004). Posttranslational modifications of histones by methylation. Adv 
Protein Chem 67, 201-222.
Wright, W.D., Shah, S.S., and Heyer, W.D. (2018). Homologous recombination and the repair of 
DNA double-strand breaks. J Biol Chem 293, 10524-10535.
Wu, C.H., Yamaguchi, Y., Benjamin, L.R., Horvat-Gordon, M., Washinsky, J., Enerly, E., Larsson, 
J., Lambertsson, A., Handa, H., and Gilmour, D. (2003). NELF and DSIF cause promoter proximal 
pausing on the hsp70 promoter in Drosophila. Genes Dev 17, 1402-1414.
Xiao, W., Adhikari, S., Dahal, U., Chen, Y.S., Hao, Y.J., Sun, B.F., Sun, H.Y., Li, A., Ping, X.L., Lai, 
W.Y., et al. (2016). Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. Mol Cell 61, 
507-519.
Xie, L., Pelz, C., Wang, W., Bashar, A., Varlamova, O., Shadle, S., and Impey, S. (2011). KDM5B 
regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription. EMBO J 
30, 1473-1484.
Xu, Q., Xiang, Y., Wang, Q., Wang, L., Brind'Amour, J., Bogutz, A.B., Zhang, Y., Zhang, B., Yu, G., 
Xia, W., et al. (2019). SETD2 regulates the maternal epigenome, genomic imprinting and 
embryonic development. Nat Genet 51, 844-856.
Yamada, T., Yamaguchi, Y., Inukai, N., Okamoto, S., Mura, T., and Handa, H. (2006). P-TEFb-
mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription 
elongation. Mol Cell 21, 227-237.
Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., and Smith, 
A. (2008). The ground state of embryonic stem cell self-renewal. Nature 453, 519-523.
Young, R.A. (1991). RNA polymerase II. Annu Rev Biochem 60, 689-715.
 153
9. References
Dissertation by Christina Ambrosi 
Yuan, W., Xu, M., Huang, C., Liu, N., Chen, S., and Zhu, B. (2011). H3K36 methylation 
antagonizes PRC2-mediated H3K27 methylation. J Biol Chem 286, 7983-7989.
Yue, F., Cheng, Y., Breschi, A., Vierstra, J., Wu, W., Ryba, T., Sandstrom, R., Ma, Z., Davis, C., 
Pope, B.D., et al. (2014). A comparative encyclopedia of DNA elements in the mouse genome. 
Nature 515, 355-364.
Zemach, A., McDaniel, I.E., Silva, P., and Zilberman, D. (2010). Genome-wide evolutionary 
analysis of eukaryotic DNA methylation. Science 328, 916-919.
Zeman, M.K., and Cimprich, K.A. (2014). Causes and consequences of replication stress. Nat Cell 
Biol 16, 2-9.
Zhang, H., Rigo, F., and Martinson, H.G. (2015a). Poly(A) Signal-Dependent Transcription 
Termination Occurs through a Conformational Change Mechanism that Does Not Require 
Cleavage at the Poly(A) Site. Mol Cell 59, 437-448.
Zhang, T., Cooper, S., and Brockdorff, N. (2015b). The interplay of histone modifications - writers 
that read. EMBO Rep 16, 1467-1481.
Zhang, Y., Xie, S., Zhou, Y., Xie, Y., Liu, P., Sun, M., Xiao, H., Jin, Y., Sun, X., Chen, Z., et al. 
(2014). H3K36 histone methyltransferase Setd2 is required for murine embryonic stem cell 
differentiation toward endoderm. Cell Rep 8, 1989-2002.
Zhao, B.S., Roundtree, I.A., and He, C. (2017). Post-transcriptional gene regulation by mRNA 
modifications. Nat Rev Mol Cell Biol 18, 31-42.
Zhou, K.I., Shi, H., Lyu, R., Wylder, A.C., Matuszek, Z., Pan, J.N., He, C., Parisien, M., and Pan, T. 
(2019). Regulation of Co-transcriptional Pre-mRNA Splicing by m(6)A through the Low-Complexity 
Protein hnRNPG. Mol Cell 76, 70-81 e79.
Zhu, K., Lei, P.J., Ju, L.G., Wang, X., Huang, K., Yang, B., Shao, C., Zhu, Y., Wei, G., Fu, X.D., et 
al. (2017). SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled 
alternative splicing. Nucleic Acids Res 45, 92-105.
 154
 10. Curriculum Vitae





2018    Funding by Forschungskredit Candoc, University of Zurich 






Schwamendingenstrasse 54, CH-8050 Zurich
+41 76 332 0407
christina.ambrosi@uzh.ch
NATIONALITY 





SINCE 11/2015  
 
Molecular Life Science PhD Program, Zurich 
University of Zurich, Switzerland 
PhD Thesis: “Exploring the Functional Role of SETD2/H3K36me3 during 
Cellular Differentiation”
10/2013 - 09/2015 Master of Science, Molecular Medicine
Charité Universitätsmedizin Berlin, Germany 
Master Thesis: “Modification of the SOX9 locus in murine embryonic stem 
cells by the CRISPR/Cas9” 
10/2010 - 09/2013 Bachelor of Science, Biology 
Free University Berlin, Germany 
Bachelor Thesis: “Funktionelle Charakterisierung einer β-Catenin-Mutante 
im Rahmen des Androgenrezeptorsignalwegs” 
 155
 10. Curriculum Vitae
Dissertation by Christina Ambrosi 
Languages 
German   mother tongue 
English  level C2 
French   level A1




• ChromID identifies the protein interactome at chromatin marks; Villaseñor R, Pfaendler R, 
Ambrosi C, Butz S, Giuliani S, Bryan E, Sheahan TW, Gable AL, Schmolka N, Manzo M, Wirz 
J, Feller C, von Mering C, Aebersold R, Voigt P and Baubec T; Nature Biotechnology, 2020 
• Efficient pre-mRNA cleavage prevents replication stress-associated genome instability; 
Teloni F, Michelena J, Lezaja A, Kilic S, Ambrosi C, Menon S, Dobrovolna J, Imhof R, 
Janscak P, Baubec T, and Altmeyer M; Molecular Cell, 2019 
• Genome-wide profiling of DNA methyltransferases in mammalian cells (Method); Manzo M, 
Ambrosi C and Baubec T; Springer Methods in Molecular Biology, 2018 
• Isoform-specific localization of DNMT3A regulates DNA methylation fidelity at bivalent CpG 
islands; Manzo M, Wirz J, Ambrosi C, Villaseñor R, Roschitzki B & Baubec T; The EMBO 
Journal, 2017 
• Dynamics and Context-Dependent Roles of DNA Methylation (Review); Ambrosi C, Manzo 
M and Baubec T; Journal of Molecular Biology, 2017
